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General introduction, aim and outline of this thesis
Every year more than 35,000 patients with traumatic brain injury (TBI) are admitted 
to emergency departments (ED) in the Netherlands. TBI incidence world-wide is 
estimated at more than 200/ 100,000, making TBI one of the most frequent 
neurological disorders (Box I). TBI represents a heterogeneous patient population of all 
ages, from infants to the elderly, with large variability in injury severity, pathophysiol-
ogy, (long term) outcome and post-traumatic sequelae. TBI is the leading cause of 
death and disability among children and young adults in the Western world and 
incidence numbers in the aged are rising. In a report on neurological disorders the 
World Health Organization (WHO) concludes that there is a silent and neglected 
epidemic of TBI, even more prominent in developing countries, with devastating 
consequences.1 TBI, especially the more severe cases, often results in reduced quality of 
life and vast socioeconomic costs, in turn leading to a high impact on the individual 
and society. For patients suffering from TBI and their next-of-kin adequate information 
on recovery and eventual outcome is highly relevant. Also, in clinical practice accurate 
estimation of the patient’s prognosis after TBI is necessary for different treatment 
decisions. The studies presented in this thesis deal with this aspect of TBI: Prognosis 
and more specifically outcome prediction. They are designed to contribute to the 
further improvement of prognostic models in TBI. This chapter presents introductory 
information on TBI, the current state of outcome prediction in TBI and provides the 
outline of this thesis.  
Box I  How common is common? – On incidence, prevalence and costs
In the United States of America the incidence of TBI’s leading to ED visits, 
 hospitalization or death has been approximated at 538/ 100,000.2 Of course, 
this incidence is an estimate and it does not take into account the people with 
a head injury, and possible mild TBI that were treated by their family physician 
or not seeking medical treatment at all. In most studies on TBI incidence figures 
are mainly based on the number of hospital admissions and patients that died. 
Therefore incidence figures presented in literature are almost certainly an under-
estimation of true TBI incidence. In 2007 the TBI-related mortality rate was 17.8/ 
100,000, resulting in more than 54,000 deaths from TBI in the United States.3 
 In Europe an aggregate TBI incidence, based on studies of hospitalized and 
fatal TBI’s published during the preceding twenty years, was estimated at 235/ 
100,000; the estimated TBI mortality was 15/ 100,000.4 More specific, the world- 
wide incidence of hospital managed mild TBI has been estimated to be 100-300/ 
100,000.5 The authors suggested a true TBI incidence above 600/ 100,000.
 A recent review looked at the incidences of several neurological diseases.6 
The incidence of TBI, in this review a combined incidence of fatal and hospitalized 
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1.1 TBI: Basic principles
Mechanism and pathophysiological processes
TBI results from a sudden external mechanical force acting upon head and brain.12 The 
force’s impact and the sequential energy transfer cause injury to the skull, brain and 
adherent tissues. In addition to direct blunt contact effects with (focal) skull and brain 
deformation, acceleration, deceleration and/ or rotational forces result in displacement 
of the brain within the skull, contributing to further brain tissue damage.12 Although 
partly arbitrary, a distinction is made between focal and diffuse TBI. Focal brain 
damage is produced when cerebral tissue is compressed underneath the cranium at 
the side of impact (coup) and/ or when tissue oppositely to the impact is injured 
(contre-coup).13 The location and severity of impact to the head ultimately determine 
the cerebral pathology and neurological deficits. Focal injury causes subdural and 
epidural hematomas, intraparenchymal hematomas and (hemorrhagic) contusions 
(Figure 1). Traumatic subarachnoid hemorrhage can be a result of focal damage but is 
often also seen in more diffuse cerebral (vascular) injury (Figure 1E). 
TBI patients among all age groups, was calculated at 91 to 105/ 100,000 and proved 
to be high compared to the incidence of for instance multiple sclerosis (4.2/ 
100,000) and amyotrophic lateral sclerosis (1.6/ 100,000). Compared to stroke 
(all ages: 183/ 100,000; >65 years: 1,093/ 100,000) TBI occurred less frequent. 
 In the Netherlands, an epidemiological study from 1997 executed in the 
greater Maastricht area, reported the incidence of head injury, based on patients 
presented at the ED, to be 837/ 100,000. TBI incidence was estimated at 213/ 
100,000 and hospital admittance for TBI at 88/ 100,000.7 Based on these figures 
yearly 35,358 TBI patients visit the EDs in the Netherlands nation-wide (population 
2010: 16.6 million). Within the general physician’s practice (Dutch huisarts) the 
incidence of head injury and TBI surpasses 200/ 100,000.8
Prevalence and costs
Only limited information on the prevalence of TBI associated morbidity is at 
hand.6 The U.S. Centers for Disease Control and Prevention (CDC) has estimated 
that nearly 2% of the entire US population has TBI related disabilities.9 Additionally 
to the substantial incidence and prevalence, average costs are estimated high as 
well.10 In the Netherlands the direct medical costs, hospitalization, outpatient 
care and rehabilitation for TBI alone are estimated at 72 million euros each year.11 
Indirect costs, amongst others loss of productivity, are not known but considering 
the fact that TBI is most common in young adults these are probably significant.
13
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General introduction, aim and outline of this thesis
Diffuse brain injury encompasses widely distributed damage to axons, diffuse 
vascular injury, hypoxic-ischemic injury and brain swelling (edema). The main injury 
mechanism responsible for diffuse injury is rapid acceleration-deceleration of the 
head as seen, for example, in high-speed motor-vehicle accidents.14,15 Brain structures 
are heterogeneous both in terms of degree of fixation to other parts of the brain 
and skull(base) and in terms of tissue consistency. As a result, during movement of 
the head, certain segments of the brain move at a slower rate than others, causing 
shear, tensile and compressive forces within the brain tissue.16 Axonal injury is the 
Figure 1  Focal and diffuse traumatic brain injury
Examples of focal and diffuse TBI on head CT. Clinically all patients were diagnosed with a severe TBI based 
on a GCS score of 8 or lower. Focal injury: (A) Left frontal hemorrhagic contusion with midline shift to the 
right and compression of the lateral ventricles. (B) Right frontal epidural hematoma with midline shift to 
the left and compression of the anterior horn of the lateral ventricle. (C) Right frontotemporoparietal 
subdural hematoma with a midline shift to the left. Diffuse injury: (D) Punctate or petechial hemorrhage 
within the right posterior limb of the internal capsule, a sign of DAI. (E) Diffuse subarachnoid hemorrhage. 
(F) Diffuse cerebral swelling with bilateral compression of the basal cisterns.
A
D
B
E
C
F
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most common consequence of diffuse TBI. It was first described in 1956 by the 
pathologist Strich as a devastating clinicopathological syndrome with extensive 
damage to the white matter.17 Later the term ‘Diffuse Axonal Injury’ (DAI), was 
suggested by Adams and colleagues, referring to prolonged coma (more than 6 
hours) and widespread injuries to white matter regions.18 DAI can be pathoana-
tomically graded into three stages of increasing severity based on the depth of the 
lesions: Grade 1 represents a pattern of lesions confined to the lobar white matter at the 
grey-and-white matter interface, grade 2 reveals additional lesions to the corpus 
callosum and grade 3 further depicts lesions to the rostral lateral-dorsal brainstem 
(Figure 2).18, 19 
During normal head movement, strain deformation manifested among axons is not 
harmful: Due to their visco-elastic nature, axons return to their normal shape and 
structure.20 However, under more extreme circumstances the threshold of maximum 
elasticity is exceeded, resulting in changes in the axonal integrity.21 Both the degree 
of the force applied to the axon and the length of time over which the force is applied 
influence the magnitude of axonal damage.22, 23 An essential factor in the 
development of shear strain is the direction of the head movement: Lateral head 
movement (Figure 4A) is associated with more severe diffuse damage than sagittal 
head movement.14 Furthermore, recent studies indicate that head contact has an 
important additive effect on the development of shear strain levels.24, 25 It should be 
noted that focal and diffuse injuries may both occur and interact within a single 
Figure 2  Diffuse traumatic brain injury
DAI on MRI: Susceptibility weighted images (SWI) of one patient with severe TBI (GCS < 8) revealing 
punctate hemorrhages (hypo-intense foci) within (A) the right frontal hemisphere, (B) right splenium of 
the corpus callosum, and (C) mesencephalon, corresponding to grade 3 DAI.
A B C
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individual, as was demonstrated in a recent MRI study.26 Both focal and diffuse TBI 
trigger extensive and complex pathophysiological processes at molecular and 
cellular level (Figure 3 for focal injury and Figure 4 for diffuse injury).
Figure 3   Simplified pathophysiological molecular and cellular processes  
after focal TBI
Increases in extracellular glutamate result in a supraphysiological Ca2+-influx that, subsequently, initiates 
several in parallel operating intracellular cascades (four are shown). Left upper corner: Increased activity of 
the calcium-dependent enzymes nNOS and eNOS enhances nitric oxide production leading to lipid 
peroxidation and eventually cellular necrosis. Left middle part: Calpain (a cystein protease) activity is also 
augmented due to an intracellular calcium increase, ultimately resulting in cellular necrosis pathways. 
Lysosomal membrane rupture and cathepsin release play an important role in this process. Right upper 
corner: Increases in intracellular calcium causing mitochondrial calcium overload result in increased 
mitochondrial membrane permeability. As a result ROS causing oxidative stress and the protein 
cytochrome-c are released into the cytoplasm. Cytochrome-c binds to the apoptosis activating protein-1 
(apaf-1) activating the apoptotis inducing caspase pathway.
Glu: Glutamate; [Glu]e: extracellular glutamate concentration; NMDA: N-methyl-D-aspartate aspartic acid; 
E.R.: endoplasmatic reticulum; [Ca2+]i: intracellular Ca2+-concentration; nNOS: neuronal NOS; eNOS: 
endothelial NOS; MPT: membrane permeability transition; ATP: adenosine triphosphate; ADP: adenosine 
diphosphate; ROS: reactive oxygen species; apaf-1: apoptosis activating protein-1; •O2: oxygen radical.
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Figure 4   Mechanical and pathophysiological mechanisms of traumatic  
axonal injury (TAI)
Sudden lateral acceleration-deceleration of the head (A) is the main injury mechanism causing TAI. (B) And 
(C) are schematic representations of the brain during rest and movement, respectively. Deformation of the 
brain during sudden head movement causes shear, tensile and compressive strains within the brain tissue. 
Predilection sites of axonal injury are the grey and white matter interface, the corpus callosum and the 
brain stem (C). Sufficiently high strains, as occur, for example in motor vehicle accidents, cause a cascade 
of pathological changes within the axon that may finally lead to axonal disconnection (D). It is suggested 
that two different processes of axonal injury exist.27 The first is characterized by altered focal axolemma 
permeability (D1.I) whereby ionic homeostasis leads to local Ca2+-influx and mitochondrial swelling. Both 
local calcium dysregulation and release of cytochrome-c from damaged mitochondria result in activation 
of cysteine proteases and breakdown of essential axonal cytoskeleton products including loss of 
microtubules, neurofilament side-arm cleavage and neurofilament compaction, impeding normal axonal 
transport. In contrast to previous suggestions there is no termination of axonal transport or axonal 
swelling. Rather, it is suggested that there is a conversion of anterograde into retrograde axonal transport 
that prevents the axon from swelling. The second type of axonal injury (D1.II) is characterized by a 
combination of local axonal swelling and altered axonal transport but no overtly altered axolemma 
permeability. It is suggested that with this injury type there may be subtle alterations of membrane 
permeability triggering the activation of calcineurin. Calcineurin in turn alters the microtubular network, 
causing a disruption in axonal transport, with accumulation of organelles and swelling. After axonal 
disconnection, which may occur after both injury types, the axon undergoes a process of degeneration 
(D2) consisting of a breakdown of the myelin sheath and the axon cylinder. The target site has now lost its 
input from the disconnected axon (D3) and may undergo synaptic reorganization, for example through 
axonal sprouting of neighboring intact fibers. This process of synaptic reorganization may be adaptive or 
maladaptive.
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Main causes of non-penetrating head injury are road traffic related (in more than 
half of all cases and predominantly represented in the younger population): motor 
vehicle accidents, injuries of cyclists and pedestrians, followed by falls (especially 
the elderly are at a higher risk), assaults and head injuries related to sports.4, 5, 28-36 
Also, a penetrating object, like a bullet, or blast waves from explosions37 can cause 
extensive cerebral damage.
Injury classification 
For almost four decades the Glasgow Coma Scale (GCS) score (Table 1 and the figure 
on page 6 of this thesis), which measures the level of consciousness of the patient, 
has been the primary clinical variable to grade initial brain injury severity in mild 
(GCS 13-15), moderate (GCS 9-12) or severe (GCS 3-8).38-40 In terms of survival (Figure 5)41 
and functional outcome the GCS score, especially the GCS motor score, assessed in 
Table 1   Glasgow Coma Scale (GCS) score according to Teasdale38, 45
GCS category GCS score Description Remarks
Eye opening 4 Spontaneous
3 To speech
2 To pain
1 None
Best verbal 
response †
5 Orientated
4 Confused conversation Disorientation
3 Inappropriate speech Use of recognizable words
2 Incomprehensible speech Use of sounds (moaning)
1 None
Best motor 
response
6 Obeying commands Best upper extremity 
response is recorded 
5 Localizing painful stimuli
4 Normal flexor response to 
painful stimuli
Rapid withdrawal
3 Abnormal flexor response  
to painful stimuli
2 Extensor posturing
1 No response
Total GCS score 3-15
† In case of oropharyngeal intubation: the verbal response is scored as 1 or t (=tube)
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the early phase post-injury, remains one of the strongest predictors,41-43 although the 
association of the GCS score with outcome has shown to decrease with intensified 
pre-hospital treatment.44
From the GCS, however, the underlying intracranial pathology cannot be inferred 
and different structural abnormalities may result in a similar clinical picture (Figure 
1). Traditionally, the duration of the period of loss of consciousness (LOC) and 
post-traumatic amnesia (PTA) duration is also used to differentiate injury severities 
especially within the mild and moderate TBI patients.46-48 Furthermore, to 
discriminate mild TBI from mere head injury and to estimate intracranial pathology 
additional criteria have been formulated as described in Box II. More than 80% of 
Figure 5   From the CRASH study: Relation between Glasgow coma scale score 
and mortality at 14 days41
Reproduced from: Predicting outcome after traumatic brain injury: practical prognostic models based on 
large cohort of international patients. MRC CRASH Trial Collaborators, Perel P, Arango M, Clayton T, Edwards 
P, Komolafe E, Poccock S, Roberts I, Shakur H, Steyerberg E and Yutthakasemsunt S. BMJ. 2008, 336(7641): 
425-429,41 with permission from BMJ Publishing Group Ltd, © 2008.
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the patients admitted to the ED is classified as mild, 10% as moderate and the 
remaining 10% as severe TBI.4
Also, the more pathophysiological features of TBI such as the distribution of the 
structural damage (focal or diffuse [Figure 1 and Figure 2]) as described above and 
the moment of onset (primary or secondary) are applied to classify the injury.49-51 
Primary injury consists of the initial damage directly resulting from the mechanical 
forces affecting the cerebral tissues. Secondary injury refers to the cascade of 
cellular and molecular processes initiated by the primary injury. In addition, it 
consists of the cerebral damage due to secondary insults like hypoglycaemia, 
hypotensive or hypoxic events, raised intracranial pressure and cerebral ischemia. 
Box II  How to define TBI severity?
Presently, TBI severity is categorized in mild (GCS 13-15), moderate (GCS 9-12) and 
severe (GCS <8) based on the GCS score.40, 52-54 Unfortunately, the moment of GCS 
assessment after the head injury that is used for the severity diagnosis is anything 
but unambiguous. This might influence the inclusion of patients in studies, and 
the results and comparability of TBI research, but also diagnosis in daily clinical 
practice. In our studies we used the GCS score after initial (surgical) assessment 
and resuscitation at the ED for TBI severity classification. Other studies and 
management guidelines have based their grading on the GCS score at presentation 
on the ED, at the scene of the accident, the highest GCS within a period of eight 
to 24 hours post-trauma, or on coma or PTA duration.29, 46, 55, 56
 Additionally, to distinguish mere head injury from MTBI several criteria have 
been developed. The MTBI Committee of the Head Injury Interdisciplinary Special 
Interest Group of the American Congress of Rehabilitation Medicine states that 
MTBI is manifested by at least one of the following: loss of consciousness (LOC), 
memory loss or post-traumatic amnesia (PTA), alteration in mental state or focal 
neurological deficit in case of traumatic head injury.47, 48 Nevertheless, traumatic 
parenchymal abnormalities detected with head CT, in studies with patients 
meeting the alleged ‘risk factors’ as have been formulated for example in the 
European Federation of Neurological Societies (EFNS) MTBI guidelines.46 The 
absence of LOC and PTA in head injured patients does not rule out MTBI.46, 57, 58 
Furthermore, injury severity classification according to GCS, LOC and/ or PTA has 
no direct relation to the intracranial traumatic pathology as can be detected for 
instance with head CT or MRI.
20
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Imaging TBI
Visualization of the full extent of damage after TBI is complex. During the acute 
phase work-up, e.g. at the ED or during observation at the intensive care, head 
computed tomography (CT) is still considered the gold standard to detect cranial 
and intracranial abnormalities related to head injury.59, 60 Not only is CT fast and easy 
to obtain, it is also favored due to its high sensitivity for (focal) injuries and as such 
gives vital information about the necessity of (neurosurgical) intervention (Figure 1 
and Box III). In addition, early CT characteristics correlate with outcome after TBI. 
One of the most important pioneering studies on this subject is the Traumatic Coma 
Data Bank (TCDB) study61 which resulted in the development of the TCDB CT 
classification also known as the ‘Marshall-classification’ (Table 2).62 This classification 
is used to categorize moderate and severe TBI patients based on the CT findings: It 
primarily discriminates between diffuse injury and injury with focal mass lesions 
with a volume larger than 25 ml. There is a strong association between outcome and 
the initial CT scan diagnosis according to the TCDB CT classification.62
Box III  Cranial computed tomography (CT): Why (not), when and how?
CT scanning of the head plays an essential role in the diagnosis and treatment of 
mild, moderate and severe TBI. In the acute phase of TBI, CT is the radiological 
tool of choice to identify intracranial abnormalities, especially potential life-
threatening abnormalities, like hematomas and contusions which may require 
immediate neurosurgical intervention and/ or extensive monitoring at an 
intensive care unit (ICU). All patients with moderate and severe TBI should 
undergo a head CT during their initial management.63-65
 In mild TBI there is no absolute agreement on the criteria when to perform a 
CT. Four major guidelines have been published in the last decade: The New 
Orleans Criteria for CT Scanning,66 the Canadian CT Head Rule,67 the European 
Federation of Neurological Societies’ (EFNS) guideline46 and most recently the 
CHIP (CT in Head Injury Patients study) Prediction Rule.68 Although these 
guidelines were able to identify all patients which eventually underwent 
neurosurgical intervention, sensitivity for the detection of traumatic neurocranial 
findings, of which the clinical importance remains unclear, varied between 76 to 
99% depending on the definitions used.69, 70 It has been demonstrated that the 
EFNS guidelines are 100% sensitive for detecting traumatic neurocranial 
abnormalities.68, 71 However, higher sensitivities were associated with relatively 
low specificities which would result in the scanning of many patients with head 
injury and mild TBI but without CT abnormalities.71 The RUNMC hospital protocol 
on MTBI, applied in the studies constituting this thesis, is for the greatest part 
21
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In the subacute and chronic phase of TBI, Magnetic Resonance Imaging (MRI) 
techniques like T2-weighted imaging or Fluid Attenuated Inversion Recovery (FLAIR) 
are preferred, because of their superior detection of lesions such as non-hemorrhagic 
contusions and edema.76, 77 Because of its microscopic nature, DAI is commonly 
equivalent to the original national Dutch MTBI guidelines72 and consistent with 
the European EFNS guideline.46
 For several reasons one has been looking for guidelines to scan as less mild 
TBI patients as possible. First of all, CT delivers a radiation dose to the TBI patient. 
Radiation exposure may lead to radiation side effects and possible development 
of cancer. An estimated 1 in 8,100 women and 1 in 11,080 men will eventually 
develop cancer from a head CT scan.73 Furthermore, the CT scan may demonstrate 
occasional findings, for instance a meningeoma, with no direct consequences or 
treatment options, leading to uncertainty for the patient. Also, from a more 
economical point of view and considering the rise in health care costs, a more 
strict CT protocol may result in financial savings.74 On the other hand, CT might be 
financially more attractive: A TBI patient with no traumatic abnormalities on 
cranial CT can be discharged and a more expensive admission for clinical observation 
is avoided.75 
Table 2   Traumatic Coma Databank (TCDB) CT classification according to 
Marshall62
Category Definition
Diffuse injury I (no visible 
pathology)
No visible intracranial pathology seen on CT scan
Diffuse injury II Cisterns are present with midline shift 0-5 mm and/ or:
lesion densities present
no high- or mixed-density lesion > 25 ml
may include bone fragments and foreign bodies
Diffuse injury III (swelling) Cisterns compressed or absent with midline shift 0-5 mm; no 
high- or mixed-density lesion > 25 ml
Diffuse injury IV (shift) Midline shift > 5 mm, no high- or mixed-density lesion > 25 ml
Evacuated mass lesion Any lesion surgically evacuated
Non-evacuated mass lesion High- or mixed-density lesion > 25 ml, not surgically 
evacuated
CT, computed tomography
22
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undetected with conventional neuroimaging techniques like CT or MRI. Due to 
simultaneous shear injury affecting neighboring microvascular structures, DAI is 
frequently accompanied by small punctuate hemorrhages, visible at the DAI 
predilection sites. MR imaging techniques which are highly susceptible to blood 
products, such as T2* gradient echo and Susceptibility Weighted Imaging (SWI), are 
now increasingly used within the clinical setting to enable diagnosis of DAI (Figure 
2).78, 79 Diffusion Tensor Imaging (DTI) is a relatively new MRI modality that produces 
in vivo information of brain tissue integrity by yielding an image on the basis of the 
diffusion of water molecules.80 Because of this property the technique offers great 
potential in the detection and delineation of (diffuse) traumatic lesions.78
Post-traumatic amnesia 
Post-traumatic Amnesia (PTA) is a key element of TBI and is characterized by 
confusion, disorientation, retrograde and anterograde amnesia.81-83 PTA duration 
designates injury severity.55, 66 Also, it has been associated with working memory 
performance measured with functional MRI,84 cognitive recovery,85-88 functional 
outcome89-93 and return to work.90-92, 94, 95 Especially in mild TBI, not only presence of 
PTA but also a longer duration is associated with an increased risk for intracranial 
traumatic abnormalities.46, 66, 68, 96 Repetitive evaluation of PTA is used to monitor 
recovery in TBI patients of all severities, to guide therapy and for rehabilitation 
decisions. 
 Despite the important role of PTA in TBI care, no gold standard for PTA assessment 
exists. Controversy remains regarding the preferred method to objectively and 
accurately measure the presence and duration of PTA. We have studied the 
miscellaneous methods physicians (residents in surgery, orthopedics and neurology) 
involved in the management of TBI patients at the ED of our hospital used to 
evaluate PTA. Not only did we find large differences between the physicians of these 
specialties, but also within the group of neurologists-in-training variation was 
considerable (Jacobs, B. unpublished data). Depending on the method chosen, 
duration of PTA may vary hours to days.97, 98 At present The Galveston Orientation 
and Amnesia Test (GOAT),99 the (Modified) Oxford PTA Scale (MOPTAS),100 the 
Westmead PTA Scale (WPTAS)101 and the Revised Westmead PTA Scale (R-WPTAS)102 
are acknowledged methods to determine PTA and the reliability of these scales has 
been established.103 
Neurosurgical intervention
One of the main treatment options in TBI is neurosurgical intervention, consisting of 
a variety of procedures: e.g. the placement of an intracranial pressure (ICP) 
monitoring device or intraventricular catheter for cerebrospinal fluid (CSF) drainage 
to lower intracranial hypertension, surgical removal of an intracranial or parenchymal 
23
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hematoma, reconstruction of damage due to skull fractures and underlying 
meningeal tears or temporary decompressive (hemi)craniectomy to treat brain 
swelling and for prolonged relieve of raised ICP.59, 104, 105 A further, more thorough, 
discussion of the various available therapeutic alternatives in TBI is beyond the 
scope of this introductory chapter.
 The need for neurosurgical intervention in mild TBI is limited, not exceeding 1% 
of patients in most studies.28, 68, 106-108 A neurosurgical operation is performed in 
17-30% of the moderate TBI patients28, 30, 33, 35, 109, 110 and in 21-67% of the severe TBI 
patients neurosurgical intervention is necessary.29, 31-34, 111
Outcomes and outcome assessment 
Functional outcome of patients in most TBI studies, especially in moderate and 
severe TBI, is traditionally assessed using the 5-point Glasgow Outcome Scale 
(GOS)112 or its successor the 8-point Glasgow Outcome Scale Extended (GOSE) 
ranging from 1 (death) to 8 (complete recovery) (Table 3).113-115 In moderate and severe 
TBI outcome is generally dichotomized in unfavorable or poor outcome (GOS: 1-3 or 
GOSE: 1-4) versus favorable or good outcome (GOS: 4-5 or GOSE: 5-8). If the GOS(E) 
is used as outcome variable in mild TBI a more stringent cut-off is used: Favorable 
outcome is defined as a GOSE of 7-8 or 8 only (GOS: 5). However, a range of other 
outcome parameters are used more frequently in mild TBI, like the Rivermead post-
concussional questionnaire score116 or the results of tests on cognitive functioning.117 
In most studies, again primarily in moderate and severe TBI, outcome is determined 
at six months post-injury. This time-frame is reasonable because it has been shown 
that the majority of severe TBI patients reaches their final functional outcome as 
measured with the GOS, and this is even more pronounced when dichotomization is 
concerned (> 95% of patients), within the first six months.118 On the other hand, a 
more recent study found an improvement in GOS scores in 36% of the surviving 
severe TBI patients between six months and one year after trauma.119
 The mortality rate in mild TBI is low: In general 1-3%. In mild TBI patients with 
GCS scores of 13 and 14 this rate increases to nearly 6%.28, 68, 106-108 The majority of mild 
TBI patients, however, shows a full spontaneous recovery within weeks to several 
months.107, 108, 117, 120-127 Post-concussional symptoms like headache, dizziness, fatigue, 
and cognitive, emotional and behavioral complaints, frequently interfering with 
return to work, are still found in up to 25% of the mild TBI patients at six months 
post-injury.116, 120, 122, 124, 128, 129 This group is sometimes referred to as the ‘miserable 
minority’.121
 In moderate and severe TBI the picture is different. Moderate TBI has not been 
studied extensively as a separate severity category in a multicenter setting, 
especially when compared to mild and severe TBI. The mortality rates of moderate 
TBI in literature are highly variable: 3-33%.28, 30, 33, 35, 109, 110 Mortality is particularly high 
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in severe TBI, ranging from 32 to 49%.28, 29, 31-34, 111 Moreover, the mortality rate after 
severe TBI has not shown any significant decline during the past two decades.130 The 
percentage of patients with an unfavorable outcome (GOSE 1-4) is high: 55-64%, and 
good recovery (GOSE:7-8) is only seen in 16-27%.31-34, 111
1.2 Outcome prediction in TBI
Knowledge of the prognosis and eventual outcome of a patient, not only in TBI, is 
highly relevant for patients, the patients’ relatives and physicians alike. In daily 
clinical practice physicians base their therapeutic decisions, including the possible 
withdrawal of care, on the patient’s prognosis. But also for the evaluation of quality 
of care and the enrolment of patients in randomized controlled clinical therapeutic 
trials, prognostic information is important.43 Therefore, accuracy of the prognostic 
information in TBI is crucial. In a recent survey among physicians, most participants 
(63%) believed that they currently do not assess prognosis accurately.131 Of the 
participating physicians, 67% reported that the availability of a more accurate 
prognostic model would change patient management, i.e. treatment decisions, and 
the way they (88% of participants) counsel the patient’s next-of-kin on prognosis. 
 Prognostic models can be used to predict the clinical outcome of a patient 
suffering from TBI. As a rule such a model combines different patient characteristics 
leading to a more robust estimation of outcome, in contrast to the association of an 
individual parameter like the GCS score or the TCDB CT classification and outcome. 
Traditionally most prognostic studies have focused on demographic data, clinical 
parameters and head CT characteristics, to give a probability estimate of a 
predefined outcome, for instance in-hospital mortality or unfavorable outcome at 
six months post-injury. Most models are constructed using a largely uniformly used 
multi-step strategy:43 Often, the association between various individual demographic, 
clinical, and radiological variables, or occasionally laboratory parameters, and a 
selected outcome score is determined by univariate analysis. This results in a set of 
possible outcome predictors, which are entered in a statistical model selection 
procedure. This results in a prediction model and a prediction rule. The discriminative 
ability of this rule is usually quantified using Receiver Operating Characteristic (ROC) 
curve analysis.132 The ROC curve plots the sensitivity versus the specificity (more 
precisely, versus 1-specificity) for the prediction rule for all possible cut-off points. 
The Area Under the ROC Curve (AUC) is a measure of predictive discrimination. 
A value of 0.50 is equivalent to random guessing, 1.0 is perfect prediction. With 
an increase of the AUC, sensitivity and specificity of that model in predicting 
a predescribed outcome, its discriminative value, also increases. When the 
discriminative ability of the prediction model is evaluated on the same data that T
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were used to construct the model, the discriminative power (sensitivity, specificity, 
AUC) is usually overestimated (‘optimism’). Hence, the discriminative ability of the 
model is finally determined using external validation, whereby the AUC, sensitivity 
and specificity are determined using a new data set. 
 When prediction models are applied in individual patients however, it has to be 
taken into account that these models predict the probability of an outcome and not 
the actual outcome. In addition, there is always a level of uncertainty in the 
estimated probability of an outcome. Nevertheless, they may be a useful aid to the 
physician in daily clinical practice. Obviously, decisions on life or death should not be 
solely based on one single prediction model, especially if this model is not perfect, 
i.e. when the AUC proves less than 1.0. Where end-of-life decisions are concerned, a 
prediction model should be highly specific for a particular outcome category, like 
death or vegetative state, consequently resulting in an extremely low number of 
false-positives to avoid unjustified treatment restrictions.
Outcome prediction in mild TBI 
Age has surfaced as one of the most consistent outcome predictors in mild TBI:117 
A higher age is associated with a worse outcome. Other predictors have been 
identified in a variety of studies providing a wide and nearly endless array: from 
‘overall CT appearance’ to signs of DAI, the GCS score, PTA, loss of consciousness, 
injury mechanism, acute post-traumatic complaints, gender, pre-existing physical 
limitations, blood alcohol level, to additional traumatic extracranial injuries.41, 117, 133-142 
These studies differed considerable in primary outcome scores - from death/ survival 
to detailed cognitive functioning or the presence of post-traumatic complaints - and in 
the time post-injury these scores were obtained, making direct evaluation difficult. 
Moreover, many studies also yielded conflicting results, for instance on the 
association of PTA92, 117, 126, 143 or CT abnormalities41, 120, 133, 135-143 with outcome. It is also 
difficult to draw solid conclusions from many of the prognostic studies due to 
relatively small sample sizes, limited univariate analyses, combination of mild TBI 
with more severely injured patients, or the analysis of variables from one individual 
category (demographic, clinical or radiological). 
 Recently, a systematic review of prediction models in TBI found only a limited 
number of studies using multivariate analysis of sufficient quality on outcome 
prediction in mild TBI.144 In 2007, two clinically applicable rules were developed to 
predict the absence of post-concussional symptoms and full return to work at six 
months after sustaining a mild TBI.120 Interestingly, premorbid physical co-morbidity 
and premorbid educational level were identified as outcome predictors, next to 
post- and peri-injury symptoms and additional extracranial injuries.
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Outcome prediction in moderate and severe TBI 
In moderate and severe TBI the development of prognostic models has been even 
more extensive and thorough than in mild TBI, reaching a temporary climax with the 
study of large patient cohorts with the MRC CRASH study28, 41 and the IMPACT 
(International Mission on Prognosis and Clinical Trial Design in TBI) project.42, 145 
Prognostic studies in moderate and severe TBI have shown more uniformity in both 
the potential predictors and the outcome scores - mortality and/ or dichotomized 
GOS(E) at six or twelve months post-injury - than in mild TBI.43, 144, 146, 147 Age, total GCS 
score or GCS-motor score, pupil reactivity and the occurrence of a post-injury 
hypotensive and/ or hypoxic period, have been amongst the most powerful 
demographic and clinical predictors in the majority of studies.29, 41, 42, 146-152
 Head CT scanning is of great value for outcome prediction in moderate and 
severe TBI. Different traumatic abnormalities like midline shift, compression of the 
perimesencephalic (basal) cisterns, traumatic subarachnoid hemorrhage (SAH), and 
the presence and type of intracranial (mass) lesions, have emerged as outcome 
predictors after multivariable analyses also including demographic and clinical 
covariates.41, 133, 138, 140, 148, 149, 151, 153-156 Several studies have used the TCDB CT classification 
described above (Table 2),62 to incorporate CT characteristics in their prediction 
models.29, 42, 149, 151, 153 Besides a valuable predictor in multivariable prediction models, 
the TCDB CT classification has a strong univariate relation with outcome as well.62 
Although widely acknowledged, the TCDB CT classification is criticized for being 
partly retrospective in nature and not addressing all CT abnormalities with 
prognostic value, in particular the presence of traumatic SAH.65, 133, 153, 157 To meet this 
criticism the Rotterdam CT classification157 has been introduced a few years ago and 
more recently the Stockholm prediction score133 was published. A combination of 
individual CT characteristics including intraventricular and traumatic SAH, 
demonstrated a better discriminative performance in both studies than the original 
TCDB classification.133, 157
 The literature on prognostic modeling is extensive and still increasing. The 
prognostic models which have been developed are highly relevant as well, but the 
methodological quality is subject to discussion.144, 146, 147 Three recent reviews 
described different limitations of available prognostic models in TBI and provided 
useful starting-points for the development of new models.43, 144, 146 Questions have 
been raised on the applicability, validity and generalizability of current available 
models.146, 147, 158
CRASH, IMPACT and beyond
The large MRC CRASH and IMPACT studies have resulted in prognostic models with 
higher accuracies for the prediction of mortality and unfavorable outcomes in 
moderate and severe TBI.41, 42 Multivariate prognostic models for predicting mortality 
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and severe disability were developed from an international study on the effect of 
corticosteroid administration in TBI (MRC CRASH trial).41 A combination of clinical 
variables - age, GCS score, pupil reactivity and major extracranial injury - and CT 
abnormalities - petechial hemorrhages, obliteration of third ventricle or basal 
cisterns, traumatic SAH, midline shift and presence of a non-evacuated hematoma 
- demonstrated the highest predictive values. 
 The IMPACT study used patient data of 8 treatment trials and 3 observational 
studies to create prognostic scores for death and unfavorable outcome at six 
months.42, 149, 159 This study also demonstrated some additional value of two 
laboratory parameters - serum glucose and hemoglobin levels - to the discriminative 
ability of prediction models based on clinical variables and CT. The discriminative 
ability, represented by the AUC, demonstrated a mere increase of maximal 2.7% with 
the addition of the laboratory predictors.42 Although at present these are the two 
largest prognostic studies in moderate and severe TBI some aspects need to be 
considered. The MRC CRASH and IMPACT models are largely based on patients 
enrolled in clinical trials and not on prospective observational cohort studies.145, 160 
Furthermore the IMPACT database exists of studies executed between 1984 and 
1997:145 The last patient was enrolled in these studies almost fifteen years ago. Since 
then, treatment protocols and epidemiological data on TBI have changed and CT 
scanners have been upgraded.59
 The currently recognized outcome predictors as described above and the prognostic 
models based on these predictors are imperfect. The accuracy of the prediction models 
developed from the CRASH and IMPACT data for instance amount to 0.77-0.83 (AUC) 
in external validation samples.41, 42 Moreover, the cumulative R2, i.e. the variance in 
outcome explained by the predictors constituting a model, of the full IMPACT model 
is merely 0.35.43 And although models mainly based on demographic, clinical and 
radiological variables provide solid grounds for the estimation of outcome 
probabilities, they still have to be improved for use in daily clinical practice where 
treatment or withdrawal of treatment decisions in an individual patient are 
concerned. How to refine the currently available prognostic models? Research on 
additional potential outcome predictors is ongoing and an additional role of 
laboratory (blood/ serum) parameters, brain specific biomarkers and genetic factors 
is expected.
 Previous research suggests that brain specific biomarker levels, measured in CSF 
or blood serum, are potentially valuable markers of the extent of the (primary) brain 
injury and as outcome predictors. Small cohort studies (n=10-100) have yielded 
several biochemical markers including glial fibrillary acid protein (GFAP),161, 162 neuron- 
specific enolase (NSE),163 S100B,161, 164-166 myelin basic protein (MBP)167 and cleaved 
tau.168 Despite promising results, at this moment biomarkers are still considered as 
insufficient markers of injury severity or outcome predictors, due to variation in 
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laboratory methods and sampling time, the use of various cutoff levels, and the lack 
of comparison with acknowledged clinical predictors. The role of biochemical 
markers may even be no more than supplemental to the already existing tools of TBI 
classification as has been implied by others. Nevertheless, further exploration and 
validation of biomarkers still remains worthwhile.169 
 An increasing number of studies is being published on genetic factors that 
might modify outcome after TBI.170, 171 Although the elucidation of TBI pathophysiology 
is probably the main role, advances in genetic research of TBI may have implications 
for outcome prediction.170 Several genes possibly influencing outcome following TBI 
have already been identified, with the apolipoprotein E (APOE) gene being the most 
thoroughly studied.171 A recent meta-analysis found a persistent association between 
the presence of the APOE e4 allele and an unfavorable outcome following severe TBI. 
In mild and moderate TBI this association could not be demonstrated.172
1.3  On the database and methods that were used for 
the studies presented in this thesis
For the studies described in chapters 3, 4, and 5 of this thesis we used patients that 
were included in the Radboud University Brain Injury Cohort Study (RUBICS) database 
from 1998 to 2006. For the studies described in chapters 2 and 6 we enrolled additional 
patients.
RUBICS database
On January 1st, 1998, the first patient was included in the Radboud University Brain 
Injury Cohort Study (RUBICS) initiating a still ongoing prospective observational 
cohort study on TBI. RUBICS is executed at the Department of Neurology of the 
Radboud University Nijmegen Medical Centre (RUNMC), a level I trauma center, 
equipped with a helicopter emergency medical service (HEMS) covering a referral 
area of 2.5-3.5 million inhabitants. RUBICS was originally initiated to collect epide-
miological data on TBI and to study the relation between various demographic, 
clinical and radiological variables and TBI outcome. By now, more than 9,000 
consecutive TBI patients, including children, with a diagnosis of mild, moderate and 
severe TBI who were presented at the ED of the RUNMC have been registered.
 Subjects are included in RUBICS when according to hospital protocol, a neurologist 
or neurosurgeon is consulted at the ED in case of a head trauma patient presenting 
with: 1) A GCS score of 3-14; 2) a GCS score of 15 with a history of loss of consciousness 
(LOC) and/ or posttraumatic amnesia (PTA); 3) a GCS score of 15 without LOC or PTA 
but fulfilling additional criteria described in the guidelines of the European 
Federation of Neurological Societies (EFNS).46 These include the presence of focal 
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neurological deficit, early post-traumatic epileptic seizure, intoxication with alcohol 
or drugs, age above sixty or below two years, high energy-accident, use of oral anti-
coagulation medication and visible trauma above the clavicles. Patients with mere 
head injury, but without TBI and not meeting the EFNS criteria are not included. 
 To define TBI severity the ED GCS score, as assessed by a neurologist (in training) 
or neurosurgeon (in training) after initial (surgical) assessment and resuscitation 
according to the principles of the Advanced Trauma Life Support (ATLS) system173 is 
used. We define mild TBI by a GCS score at the ED of 13-15 after initial resuscitation, 
or an admission GCS of 13-15 followed by sedation and intubation during resuscitation 
if necessary for a non-neurological cause. We further apply the EFNS guidelines to 
distinguish head injury from MTBI in patients with a maximal GCS score at 
presentation.46 Patients suffering from moderate TBI have a GCS score of 9-12 after 
initial resuscitation, or an admission GCS of 9-12 followed by possible sedation and 
intubation. Severe TBI is characterized by an ED GCS score of <8 after resuscitation, 
preferably obtained before the eventual sedation and intubation. This implies that 
TBI patients admitted to the ED, already sedated and intubated scoring a GCS of 3, 
who do not improve at the ED, are categorized as a severe TBI, despite the GCS score 
at the scene of the accident.
 The RUBICS database comprises demographic data (e.g. age and gender), clinical 
variables, head CT characteristics, information on laboratory parameters and blood 
serum biomarkers, trauma severity scores, and various outcome scores, amongst 
others the GOSE at six months post-injury. Injury characteristics which are registered 
include: injury mechanism, the Abbreviated Injury Scale of the Head (AISH), the 
Injury Severity Score (ISS),174 GCS score, day-of-injury alcohol intoxication (blood 
alcohol level >100mg/L), the use of oral anticoagulants, and the presence and 
duration of loss of consciousness/ coma and PTA. Also, the post-injury occurrence of 
hypotension (systolic BP <90mm Hg, equal to shock class III–IV)63 and hypoxia (blood 
oxygen saturation <90% as measured by pulse oximetry), during the pre-hospital 
period or at the ED is recorded. To quantify additional extracranial injuries separately, 
an alternative modified ISS score is calculated, based on the three most severely 
injured body areas excluding the head, as the ISS-extracranial score (ISSe). Finally, 
extensive data on the initial head CT scans are recorded including the Traumatic 
Coma Databank (TCDB) CT classification (Table 2).62 All clinical data are collected by 
a trained research nurse post-injury as soon as possible, generally on the day of 
injury, and recorded on forms before entry into our digital database.
Subjects included in the studies of this thesis
For the studies described in chapters 3, 4, and 5 of this thesis we used the patients 
included in RUBICS of sixteen years and older and admitted to the ED of our hospital 
between January 1st, 1998 and January 1st, 2006. The TBI patients described in 
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chapters 2 and 6 were also registered in RUBICS, but additionally recruited for these 
separate studies.
Introduction to the methods: Cranial computed tomography in this 
thesis (chapters 3, 4, and 5)
CT scanning of the head was performed using a 4 slice (until 2002) or a 16 slice CT 
scanner (after 2002) and in general carried out in the axial plane with slices scanned 
parallel to the orbito-meatal line. Before 2002 slice thickness was 4.5 mm 
infratentorial and 6.0 mm supratentorial; from 2002 on, 5.0 mm reconstructions 
were made out of 0.75 mm slices in both the supra- and infratentorial regions. In 
general only the initial CT scans obtained within 24 hours after sustaining the head 
injury were used. Each CT scan was scored as soon as possible post-trauma by one of 
three raters who also performed joined readings to get and stay familiar with the 
predefined scoring format. Next to the TCDB CT classification, the following 
traumatic CT abnormalities were recorded on standardized data sheets:
•	 	The status (normal presence, compression, or absence) of the ventricular system 
and cisterns;
•	 	The presence, type, localization, number and dimensions were registered 
separately for subdural hematomas (SDH), epidural hematomas (EDH), intra-
parenchymal hematoma and (hemorrhagic) contusions. Intraparenchymal high 
density lesions were considered hematomas, mixed density lesions hemorrhagic 
contusions and focal low density lesions were considered contusions. Intrapa-
renchymal lesions were grouped because they belong to the same category of 
traumatic lesions: Contusions. The volumes (in ml) of all lesions mentioned 
above were calculated using the ellipsoid method described before.175-177 The 
largest lesion was considered the dominant lesion and used for classification 
according to the TCDB CT classification. When multiple intracranial lesions were 
present a total volume was calculated;
•	 	The presence, type and quantity of subarachnoid and intraventricular hemorrhage;
•	 	The presence and location (subcortical, basal ganglia/ corpus callosum, or 
brainstem) of punctate hemorrhages (diameter <5mm);
•	 	The presence and location of edema (focal or diffuse);
•	 	The presence and quantity of midline shift (mm), defined as displacement of 
the septum pellucidum in relation to the midline;
•	 	The presence and localization of pneumocephalus;
•	 	The presence and type of facial, vault, or skullbase fractures;
•	 	The presence and location of extracranial hematomas.
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Introduction to the methods: Outcome assessment
For the studies presented in chapters 3 through 6, outcome was assessed at six 
months post injury according to the Glasgow Outcome Score Extended (GOSE) using 
a structured interview during regular visits to the out-patient clinic or during 
consultation by telephone (Table 3).112, 113, 178 Patients not visiting the outpatient clinic 
were sent a GOSE questionnaire by regular post, and when not returned a reminder 
was sent.115 Finally, we attempted to reach all non-responding patients by telephone 
to acquire an outcome score. In mild TBI (chapter 3), we considered a GOSE score of 
6 or lower an unfavorable outcome. In moderate and severe TBI a poor outcome was 
defined as a GOSE of less than 5, including the patients that died (GOSE 1). Next to 
this traditional dichotomization of the GOSE, in one of our studies (chapter 5) we 
also studied unfavorable outcome at six months in the group of surviving patients 
(GOSE 2-4).
1.4 General aim and outline of this thesis
The most important aim of this thesis is to improve the accuracy of outcome 
prediction in mild, moderate and severe TBI. The studies were designed to enhance 
the quality and validity of PTA assessment and to investigate in-depth the prognostic 
value of CT in TBI of all severity categories. Additionally, they aimed to combine 
different variables for the development of prediction models that are easy-to-use in 
clinical practice, and to follow-up on the verification of the predictive value of 
brain-specific biomarkers.    
 Chapter 2 focuses on post-traumatic amnesia (PTA) as a key aspect of TBI. 
Presence and duration of PTA are associated with prognosis of TBI, making PTA a 
valuable outcome predictor. We argue that there is need for the improvement of PTA 
assessment. In this chapter the construction and external validation of an examiner 
independent PTA scale is described. We also assessed the concurrent validity of our 
new scale by comparing it to existing PTA scales.
 In chapter 3 a study on mild TBI is presented of which the goal is twofold. First, 
the aim was to gain insight into the composition and frequency of several 
demographic, clinical, and CT variables in mild TBI. Secondly, we aimed to identify 
predictors of functional outcome after mild TBI by studying the association of CT 
characteristics in combination with demographic and clinical variables and outcome. 
Using multivariate binary logistic regression analysis, predictive models were 
designed which may be useful in daily clinical practice.
 The studies described in chapter 4 (4.1 and 4.2) were intended to systematically 
and extensively explore the prognostic value of individual traumatic CT characteris-
tics in moderate and severe TBI and hence to further optimize the use of the 
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predictive value of CT variables in new prognostic models. Chapter 4.1 deals with 
the association of the status of the different cisterns, ventricles and outcome both 
individually and in a multivariate analysis. The objective of the study discussed in 
chapter 4.2 was to determine the value in prognostication of different thresholds of 
lesion volume and midline shift as applied in the TCDB CT classification and the ISS 
score. Eventually these studies might result in refinement of TBI prognosis and 
patient classification. Both studies also provide data on the interobserver variation 
in the visual assessment of ventricles, cisterns, hematoma volume and midline shift 
as detected with head CT scanning.
 The development and external validation of several new prognostic models for 
moderate and severe TBI, incorporating demographic, clinical and radiological 
variables, are described in chapter 5. Also, a new CT prediction rule was developed, 
using the results of chapter 4, and compared to the existing TCDB and Rotterdam CT 
classifications. Additionally, we studied the association of different variables and 
unfavorable outcome in TBI survivors. For a more easy use of our models in daily 
clinical practice we designed a web-based calculator which is available at: www.
tbi-prognosis.com. 
 Previously, GFAP and S100B measured in serum have shown to predict death 
and unfavorable outcome in moderate and severe TBI.161 In chapter 6 we validate the 
predictive values of these two biomarkers, using the serum level thresholds 
mentioned above, for outcome in a multivariate analysis with demographic, clinical 
and radiological indices. 
 In chapter 7 the results from the studies presented in the preceding chapters 
are summarized, discussed and final conclusions are drawn. Future research 
perspectives are suggested. Chapter 8 summarizes the main findings of this thesis 
in Dutch.
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Abstract 
Background: Post-traumatic amnesia (PTA) is a key symptom of traumatic brain 
injury (TBI). Accurate assessment of PTA is imperative in guiding clinical decision 
making. Our aim was to develop and externally validate a short, examiner 
independent and practical PTA scale, by selecting the most discriminative items 
from existing scales and using a three-word memory test.
Methods: Mild, moderate and severe TBI patients and control subjects were 
assessed in two separate cohorts, one for derivation and one for validation, using a 
questionnaire comprised of items from existing PTA scales. We tested which 
individual items best discriminated between TBI patients and controls, represented 
by sensitivity and specificity. We then created our PTA scale based on these results. 
This new scale was externally evaluated for its discriminative value using Receiver 
Operating Characteristic (ROC) analysis and compared to existing PTA scales.
Results: The derivation cohort included 126 TBI patients and 31 control subjects; 
the validation cohort consisted of 132 patients and 30 controls. A set of seven 
items was eventually selected to comprise the new PTA scale: age, name of hospital, 
time, day of week, month, mode of transport and recall of three words. This scale 
demonstrated adequate discriminative values compared to existing PTA scales on 
three consecutive administrations in the validation cohort.
Conclusion: We introduce a valid, practical and examiner independent PTA scale, 
which is suitable for mild TBI patients at the emergency department and yet still 
valuable for the follow-up of more severely injured TBI patients. 
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Background
Post-traumatic amnesia (PTA) is an essential aspect of traumatic brain injury (TBI), 
characterized by confusion, disorientation, retrograde and anterograde amnesia. 81-83 
PTA duration designates injury severity,55, 66 and predicts cognitive recovery,87, 88 
functional outcome89-92 and return to work.90-92, 94, 95 Additionally, after mild TBI, the 
presence and duration of PTA are associated with the risk for intracranial traumatic 
lesions.46, 66, 68, 96 Evaluation of PTA is further used to monitor TBI recovery and to 
guide therapy and rehabilitation decisions. Despite the importance of accurate PTA 
assessment, no gold standard for PTA assessment exists, and controversy remains 
regarding the preferred method to objectively measure the presence and duration 
of PTA. 
 Existing PTA scales including the Galveston Orientation and Amnesia Test 
(GOAT),99 the (Modified) Oxford PTA Scale (MOPTAS),100 the Westmead PTA Scale 
(WPTAS)101 and the Revised-WPTAS (2004, Ponsford version)102 use standardized 
assessment formats (Table 1). Limitations associated with these scales refer to 
imperfect accuracy, because not all answers to memory questions can be verified. 
Furthermore, several test items are retrospective in nature,81 and pictures are used 
instead of words as memory items, which may be impractical, especially in 
emergency department (ED) settings.179, 180 In addition, test items that require 
remembering the examiner’s name and face are unfeasible given the fact that 
longitudinal PTA assessment often requires multiple testing.102 The item name of 
examiner is also often failed by a substantial proportion of control subjects.102 A 
final area of concern is the level of task difficulty. Although widely accepted as a 
legitimate test item, the three-picture memory test has been shown to be less 
sensitive to test PTA than a three-word memory test.180-182
 To overcome the accuracy and practical shortcomings related to existing PTA 
scales the present study was undertaken. In the first part we constructed an 
examiner independent PTA scale composed of a set of individual items with the 
highest discriminative value taken from existing PTA scales. In part two this newly 
composed scale was subsequently validated in patients and controls, and the 
concurrent validity was assessed by comparing it to the existing GOAT,99 MOPTAS100 
and (Revised-)WPTAS101, 102 scales.
Methods 
Subjects
This single center prospective cohort study was executed at the ED and neurological 
and surgical wards of the Radboud University Nijmegen Medical Centre, a level I 
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trauma centre; the first part of the study (derivation) between 2005 and 2006 and 
the second part (validation) in 2009. 
 All consecutive TBI patients, over 16 years of age and admitted to the ED, were 
eligible for inclusion. TBI was classified, based on the admission Glasgow Coma Scale 
(GCS) score at the ED, as mild (GCS: 13-15), moderate (GCS: 9-12) or severe (GCS< 8).46 
 Two control groups for both the derivation and the validation study were 
recruited, one group of healthy controls and a second control group of patients with 
isolated traumatic orthopedic injuries who were admitted to the ED and the surgical 
ward. For the derivation study we recruited an extra control group of neurological 
patients admitted for a central nervous system disease. Including orthopedic trauma 
Table 1   The combined PTA questionnaire administered to participants;  
a composite of items from existing PTA scales
Questionnaire
reference
GOAT
 99
WPTAS 
101
R-WPTAS 
102
MOPTAS
100
01. Name
02. Age
03. Date of birth
04. Residence
05. Marital status
06. Children
07. Occupation 
08. Recognition face examiner
09. Recall name examiner
10. Kind of place
11. Name of place
12. City of hospital
13. Date of admittance
14. Mode of transport
15. Last memory preceding injury
16. First memory following injury
17. Period of day
18. Time of day
19. Day of week
20. Date
21. Month of year
22. Year
23. 3-item memory test
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
√
Maximum Score
Criterion – PTA present (disease positive)
100
≤ 75
12
≤ 11
10
≤ 9
15
≤ 14
PTA, post-traumatic amnesia; GOAT, Galveston Orientation and Amnesia Test; WPTAS, Westmead PTA scale; 
R-WPTAS, revised Westmead PTA scale; MOPTAS, modified Oxford PTA scale.
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patients permitted controlling for factors such as pain and traumatic stress. By 
including neurological control subjects we aimed to control for aspects of admittance 
at a hospital ward due to neurological disease.
 Exclusion criteria for participants were the following: age below 16 (no upper 
age limit), previous history of moderate or severe TBI, a history of alcohol and/or 
drug abuse, previous diagnosis of dementia, and inability to communicate, for 
example due to aphasia, a tracheostoma or a language barrier. Participants were not 
included during weekend- or night shifts. However, follow-up testing of included 
participants was carried out during weekends. Test administrations were also 
missed if the subject was unable to participate, for instance due to surgery. 
 The local ethics committee waived the need for review board approval and 
written informed consent.
PTA assessment
Assessment of PTA started immediately on presentation to the ED for the mild TBI 
and orthopedic patients and the day after admittance for the neurological controls. 
The moderate/severe TBI patients were assessed as soon as possible after regaining 
consciousness and when they were able to cooperate sufficiently. During derivation 
and validation a 23-item questionnaire composed of all the individual test items 
derived from the GOAT,99 MOPTAS100 and (R-)WPTAS101, 102 scales (Table 1) was 
administered by the same examiner on a daily basis to the participants until the 
formal criteria of these tests were met or until discharge or transfer from our 
hospital. During PTA assessment patients were told the correct answer to a question 
if the answer was incorrect.
  In order to prospectively test anterograde memory and compare the use of 
pictures against words, patients and controls included in the derivation cohort were 
randomized using a sealed envelope method for a pictures group (PG) or a words 
group (WG). For both groups 35 sets, each comprising three memory items, pictures 
or words, were created as we previously described.181 At the end of the combined PTA 
questionnaire the participant was instructed to memorize three items (pictures or 
words). If free recall was not perfect during the following test (preferably 24 hours 
after the initial administration and every subsequent 24 hours), the participant had 
to select the three target pictures or words out of nine distracters. Each time 
recognition was tested, new sets of distracters were used. In case of errors in 
recognition, the same three memory items were presented again, and the participant 
was asked to remember the items until the subsequent test day. The set of target 
items was changed only in case of flawless recognition. In the (R-)WPTAS, 
performance on the three-picture test is used to calculate a total test score. In our 
study, total (R-)WPTAS test scores are based on either the three-picture or the 
three-word memory test.
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Test procedures in the validation study were similar to those described above with 
three exceptions. First, based on the results of the PTA scale derivation, only words 
were used as memory items. Second, one extra administration (next to the initial 
administration and the subsequent assessments each 24 hours) of the composite 
PTA questionnaire was introduced at one hour after the first administration. Finally, 
recall and recognition of three words were also tested at five minutes after 
presentation during the initial questionnaire administration.  
Data analysis
Since no gold standard exists to define PTA, we compared patients and controls, 
recognizing that not all TBI patients suffered from PTA. The discriminative value of 
individual test items was determined separately for both the derivation and 
Figure 1   Inclusion flow diagram of the derivation cohort (Cohort I) and the 
validation cohort (Cohort II)
Sep., September; Oct., October; Dec., December; TBI, traumatic brain injury; mTBI, mild traumatic brain 
injury; Mod., moderate; Sev., severe.
n = 242  
n = 2  
n =132  
n = 18  
TBI admissions to emergency department 
Mod./ Sev. TBI n = 15  mTBI n = 117  
Patients excluded 
Reasons for exclusion: 
Age < 16 years 
History of moderate/ severe TBI  
History of alcohol/ drug abuse   
History of dementia/ amnestic syndrome  
Not able to communicate  
Presentation during weekend- or night shifts 
Cohort I:  
Sep. 2005 - Dec. 2005/  
Oct. 2006 - Dec. 2006 
Cohort II:  
April - Oct. 2009 
n = 348  
n = 20  
n = 198 
n = 4  
n = 126  
mTBI n = 105  
n = 394  
Mod./ Sev. TBI n = 21  
Patients died before inclusion 
No consent 
Patients included 
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validation study by calculation of the sensitivity and specificity. The sensitivity of a 
test item was defined as the proportion of TBI patients giving an incorrect answer to 
that particular item whereas specificity referred to the proportion of controls 
answering the particular test item correctly.
 To develop an examiner independent and objective PTA scale, the examiner 
related items (name and face of examiner) and the items that cannot objectively be 
verified for correctness (last memory preceding and first memory following injury), 
were excluded from further analysis. Performance of patients and controls was 
compared using Chi-squared and Fisher’s exact tests: For the orientation items the 
scores on day one (first administration) and day two were used. We used the score 
on day two for the memory items. Pearson’s correlation analysis was performed 
for all items on test day one to determine inter-item correlation. To compose a new 
PTA scale, items with the highest sensitivity and specificity, taking the inter-item 
correlation into account, were chosen. 
 The discriminative value (patients versus controls) of free recall versus recognition 
of the three-word memory test in the validation sample was determined by 
computing Receiver Operating Characteristic (ROC) curves. Spearman correlation 
coefficients were calculated to examine the association between performance on 
our proposed PTA scale and performance on the GOAT, MOPTAS and (R-)WPTAS 
scales. Since we used a three-word memory test instead of a three-picture test in 
this validation cohort the total scores of the MOPTAS and (R-)WPTAS scales were 
calculated using the three-word recognition scores. 
 Finally, to compare the performance of our PTA scale with existing scales, we 
also carried out ROC analyses of the sum scores of all PTA scales to calculate the 
individual discriminative values (patients versus controls). For all statistical analyses 
a p<0.05 (two-sided) was considered statistically significant. 
Results
 
Figure 1 shows the inclusion procedure of the TBI patients for both cohorts. In the 
derivation study 10 healthy, 10 orthopedic (upper or lower leg fracture) and 11 
neurological controls (10 patients suffering from a sensorimotor ischemic stroke 
without aphasia and 1 patient with a benign cerebral tumor) were included. For the 
validation study we recruited 20 healthy individuals and 10 patients with traumatic 
orthopaedic injuries. The different control groups were collapsed into one single 
control group per cohort. Table 2 demonstrates the demographic and clinical charac-
teristics of TBI patients and control subjects. Within the derivation study, patients 
and controls differed considerably in gender and age (Table 2a). For the validation 
cohort differences were less apparent except for the age difference of nine years 
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between mild TBI patients and controls (Table 2b). The first PTA assessment in the 
moderate/severe patients included in the derivation cohort was executed at a mean 
of 17,3 days (standard deviation [sd] 14,9) post-injury, for the validation cohort the 
mean was 8,6 (sd 10,1) days.
Table 2   Participant characteristics
2a. Derviation cohort
Mild TBI Moderate/ severe TBI Control subjects
n 105 21 31
Gender (male), n (%) 64 (61) 18 (86) 12 (39)
Age, mean (sd) 46.6 (20.4) 30.1 (16.9) 52.6 (14.2)
Educational level, n (%)a
   - Low 31 (30) 8 (38) 11 (35)
   - Intermediate 22 (21) 6 (29)   6 (19)
   - High 24 (23) 1   (5)   9 (29)
   - missing 28 (27) 6 (29)   5 (16)
Injury mechanism, n (%)
   - traffic related 54 (51) 12 (57) 3 (30)
   - fall 29 (28)   3 (14) 7 (70)
   - violence - - -
   - other 22 (21)   6 (29) -
2b. Validation cohort
n 117 15 30
Gender (male), n (%) 76 (65) 10 (67) 17 (57)
Age, mean (sd) 50.7 (22.3) 39.7 (19.6) 41.4 (18.7)
Educational level, n (%)a
   - Low 28 (24) 1   (7)   8 (27)
   - Intermediate 34 (29) 7 (47) 10 (33)
   - High 36 (31) 2 (13) 12 (40)
   - missing 19 (16) 5 (33) -
Years of education, mean (sd) 13.7 (4.3) 13.3 (3.4) 15.3 (4.8)
aBased on Dutch educational system and categorized in three groups: low (about ten years of formal 
education or less), intermediate (about 11-14 years of formal education) and high level of education (15 
years of formal education or more). TBI, traumatic brain injury; n, number; sd, standard deviation.
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Table 3 shows the sensitivity and specificity of individual items administered to the 
derivation cohort on test days one and two. Moderate/severe TBI patients performed 
poorer on all items compared to controls except for name, date of birth, residence, 
marital status, offspring and occupation (not shown in Table 3). In mild TBI, only time 
of day (margin 30 minutes) on day one and mode of transport on days one and two 
showed a significant difference between patients and controls. 
 No significant differences in test performance on the memory items were found 
between the picture and word groups (data not shown). Both item groups were 
combined for further analyses. The 24-hours free recall and recognition scores did 
not differ significantly between mild TBI patients and controls (Table 3), whereas 
moderate/severe TBI patients performed significantly poorer than controls. The 
24-hours free recall of memory items proved to be more difficult than recognition 
for both patients and controls, as demonstrated by higher sensitivity and lower 
specificity values. 
 A correlation was found between name of hospital and city of hospital (r=0.61; 
p<0.0001) and month, day of week, time and period of day (0.50<r<0.56; p<0.0001). 
Not surprisingly, date and date of admission showed a correlation in the mild TBI 
patients (r=0.67; p<0.0001).
 For our PTA scale (Figure 2), to be validated in the second part of this study, we 
selected the items age, name of hospital, time, day of week, month, mode of transport 
and recall of three words after 24 hours based on the following arguments. For the 
use of a new scale at an ED, we chose items with discriminative value from at least 
day one in mild TBI patients: time and mode of transport. Both items showed high 
specificity (>95%). We selected age since it showed significant differences in 
sensitivity and specificity in moderate/severe TBI patients on at least two 
consecutive days. 
Table 2   Continued
2b. Validation cohort
Injury mechanism, n (%)
   - traffic related 47 (40) 9 (60) 1 (10)
   - fall 52 (44) 3 (20) 3 (30)
   - violence   6 (5) - -
   - other   9 (8) 3 (20) 6 (60)
   - missing   3 (3) - -
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Table 3   Discriminative value: Sensitivity and specificity of individual test items 
on first two days of admission
Mild TBI                             
(n=105/ n=51)a
Moderate/ Severe TBI
(n=21/ n=18)a
Controls           
(n=31/ n=31)a
Items Sensitivity 
(%)
p Valueb Sensitivity 
(%)
p Valueb Specificity  
(%)
Selected
Age Day 1   6 0.336 19 0.022 100
Day 2   6 0.292 22 0.016 100
Name of hospital Day 1 11 0.068 50 0.000 100
Day 2 12 0.412 35 0.011   96
Time Day 1 23 0.002 33 0.001 100
Day 2 20 0.087 39 0.005   96
Day of week Day 1 11 0.732 33 0.022   93
Day 2 13 0.088 28 0.008 100
Month Day 1   8 0.198 33 0.001 100
Day 2   0 - 29 0.006 100
Mode of transport Day 1 19 0.044 48 0.000   97
Day 2 18 0.025 56 0.000 100
Recall memory items Day 2 46 0.541 71 0.039   62
Recognition  
memory items
Day 2 27 0.273 50 0.013   85
Rejected
City of hospital Day 1   4 0.574 24 0.008 100
Day 2   6 0.547 17 0.062 100
Period of day Day 1   8 0.198 33 0.001 100
Day 2 10 0.161 33 0.003 100
Date Day 1 25 1.0 62 0.008   77
Day 2 24 0.122 39 0.021   92
Year Day 1   3 1.0 29 0.013   97
Day 2   6 1.0 22 0.142   96
Admission date Day 1 29 0.438 71 0.062   62
Day 2 24 1.0 72 0.001   80
a Number of patients between parenthesis: first number on day 1, second number on day 2.  
b p Value: patients versus controls. TBI, traumatic brain injury. 
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The items name of hospital, day of week and month were selected because of high 
specificity and significant differences in test performances between moderate/
severe TBI and controls. Year demonstrated discriminative value only on day one, 
hence it was excluded. Items date and admission date were not selected since 
specificity was low (<80%). Period of day was not selected because it correlated with 
time. Finally, city of hospital was excluded as it correlated with name of hospital and 
proved significant only on day one in the moderate/severe TBI patients.
 To test anterograde amnesia, we selected for our new PTA scale words instead 
of pictures as memory items, as they were not inferior to pictures and might be 
more practical, especially at ED settings. We preferred recall rather than recognition 
based on its superior sensitivity.  
Figure 2   Proposed new PTA scale
PTA, post-traumatic amnesia
 
1.  What is your age?                                                                               
 
…. /1 
…. /1 
…. /1 
…. /1 
…. /1 
…. /1 
…. /3 
…. /9 
2. Where are you now? (name hospital)     
3. What time is it? (margin 30 minutes)                           
4. Which day of the week do you think it is?                                              
5. Which month of the year do you think it is?                                            
6. How did you get here? (mode of transport)     
 
On first administration end here and present three words as memory items (procedure 
see below); on the consecutive administrations (for instance one hour) continue: 
 
7. Can you recall the three words you heard last administration? 
 
 -  If less than 3 words are recalled: present the same three words that should have 
been remembered for this day as memory items.  
                  
            While presenting the new words: 
Can you repeat the words I am presenting you? 
            Immediately after presenting the three words: 
            Can you tell me the three words you just have heard?                                                         
If not: present the words once more and have the patient repeat them. 
 
Score one point for every correct answer to the items 1-6 (maximum 6 points)  
and 1 point for every word correctly recalled.                   Sum score     
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Table 4 demonstrates the sensitivity and specificity of each individual item of 
our proposed PTA scale as found in the validation cohort on the three primary 
 admini strations (TBI patients and control subjects grouped together). Additionally, 
data on three-word recognition are given. In the validation cohort specificity of the 
item time of day was lower at the first (86% versus 96%) and 24-hours administration 
(89% versus 100%). The other items were never failed by the control subjects. 
The Area Under the Curve (AUC) of free recall was larger than that of recognition. 
Consequently, free recall demonstrated better discriminative values: First administration: 
0.71 (95% confidence interval [CI]: 0.62-0.79) versus 0.62 (95% CI: 0.52-0.72); second 
administration: 0.76 (95% CI: 0.61-0.92) versus 0.60 (95% CI: 0.42-0.77); third 
administration: 0.87 (95% CI: 0.79-0.96) versus 0.71 (95% CI: 0.58-0.84). 
 Performances on our proposed PTA scale and existing PTA scales showed strong 
and significant correlations, except for the modest, nevertheless significant, correlations 
between performances on our PTA scale and the GOAT (Table 5). 
 Table 6 compares the sensitivity and specificity of the proposed PTA scale with 
current PTA scales, based on the sum scores of each individual scale (Table 1). Our 
new PTA scale had largely comparable AUCs to the existing PTA scales.
Table 4   Sensitivity and specificity of each individual item of the proposed  
PTA scale
1st administration one hour after  
1st administration
24 hours after  
1st administration
Item Sens. 
(n=132)
Spec.
(n=30)
Sens.
(n=21)
Spec.
(n=22)
Sens.
(n=46)
Spec.
(n=19)
1. Age
2. Name of place
3. Mode of transport
4. Time
5. Day
6. Month
7. 3-words, recall
  5
14
25
24
13
  6
58
100
100
100
86
100
100
  77
  0
  5
29
29
  5
  5
60
100
100
100
100
100
100
  91
  2
  7
15
22
17
  7
77
100
100
100
  89
100
100
  95
3-words, recognition 27 97 25 96 42 100
PTA, post-traumatic amnesia; Sens., sensitivity, %; Spec., specificity, %.
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Table 5   Spearman correlation coefficients demonstrating the relationship 
between our proposed PTA scale and existing PTA scales
Proposed PTA scalea
1st administration 2nd administration 
(one hour)
3rd administration   
(24 hours)
GOAT 0.66 0.67 0.59
MOPTAS 0.76 0.79 0.81
WPTAS 0.74 0.73 0.80
R-WPTAS 0.75 0.65 0.76
aAll correlations were significant at p<0.0001. PTA, post-traumatic amnesia; GOAT, Galveston orientation 
and amnesia test; MOPTAS, modified Oxford PTA scale; (R-)WPTAS, (Revised-)Westmead PTA scale.
Table 6   Sensitivity, specificity and AUCs (ROC analysis) of our proposed PTA 
scale and existing PTA scales
1st administration one hour after  
1st administration
24 hours after  
1st administration
PT
A
 
Sc
al
e
Se
ns
.
Sp
ec
.
A
U
C
95
%
 C
.I.
Se
ns
.
Sp
ec
.
A
U
C
95
%
 C
.I.
Se
ns
.
Sp
ec
.
A
U
C
95
%
 C
.I.
New  
PTA scale
68 77 0.77 0.69 - 0.85 76 91 0.85 0.73 - 0.97 80 95 0.89 0.81 - 0.97
GOAT 22 100 0.71 0.63 - 0.80 10 100 0.76 0.61 - 0.91 11 100 0.75 0.63 - 0.86
MOPTAS 92 43 0.84 0.77 - 0.90 67 91 0.78 0.64 - 0.93 85 100 0.92 0.86 - 0.99
WPTAS 89 43 0.80 0.73 - 0.87 57 91 0.75 0.60 - 0.90 83 100 0.91 0.84 - 0.98
R-WPTAS 46 97 0.72 0.64 - 0.80 38 96 0.66 0.50 - 0.83 50 100 0.74 0.63 - 0.86
AUC, area under the curve; ROC, receiver operating characteristic; PTA, post-traumatic amnesia; Sens., 
Sensitivity, %; Spec., Specificity, %. Based on optimal scores. C.I., confidence interval. GOAT, Galveston 
orientation and amnesia test; MOPTAS, modified Oxford PTA scale; (R-)WPTAS, Revised-Westmead PTA 
scale.
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Discussion 
We derived and externally validated a new PTA scale consisting of seven objective 
items including an anterograde memory test of three words. In general, the new 
scale proved to have equal discriminative capacity compared to existing PTA scales, 
while being more practical, less time consuming and examiner independent.
 An essential feature of ongoing PTA is the inability to store new information. 
Therefore, anterograde memory testing should be included in a PTA scale.97 At 
present, several acknowledged PTA scales, i.e. MOPTAS and (R-)WPTAS, use pictures 
as memory items. However, the use of words is probably more practical. Moreover, 
in the derivation cohort the specificity of words as memory items was not inferior to 
pictures but had a higher sensitivity, confirming earlier findings.180-182 On the other 
hand, pictures might still be useful in patients with dysphasia disorders or in case of 
a language barrier. In line with previous research,181 compared to recognition, free 
recall of memory items was overall more sensitive and equally specific in diagnosing 
patients with TBI. Moreover, in the validation cohort, free recall of words showed 
higher discriminative values (AUCs: 0.71-0.87) than recognition (AUCs: 0.60-0.71) on 
three consecutive administrations. One explanation for this finding may be that 
after having sustained a TBI recognition of memory items recovers more swiftly 
than free recall of memory items.98, 180, 182
 For the external validation of the Nijmegen PTA scale, we recruited a new cohort 
of participants. Using ROC analysis we studied the discriminative value of our scale 
across three consecutive administrations in relation to existing PTA scales. During all 
three test moments our PTA scale showed good discriminative values (AUCs: 0.77, 
0.85 and 0.89) and even the highest value of all scales at the second administration 
(one hour after initial administration). Although not entirely comparable, the 
performances of our PTA scale are in agreement with a recent study on the accuracy 
of the R-WPTAS in the first 24 hours after mild TBI:183 The specificity of the R-WPTAS 
was 91%, compared to the 84% maximum specificity of our scale, whereas the 
sensitivity of the R-WPTAS scale proved 60% and 80% for our proposed PTA scale. 
 This study has some limitations. Because no gold standard for the assessment 
of PTA exists, we evaluated test performances of TBI patients against control 
subjects. The proportion of patients that failed a test item was interpreted as the 
sensitivity of that particular item. However, as not all TBI patients suffer from PTA,46 
the sensitivity of test items appeared relatively low. Specificity was evaluated by 
administrating the test to control subjects without previous head injury, who 
consequently did not suffer from PTA. Hence, we think that the specificity of the test 
items was determined satisfactorily. Furthermore, in the validation study we 
compared the Nijmegen PTA scale with currently acknowledged PTA scales, which 
served as surrogate gold standards. In general, we found correlations of more than 
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0.70 indicating that the level of performance on our PTA scale accurately estimates 
the cognitive state of the patient. However, no other measures of cognitive 
functioning were administrated. 
 In the derivation cohort, some differences in the demographic characteristics 
existed between patients and controls. The control group consisted of more males, 
and controls were older than the moderate/severe TBI patients. To our knowledge, 
no evidence exists that gender effects PTA test performance or PTA emergence. 
Furthermore, older age is normally associated with poorer cognitive test performance. 
Despite their older age, controls were generally able to obtain maximum scores on 
all test items. In both study cohorts the moderate/severe TBI patients had received 
less formal education than the mild patients and the controls. This might have 
influenced the performance of the moderate/severe patients in a negative way, 
although we think that also most of the lower educated subjects have to be able to 
answer the questions of the different PTA scales correctly.   
 Some caution is needed when interpretating the results since the number of 
moderate/severe TBI patients was restricted possibly reducing the generalizability 
of our scale to this patient category. And, the number of mild TBI patients tested on 
consecutive trials decreased which may have increased the sensitivity at later ad-
ministrations. It is possible that assessing PTA at later stages after injury might have 
lead to higher sensitivity because better performing patients were already 
discharged from the hospital. Furthermore, in half of the subjects participating in 
the derivation study and in all participants of the validation study, words were 
administered as memory items. However, the MOPTAS and (R-)WPTAS scales 
normally use a set of pictures to assess a patient’s memory. Substitution of picture 
recognition scores with word recognition may have influenced the results. Previous 
studies have shown that picture recognition and recall are less sensitive but equally 
specific to word recognition and recall.180-182
 We have developed a PTA scale that proved to be accurate in discriminating TBI 
patients in PTA from control subjects. However, we did not specifically focus our 
study on the criteria that are required to consider a patient as emerged from PTA. 
Nevertheless, we consider it reasonable to state that two consecutive maximum 
test results preclude ongoing PTA.
 In this study the inter-rater reliability of our new PTA scale has not been 
determined. Moreover, we did not study the association of PTA test scores with 
other TBI (severity) indices - e.g. GCS score, duration of loss of consciousness, and 
imaging characteristics - and outcome. These additional studies are valuable for 
further validation of our PTA scale. We also think that an external validation 
particularly in a larger cohort of moderate/severe TBI patients may be favorable.
 PTA assessment may be further improved, especially in patients with MTBI at 
an ED. We suggest that the diagnostic accuracy of the three-word memory test 
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deserves additional examination, particularly over a time period of 10 to 30 minutes 
after the first assessment. Moreover a stricter criterion might be developed on the 
basis of which a patient can be considered as emerged from PTA. Also, research 
aimed at a more demanding memory task, for instance a four-item memory test,184 
might contribute to the development of more sensitive PTA scales. 
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Abstract
Mild traumatic brain injury (mTBI) is a common heterogeneous neurological 
disorder with a wide range of possible clinical outcomes. Accurate prediction of 
outcome is desirable for optimal treatment. This study aimed both to identify the 
demographic, clinical, and computed tomographic (CT) characteristics associated 
with unfavorable outcome at 6 months after mTBI, and to design a prediction model 
for application in daily practice. All consecutive mTBI patients (Glasgow Coma Scale 
[GCS] score: 13–15) admitted to our hospital who were age 16 or older were included 
during an 8-year period as part of the prospective Radboud University Brain Injury 
Cohort Study (RUBICS). Outcome was assessed at 6 months post-trauma using the 
Glasgow Outcome Scale-Extended (GOSE), dichotomized into unfavorable (GOSE 
score 1–6) and favorable (GOSE score 7–8) outcome groups. The predictive value of 
several variables was determined using multivariate binary logistic regression 
analysis. We included 2784 mTBI patients and found CT abnormalities in 20.7% of 
the 1999 patients that underwent a head CT. Age, extracranial injuries, and day- 
of-injury alcohol intoxication proved to be the strongest outcome predictors. The 
presence of facial fractures and the number of hemorrhagic contusions emerged as 
CT predictors. Furthermore, we showed that the predictive value of a scheme based 
on a modified Injury Severity Score (ISS), alcohol intoxication, and age equalled the 
value of one that also included CT characteristics. In fact, it exceeded one that was 
based on CT characteristics alone. We conclude that, although valuable for the 
identification of the individual mTBI patient at risk for deterioration and eventual 
neurosurgical intervention, CT characteristics are imperfect predictors of outcome 
after mTBI.
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Introduction
Mild traumatic brain injury (mTBI) is one of the most common neurological disorders, 
with an incidence of 100–300/100,000 population.5 To optimize treatment and for 
prognostic purposes, knowledge of the demographic, clinical, and radiological 
parameters related to adverse outcomes are relevant.
 Computed tomography (CT) imaging of the brain is the gold standard to detect 
acute intracranial abnormalities related to head injury. In mTBI, CT is primarily used 
to identify life-threatening hematomas (extradural, subdural, and intraparenchy-
mal), and other abnormalities including depressed skull fractures, that may require 
neurosurgical intervention, and further to decide if patients should be admitted, 
transferred to a neurosurgical center, or discharged.46, 67, 69, 75, 185, 186 The majority of 
mTBI patients show normal CT scan findings.106, 187 However, the incidence of CT 
abnormalities found after mTBI differs considerably among studies, ranging from 
3.3–38.8%, depending on the inclusion and exclusion criteria used.58, 66, 67, 69, 70, 135, 137, 
188-206 In a selected group of patients with clinical signs of skull (base) fractures the 
percentage of intracranial abnormalities found on head CT may reach 70.2%.207 The 
value of CT in identifying acute life-threatening hematomas in individual patients 
has been clearly established. For this reason exploration of the association between 
CT abnormalities and the long-term effects of mTBI seems reasonable. However, the 
search for CT predictors of long-term outcome after mTBI has yielded conflicting 
results thus far. Both a positive correlation,41, 135-142 and an absence of correlation143, 208 
between the presence of intracranial abnormalities on CT and 6- to 12-month 
outcome have been found. The primary outcome measures in these studies differed 
considerably, and varied from death/survival to cognitive functioning and the 
presence of post-traumatic complaints. Furthermore, the CT characteristics that 
have surfaced as predictors of adverse outcome differ per study. Traumatic 
subarachnoid hemorrhage,140 edema,142 the presence of focal lesions,141, 142 visible 
hematomas,138 signs of diffuse axonal injury, signs of parenchymal damage,139 and 
the size of focal lesions,136 all have been identified as outcome predictors. Finally, the 
mere presence of acute CT abnormalities,135, 137 and the overall CT appearance,140 have 
also been suggested to be associated with functional outcome. Unfortunately, it is 
difficult to draw solid conclusions from these studies of the predictive value of CT 
for mTBI outcomes, because CT predictors were not compared with clinical and 
demographic factors,139, 142 the studies used relatively small sample sizes,136, 141, 142 or 
data were only analyzed in a univariate way.137, 141, 143 In addition, mTBI patients were 
combined with more severely brain-injured patients.136, 138, 140, 141, 209 This may mistakenly 
result in concluding that CT variables are predictive of outcome for all TBI severities, 
though the actual predictive value of the CT abnormalities is based on their 
predictive power in the most severely affected patients.
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 In contrast, studies investigating clinical and demographic predictors of 
outcome, but excluding radiological characteristics, emphasize the predictive ability 
of the Glasgow Coma Scale (GCS), post-traumatic amnesia (PTA), initial complaints 
(headache, nausea, and dizziness), age, and gender for mTBI.117, 210 Whereas hypoxia 
and hypotension are strong predictors in moderate and severe TBI,151 they have not 
emerged as outcome predictors in mTBI.117 In a multiple regression analysis PTA, but 
not GCS score at hospital admission, predicted outcome as assessed with the 
Glasgow Outcome Scale (GOS).211 This predictive value of PTA, however, was not 
confirmed by others.126, 143 Additional extracranial injuries such as long bone or pelvic 
fractures may prolong the rehabilitation period and are independent outcome 
predictors in mTBI.120, 134, 138 Furthermore, it has been consistently shown that acute 
post-traumatic complaints (e.g., dizziness, headache, or vomiting) in the ED predict 
post-traumatic complaints at 1–6 months post-injury.120, 212-214 Interestingly, GCS score 
had only a very modest predictive capacity in a number of studies.92, 120, 143 Finally, 
using multivariate analysis, results of a large prospective study demonstrated the 
predictive value of age, pre-existing physical limitations, and a history of brain 
illness;215 however, the variance in outcomes in this study was low.
 A recent large international multicenter study investigated the predictive value 
of demographic, clinical, and CT characteristics multivariately in patients suffering 
from mild (GCS score 13–14), moderate (GCS score 9–12), or severe (GCS score <8) 
TBI.41 The GCS score, pupil reactivity, major extracranial injury, age, and several CT 
characteristics (compression of the basal cisterns and third ventricle, subarachnoid 
hemorrhage [SAH], midline shift, and presence of a non-evacuated hematoma) 
were the strongest independent predictors of unfavorable outcome at 6 months 
post-injury. However, it is not possible to use these factors in the modeling of mTBI 
outcome prediction because no subdivision was made by injury severity.
 Only a few studies have compared the relative predictive ability of CT characteristics 
with demographic and acute clinical variables in a multivariate analysis.120, 135, 138, 140 
The presence of acute CT abnormalities was associated with an increasingly worse 
6-month outcome with decreasing GCS score.135 In two studies, both including more 
severely-injured TBI patients, the presence of a traumatic hematoma,138 and a 
combination of traumatic SAH and poor overall CT appearance140 were independent 
predictors when age, GCS score, and pupil reactivity were also entered into the 
prediction models. In a recent study CT abnormalities did not improve outcome 
prediction in mTBI when the patient’s education, subacute post-traumatic symptoms 
(nausea, vomiting, and pain), and concurrently sustained extracranial injuries were 
included.120 
 In this study we aim to gain insight into the composition and frequency of 
several demographic, clinical, and CT variables of mTBI. To identify the predictors of 
functional outcome after mTBI, we compared CT characteristics with demographic 
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and clinical variables in a prospective cohort of consecutive patients. After 
multivariate analysis, predictive models were designed that may be useful in daily 
clinical practice.
Methods
Subjects 
All patients with mTBI aged 16 and older admitted to the emergency department 
(ED) of the Radboud University Nijmegen Medical Centre (RUNMC), a level I trauma 
center with a referral area of 2.5 million inhabitants, between January 1998 and 
January 2006, were eligible for inclusion. mTBI was defined as an acute insult to the 
brain caused by an external physical force, and an ED GCS score of 13–15 after initial 
resuscitation, or a GCS score of 13–15 at admission before sedation and intubation 
during resuscitation for a non-neurological cause. Patients suffering from 
penetrating head injury, defined as head injury caused by penetration of a foreign 
body like a knife or bullet, were excluded. Polytrauma patients with significant 
extracranial injury (Injury Severity Score [ISS] >16) were not excluded.
 The data for this study were obtained from the Radboud University Brain Injury 
Cohort Study (RUBICS). RUBICS is an ongoing prospective observational cohort 
study that started January 1, 1998. All consecutive patients, including children, 
admitted to the ED of the RUNMC with a diagnosis of mild, moderate, or severe TBI 
are included. Patients are registered in the RUBICS database when according to the 
hospital protocol, a neurologist and/or neurosurgeon is consulted in the ED when a 
head trauma patient is presented with: (1) a GCS score of 3–14; or (2) a GCS score of 
15 with loss of consciousness (LOC) and/or PTA; or (3) a GCS score of 15 without LOC 
or PTA, but fulfilling additional criteria according to the guidelines proposed by the 
European Federation of Neurological Societies (EFNS), which include unclear or 
ambiguous accident history; persistent or progressive headache, nausea, and 
vomiting; intoxication with alcohol or drugs; epileptic seizure; coagulation disorders; 
use of platelet aggregation inhibitors or oral anticoagulation; confusion, retrograde 
amnesia, or focal neurological deficits; age >60 and <2 years; high-energy accident; 
or visible trauma above the clavicles (including signs of skull or skullbase fracture).46 
Recently it was shown that the EFNS guidelines have 100% sensitivity for the 
identification of neurocranial complications after minor head injury.68 Using these 
guidelines all mTBI patients would be included in the RUBICS database, which is also 
in accordance with the criteria of the mTBI Committee of the Head Injury Interdisci-
plinary Special Interest Group of the American Congress of Rehabilitation Medicine.47
 The RUBICS database comprises demographic data (age and gender), clinical 
and radiological injury variables, and outcome scores. Injury characteristics recorded 
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for this study include: injury type, presence of hypotension (systolic BP <90mmHg, 
equal to shock class III–IV),63 and hypoxia (oxygen saturation <90% as measured by 
pulse oximetry), during the prehospital period or at the ED. Further, the Abbreviated 
Injury Scale of the Head (AISH) score, ISS score,174 GCS score, pupil responses, presence 
and duration of coma, and PTA were also recorded. The presence and duration of 
both LOC and PTA were based on witness and paramedic reports when available. In 
the ED, the presence of amnesia and ongoing PTA were determined by emergency 
physicians and neurological consultants using a PTA questionnaire. When 
information regarding the pre-hospital presence of LOC and PTA was ambiguous 
this was recorded as such, but for statistical analysis these cases were added to the 
“absent” category. Finally, we recorded a clinical suspicion of day-of-injury alcohol 
intoxication or definite day-of-injury intoxication when the blood alcohol level 
exceeded >100mg/L, and the use of oral anticoagulants. Additionally, several CT 
characteristics and the Trauma Coma Databank (TCDB) CT classification were 
recorded.62 To quantify additional extracranial injuries, an alternative modified ISS 
score was calculated based on the three most severely injured body areas excluding 
the head, as the ISS-extracranial score (ISSe). Patients were categorized as having 
isolated mTBI (versus polytrauma) when they sustained a mild TBI without any 
substantial additional injury, defined by an AIS score <2 in one of the AIS-ISS body 
regions. Patients were assessed by neurologists (residents) and/or neurosurgeons 
(residents) according to hospital protocol, and data were recorded as such, after 
which all clinical data were collected by a trained research nurse as soon as possible 
post-injury, generally on the day of injury, and recorded on forms before entry into 
our digital database.
Outcome assessment 
Outcome was assessed at 6 months post-injury according to the Glasgow Outcome 
Score-Extended (GOSE), using a structured interview during regular visits to the 
outpatient clinic or during consultation by telephone.178 In short, the GOSE is an 
8-point scale expressing functional outcome, ranging from 1 = death, to 8 = complete 
recovery. GOSE score 2 represents a vegetative state, GOSE score 3 indicates 24-h 
dependency (at home), GOSE 4 score means that the patient is dependent but can 
do without help for at least eight consecutive hours, GOSE score 5 denotes 
independence in activities of daily living but no resumption of former employment, 
GOSE score 6 means reduced capacity for work, and GOSE score 7 indicates 
resumption of former employment, but with persistent complaints that interfere 
with activities of daily living.178 A GOSE score of 6 or lower was considered as an 
unfavorable outcome in this study and was dichotomized as such for statistical 
purposes. Patients not visiting the outpatient clinic were sent a GOSE questionnaire 
by regular mail, and if not returned a reminder was sent.115 Finally, we attempted to 
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reach all non-responding patients by telephone. If no outcome was obtained directly 
from the patient, charts and correspondence were reviewed to determine outcome 
and construct a GOSE score using the structured interview178 as a guideline. Because 
retrospective determination of outcome based on chart review rather than a formal 
personal interview may be considered artificial and susceptible to errors, several 
analyses were also carried out without inclusion of these patients. Outcomes 
determined within 3 months were also accepted if no outcome at 6 months was 
available. When the patient had a GOSE score of 7 or 8 by 4.5 months post-injury, it 
was considered a definitive outcome. Patients with no outcome score or an outcome 
score that did not meet the above criteria were considered lost to follow-up.
Computed tomography 
Patients were scheduled to undergo a CT scan of the head according to EFNS 
guidelines.46 Only the initial CT scans of patients admitted to the hospital within 72h 
after sustaining head injury were used in this study. Each CT scan was scored as 
soon as possible post-injury by one of three raters (B.J., T.B. and P.E.V.) using a 
predefined format (see below). In addition, all scans were classified according to the 
TCDB CT classification.62 Using a structured format the following CT characteristics 
were recorded on data entry sheets: 
•	 	The status (presence, compression, or absence) of the ventricular system and 
the cisterns
•	 	The presence, location, type, number, and size of any low-, mixed-, or high-density 
lesions, including subdural hematomas (SDH), epidural hematomas (EDH), in-
traparenchymal hematomas, and hemorrhagic contusions; intraparenchymal 
hematomas and hemorrhagic contusions were combined into one category, 
hemorrhagic contusions; where applicable the volume of space-occupying 
lesions was calculated as previously described176, 177
•	 	The presence and type of subarachnoid and intraventricular hemorrhage
•	 	The presence and location (subcortical, basal ganglia/corpus callosum, or 
brainstem) of punctate hemorrhages (diameter <5mm)
•	 	The presence and location of edema (focal or diffuse)
•	 	The presence and quantity of midline shift
•	 	The presence of pneumocephalus
•	 	The presence and type of facial, vault, or skullbase fractures
•	 	The presence of extracranial hematomas
Statistical analysis 
To detect significant differences between the patients included in the outcome 
analysis and the patients lost to follow-up, the Student’s t-test, chi-square test, and 
non-parametric variants were used where applicable. We used binary logistic 
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regression analysis to identify the demographic, clinical, and CT characteristics 
associated with unfavorable outcome after mTBI. Missing data were excluded from 
the analysis. As dependent variables we dichotomized the 6-month outcome as 
favorable (GOSE score 7 or 8), or unfavorable (GOSE score 1–6). Initially all 
demographic, clinical, and CT characteristics, were tested univariately. Age was 
analyzed per year, and GCS, AISH, ISS, and ISSe scores were all analyzed numerically. 
The other clinical variables were binary (presence versus absence). With regard to 
the CT parameters, midline shift was analyzed per millimeter, the volume of the 
lesions per milliliter, and the number of hematomas/contusions was assessed. The 
remaining variables were nominal: ‘largest lesion,’ ordinal: ‘presence of lesions,’ or 
dichotomous categorical variables. The clinical variables were analyzed for the entire 
mTBI group, and CT characteristics were analyzed only in patients in whom a CT of 
the head was performed.
 Possible predictors of unfavorable outcome at 6 months post-mTBI were 
analyzed multivariately, using the forward stepwise likelihood ratio method. The 
clinical and demographic variables were combined, as were the CT variables. Besides 
a multivariate analysis including the ISS, a combination of AISH and ISSe replacing 
the ISS was included as an analogue multivariate analysis. In addition, by using the 
independent predictive variables, three prediction rules were designed to enable the 
utilization of these predictors in daily clinical practice: one “clinical rule,” comprising 
demographic and clinical variables, and one “CT rule,” comprising CT parameters. 
The independent demographic, clinical, and CT predictors were combined, and their 
predictive value was subsequently used to design the third “combination” rule. The 
three prediction models were analyzed for their sensitivity and specificity in 
predicting unfavorable outcome using receiver operating characteristic (ROC) 
analysis, quantified by the area under the receiver operating curve (AUC). This is a 
measure of predictive discrimination, in which a score of 0.50 (50%) is equivalent to 
random guessing, and a score of 1.00 (100%) is perfect prediction. The higher the 
AUC, the higher the sensitivity and specificity (i.e., the ability to correctly predict 
outcome).
 Previously we demonstrated a strong relationship between extracranial injuries 
and outcome after mTBI.134 Therefore, we also explored the predictive value of all 
variables in isolated mTBI using the same procedures as those described above.
 Throughout we used a two-sided p value of 0.01 as the criterion for significance, 
except for the AUC (for which we used p <0.05). We chose 0.01 in order to avoid 
irrelevant findings of statistical significance due to the large number of variables 
involved.
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Results
Figure 1 shows the inclusion and exclusion criteria and the total numbers of patients 
considered for the study. The demographic and clinical characteristics at presentation 
were evaluated in 2784 patients, the CT characteristics were evaluated in 1999 
patients, and for the outcome prediction 1069 patients were analyzed. In 53 (5.0%) 
of these patients the GOSE scores were determined based on outcome information 
from the patients’ charts.
Demographic and clinical characteristics of all included patients, and the patients 
eventually used in the outcome analysis, are shown in Table 1.
Figure 1   Diagram showing the inclusion and exclusion of patients in this study
RUBICS, Radboud University Nijmegen Brain Injury Cohort Study; TBI, traumatic brain injury; ED, emergency 
department; CT, computed tomography; MTBI, mild traumatic brain injury.
4188 TBIs included in RUBICS database (1998-2005) 
Excluded  
675 age < 16 yrs  
  12 penetrating TBI  
126 moderate TBI  
574 severe TBI  
  17 ED/ CT > 72 hours  
 
2784 Mild TBI  
 
1069 included in outcome analysis
785 no head CT  1999 head CT  
930 lost to follow-up  
- from abroad (n=25)  
- non responders (n=905)
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Table 1   Patient demographic and clinical characteristics at presentation
Variable
 A: MTBI 
total                   
(n= 2784)
B: CT-
positive     
(n=1999)       
C: CT-positive 
& GOSE-
positive 
(n=1069)
D: CT-positive 
& GOSE- 
negative 
(n=930)
Difference 
C and D
Gender - male 1823 (66%) 1351 (68%) 695 (65%) 656 (71%) p=0.008
Age - mean (sd)a 41.2 (19.0) 42.7 (19.3) 42.4 (18.5) 43.0 (20.3) n.s.
Trauma mechanism
Traffic 1534 (55%) 1092 (55%) 615 (58%) 477 (51%) p<0.0001
Fall 793 (29%) 591 (30%) 304 (28%) 287 (31%)
Sports 160 (6%) 109 (6%) 64 (6%) 45 (5%)
Violence 231 (8%) 165 (8%) 64 (6%) 101 (11%)
Suicide 20 (1%) 12 (1%) 6 (1%) 6 (1%)
Other/ missing 46 (2%) 30 (2%) 16 (2%) 14 (2%)
GCS at ED 13 130 (5%) 118 (6%) 81 (8%) 37 (4%) p<0.0001
                   14 342 (12%) 318 (16%) 189 (18%) 129 (14%)
                   15 2312 (83%) 1563 (78%) 799 (75%) 764 (82%)
AISHa 2.1 (0.8) 2.2 (0.8)  2.3 (0.9) 2.0 (0.7) p<0.0001
ISSa 8.7 (7.4) 9.1 (7.6) 10.0 (8.1) 8.1 (6.8) p<0.0001
Hypotensive episode 34 (1%) 33 (2%) 20 (2%) 13 (1%) n.s.
Hypoxic episode 33 (1%) 33 (2%) 22 (2%) 11 (1%) n.s.
At least one non-
reactive pupil
28 (1%) 26 (1%) 18 (2%) 8 (1%) n.s.
Intoxication Ethanol 766 (28%) 607 (30%) 275 (27%) 332 (36%) p<0.0001
Ethanol ‰ at EDa 2.1 (0.9) 2.2 (0.9) 2.1 (0.9) 2.2 (1.0) n.s.
Presence of PTA 1511 (54%) 1228 (61%) 712 (67%) 516 (56%) p<0.0001
PTA duration (min.)b 15 30 30 15 n.s.
Presence of LOC 1060 (38%) 811 (41%) 460 (43%) 351 (38%) p=0.039
LOC duration (min.)b 5 5 5 5 n.s.
Use of 
Anticoagulants
117 (4%) 104 (5%) 54 (5%) 50 (5%) n.s.
Neurosurgical 
intervention
19 (1%) 19 (1%) 16 (2%) 3 (0.3%) p=0.007
Outcome (n=1226) (n=1069)
Death (GOSE 1) 40 (3%) 38 (2%) 38 (4%) - -
Unfavorable  
(GOSE 1-6)
285 (23%) 257 (13%) 257 (24%) - -
aMean (sd); bmedian; all other variables: n and (%). MTBI, mild traumatic brain injury; GCS, Glasgow Coma 
Scale; ED, emergency department; AISH, Abbreviated Injury Scale of the Head; ISS, Injury Severity Score; 
GOSE, Glasgow Outcome Scale-Extended; PTA, post-traumatic amnesia; LOC, loss of consciousness; min., 
minutes; sd, standard deviation; n.s., not significant.
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 We focused our analysis on the patients that underwent a head CT. In this group 
demographic and clinical data were missing in less than 1.5%, except for the presence 
of alcohol intoxication (3%; n=61). The presence of PTA was uncertain in 261 patients 
(9.4%), and LOC in 694 (25%) patients. Our study participants were predominantly 
male (68%) with a mean age of 42.7 years. The leading causes of trauma were traffic 
accidents (55%) and falls (30%). The majority of patients experienced mild trauma, as 
represented by the low mean ISS score of 9.1. In 19 (0.7%) patients neurosurgical 
intervention was necessary. Seven patients were operated on for EDH (one in 
combination with compression fracture), seven patients were operated on for SDH, 
three patients for a hemorrhagic contusion (one in combination with a compression 
fracture), and two patients for a combination of an EDH and a SDH. A total of 38 (2%) 
patients died, and 257 (13%) mTBI patients had an unfavorable outcome (GOSE score 
1–6). Although the differences were small, the patients included in the outcome 
prediction analyses differed significantly from the patients lost to follow-up, with 
regard to gender, trauma mechanism, GCS at the ED, AISH score, ISS score, day-of-injury 
alcohol intoxication, presence of PTA (for duration of PTA they did not differ 
significantly), and neurosurgical intervention. Thus they had a more severe injury 
profile. The distribution of major CT characteristics, including the patient distribution 
over the different categories of the TCDB CT classification, is presented in Table 2.
 For all CT characteristics fewer than 0.5% of the required values were missing. 
Intracranial abnormalities were found in 389 (20%) patients. When vault and 
skullbase fractures were included, abnormalities were present in 414 (21%) patients. 
Edema was the most frequent intracranial abnormality (239; 12%), with an inter-rater 
agreement (B.J. and P.E.V.) of 82%. Isolated edema, focal or diffuse, without any 
other intracranial abnormality was seen in 63 (3%) patients. In 186 patients (9%) one 
or more lesions, excluding punctate hemorrhages, were present; in 40 patients (2%) 
an EDH was the dominant lesion, in 50 patients (3%) an SDH was the dominant 
lesion, and in 95 patients (5%) a hemorrhagic contusion was the dominant lesion. Of 
all lesions, 40 had a volume of 25mL or more. The mean volume of the largest lesion 
per patient was 21.0mL (median: 6.8mL). Traumatic SAH was demonstrated in 115 
patients (6%), and 67 patients (3%) showed evidence of abnormal basal cisterns. 
Finally, in 52 patients (3%) there was a midline shift (mean 4.6mm; median 3.9mm). 
Subdivided by GCS score, intracranial abnormalities were found in 16% of patients 
with a GCS score of 15, 27% of patients with a GCS score of 14, and 46% of patients 
with a GCS score of 13. Aside from the status of the foramen magnum and basal 
cisterns, the patients lost to follow-up were significantly less severely injured 
according to CT abnormalities, than patients for whom GOSE scores were available.
 Univariate binary logistic regression analysis showed that several clinical and CT 
characteristics predict outcome after mTBI (Table 3). In addition we re-analyzed the 
predictive value of the presence of PTA and LOC, including the ambiguous scores; again 
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Table 2   CT characteristics of 1999 MTBI patients included in the RUBICS 
database (1998-2005)
CT characteristics A: MTBI 
patients         
(n = 1999)
B: GOSE-
positive 
(n=1069)   
C: GOSE-
negative 
(n=930)    
Difference    
B & C
Intracranial abnormalities 389 (20%) 281 (26%) 108 (12%) p < 0.0001
within GCS 13   54 (46%)  45 (56%)   9 (24%)
within GCS 14   84 (27%)  62 (33%) 22 (17%)
within GCS 15 251(16%) 174 (22%) 77 (10%)
Intracranial abnormalities & 
fractures 
414 (21%) 299 (28%) 115 (12%) p < 0.0001
TCDB-classification p < 0.0001
Diffuse Injury I 1607 (80%) 786 (74%) 821 (88%)
Diffuse Injury II   311 (16%) 217 (20%) 94 (10%)
Diffuse Injury III  30 (2%) 24 (2%) 6 (1%)
Diffuse Injury IV      1 (0.1%)     1 (0.1%) -
Evacuated mass lesion or 
  neurosurgical intervention
 19 (1%) 16 (2%)    3 (0.3%)
Non-evacuated mass lesion  28 (1.4%) 23 (2%) 5 (1%)
- missing     3 (0.1%)     2 (0.2%)    1 (0.1%)
Foramen magnum p = 0.038
- normal 1987 (99%) 1059 (99%) 928 (99.8%)
- abnormal   12 (1%)  10 (1%)   2 (0.2%)
- missing - -
Basal cisterns p < 0.0001
- normal 1932 (97%) 1013 (96%) 919 (99%)
- abnormal   67 (3%)  56 (5%) 11 (1%)
- missing    - - -
No lesion 1809 (91%) 919 (86%) 890 (96%) p < 0.0001
- one  lesion 130 (7%) 98 (9%) 32 (3%)
- multiple lesions   56 (3%) 49 (5%) 7 (1%)
- missing       4 (0.2%)     3 (0.3%)    1 (0.1%)
Dominant (largest) lesion p < 0.0001
- EDH 40 (2%) 32 (3%)  8 (1%)
- SDH 50 (3%) 41 (4%)  9 (1%)
- Hemorrhagic contusion 95 (5%) 73 (7%) 22 (2%)
- missing  5 (0.3%)     4 (0.4%)     1 (0.1%)
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Table 2   Continued
CT characteristics A: MTBI 
patients         
(n = 1999)
B: GOSE-
positive 
(n=1069)   
C: GOSE-
negative 
(n=930)    
Difference    
B & C
Volume dominant lesion (ml)a 21.0 (39.2) 21.4 (40.0) 19.6 (36.0) n.s.
EDH - present   49 (3%) 40 (4%) 9 (1%) p < 0.0001
SDH - present   69 (4%) 56 (5%) 13 (1%) p < 0.0001
Hemorrhagic contusion  
present
116 (6%) 92 (9%) 24 (3%) p < 0.0001
Total number of lesions 
- EDH   49 40 9 p < 0.0001
- SDH   77 61 16 p < 0.0001
- Hemorrhagic contusion 142 112 30 p < 0.0001
- missing     2 2 0
SAH - presence 115 (6%) 83 (8%)  32 (3%) p < 0.0001
- focal, thickness < 1 mm 72 (4%) 54 (5%)  18 (2%) p < 0.0001
- focal, thickness > 1 mm   24 (1%) 15 (1%)   9 (1%)
- diffuse/ intraventricular   19 (1%) 14 (1%)   5 (1%)
- missing       4 (0.2%)     3 (0.3%)     1 (0.1%)
Petechial hemorrhage 75 (4%) 52 (5%) 23 (3%) p = 0.009
- subcortical 69 (4%) 49 (5%) 20 (2%) p = 0.005
- basal ganglia     6 (0.3%)   5 (1%)      1 (0.1%)
- brainstem     3 (0.2%)     1 (0.1%)      2 (0.2%)
- missing     4 (0.2%)     3 (0.3%)      1 (0.1%)
Edema   239 (12%) 174 (16%) 65 (7%) p < 0.0001
- focal  197 (10%) 143 (13%) 54 (6%) p < 0.0001
- diffuse  42 (2%) 31 (3%) 11 (1%)
- missing      4 (0.2%)     4 (0.4%)     1 (0.1%)
Vault fracture 69 (4%) 56 (5%) 13 (1%) p < 0.0001
- linear 63 (3%) 52 (5%) 10 (1%) p < 0.0001
- impression     6 (0.3%)     3 (0.3%)     3 (0.4%)
- missing     4 (0.2%)     3 (0.3%)     1 (0.1%)
Skullbase fracture 71 (4%) 60 (6%) 11 (1%) p < 0.0001
- missing     4 (0.2%)     3 (0.3%)     1 (0.1%)
Pneumocephalus 59 (3%) 50 (5%) 9 (1%) p < 0.0001
- missing     5 (0.3%)     4 (0.4%)    1 (0.1%)
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the presence of PTA (odds ratio [OR] 1.0, 99% confidence interval [CI] 0.7, 1.5) and LOC 
(OR 0.8, 99% CI 0.5, 1.2) were not indicative of outcome. When the univariate analysis 
was performed without the neurosurgical patients, the GCS (OR 0.8, 99% CI 0.6, 1.02), 
and the presence of pneumocephalus (OR 2.0, 99% CI 0.9, 4.4) lost their predictive value. 
Multivariate analysis of the demographic and clinical variables showed that age, ISSe, 
and AISH scores were predictors of unfavorable outcome, whereas day-of-injury alcohol 
intoxication was associated with a favorable outcome. The multivariate analysis was 
carried out without the neurosurgical patients as well, which did not change the results. 
A multivariate analysis of the possible clinical predictors and age done without the 53 
patients that had an interpreted GOSE score did not change the results; only the 99% CIs 
changed minimally (data not shown). These four variables were used to design the 
“clinical” predictive rule (Table 5). The combination of ISSe and AISH could be replaced by 
the total ISS score (OR 1.07, 99% CI 1.06, 1.1). Multivariate analysis of the CT characteris-
tics showed that the number of hemorrhagic contusions and the presence of facial 
fractures were outcome predictors (Table 3). From these characteristics the predictive 
“CT rule” was formulated (Table 5). The multivariate analysis of potential CT predictors 
was carried out sequentially, excluding the neurosurgical patients and the 53 patients 
mentioned above as well. Again the results did not change significantly; the OR of the 
number of hemorrhagic contusions slightly increased to 1.9 (99% CI 1.2, 3.1), as was true 
for the OR of the presence of facial fractures (OR 1.8, 99% CI 1.2, 3.0).
Table 2   Continued
CT characteristics A: MTBI 
patients         
(n = 1999)
B: GOSE-
positive 
(n=1069)   
C: GOSE-
negative 
(n=930)    
Difference    
B & C
Facial fracture 303 (15%) 184 (17%) 119 (13%) p = 0.006
- missing     4 (0.2%)     3 (0.3%)     1 (0.1%)
Midline shift 52 (3%) 41 (4%) 10 (1%) p < 0.0001
- > 5mm 13 (1%) 11 (1%)     2 (0.2%) p < 0.0001
- missing     1 (0.1%)     1 (0.1%) -
aMean (sd); all others = number (%). 
CT, computed tomography; RUBICS, Radboud University Brain Injury Cohort Study; MTBI, mild traumatic 
brain injury; GCS, Glasgow Coma Scale, TCDB, trauma coma databank; EDH, epidural hematoma; SDH, 
subdural hematoma; SAH, subarachnoid hemorrhage; GOSE, Glasgow Coma Scale-Extended.
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Table 3   Results of the univariate and multivariate analyses of clinical and CT 
characteristics (n=1069)
Univariate analysis Multivariate analysis
Characteristic O.R. 99% C.I. O.R. 99% C.I.
Clinical 
Gender 1.3 0.9-1.8
Age – yeara  1.02 1.01-1.03  1.02 1.01-1.03
GCS b 0.7 0.6-0.99
Abnormal pupillary response 1.6 0.4-5.8
Hypotensive episode 2.7 0.9-8.2
Hypoxic episode 2.2 0.7-6.9
AIS – headb 1.4 1.1-1.7              1.3 1.1-1.7
ISSb  1.07 1.05-1.09
ISSeb  1.06 1.04-1.09  1.06 1.03-1.1
Presence of PTA 0.7 0.5-1.0
Presence of LOC 0.8 0.5-1.1
Ethanol intoxication 0.4 0.3-0.7  0.5 0.3-0.8
Use of anticoagulants 1.8 0.8-3.8
Computed tomography
Foramen magnum - 
abnormal
3.2 0.6-16.5
Basal cisterns - abnormal 2.1 1.03-4.4
No lesion ref.
One lesion 1.5 0.8-2.7
Multiple lesions 3.1 1.5-6.7
Largest lesion - no lesion ref.
EDH 1.6 0.6-4.4
SDH 1.6 0.7-4.0
Hemorrhagic contusion 2.2 1.1-4.2
Number of EDHs per patientc 1.7 0.7-4.2
Number of SDH’s per patientc 2.0 0.9-4.1
Number of hem. cont. p.p.c 1.9 1.1-3.6 1.8 1.1-2.8
Dominant lesion volume (ml)d  1.01   1.0-1.02
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Thus age, ISSe, alcohol intoxication, and the number of hemorrhagic contusions 
emerged as significant outcome predictors after multivariate analysis of the 
combined demographic, clinical, and CT variables (Table 4). The third predictive rule, 
“combined,” was designed using these predictors (Table 5C). When we reanalyzed 
the multivariable analysis without, successively, the neurosurgical and the 
interpreted GOSE, the OR of the number of hemorrhagic contusions increased from 
1.9 to 2.1 (99% CI 1.2, 3.5).
 Of the patients with a head CT, 1315 (66%) suffered from an isolated mTBI. Of 
these patients, 223 (17%) had intracranial abnormalities. Abnormal CTs were found in 
165 (24%) patients in the polytrauma group. For outcome prediction 669 (51%) 
isolated mTBI patients could be analyzed. Unfavorable outcomes occurred in 128 
(16%) patients with isolated mTBI, in contrast to the 152 (36%) patients in the 
polytrauma group. Death occurred in 26 (3%) of patients with isolated mTBI, and in 
14 (3%) polytrauma patients.
 In the isolated mTBI group univariate (n=669; results not shown), and 
subsequent multivariate analysis of the demographic and clinical variables showed 
that age (OR 1.02; 99% CI 1.003, 1.03), AISH score (OR 1.5, 99% CI 1.2, 2.0), and 
Table 3   Continued
Univariate analysis Multivariate analysis
Characteristic O.R. 99% C.I. O.R. 99% C.I.
Computed tomography
Presence of petechial hem. 1.1 0.6-2.1
Presence of SAH 2.0 1.1-3.7
Presence of edema 1.8 1.1-2.8
Vault fracture 2.0 1.0-4.2
Skullbase fracture 1.4 0.7-2.9
Pneumocephalus 2.2  1.03-4.8
Facial fracture 1.8 1.1-2.8 1.7 1.1-2.7
Shift 2.0 0.9-4.7
- shift mmd 1.1 1.0-1.3
    aAge was computed per year; bcomputed per point on scale; cper hematoma, dper milliliter respectively per 
millimeter. 
CT, computed tomography; O.R., odds ratio; C.I., confidence interval; GCS, Glasgow Coma Scale; AIS, 
Abbreviated Injury Scale; ISS, Injury Severity Scale; ISSe, Injury Severity Score extracranial; PTA, post-traumatic 
amnesia; LOC, loss of consciousness; EDH, epidural hematoma; SDH, subdural hematoma; hem. (cont.), 
hemorrhagic (contusion); p.p., per patient; SAH, subarachnoid hemorrhage; ref., reference.
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day-of-injury alcohol intoxication (OR 0.3, 99% CI 0.2, 0.7) were predictors of 
outcome. When the CT parameters were analyzed, only the number of hemorrhagic 
contusions demonstrated independent predictive value (OR 2.4, 99% CI 1.3,4.4). 
After multivariate analysis of the demographic, clinical, and CT variables, age (OR 
1.02, 99% CI 1.004, 1.03), AISH score (OR 1.5, 99% CI 1.1,2.0), and alcohol intoxication 
(OR 0.3, 99% CI 0.2,0.7) proved to be outcome predictors. In this analysis, AISH was 
not replaced by the number of hemorrhagic contusions, in contrast to the analysis of 
the complete mTBI group. In conformity with the models predicting outcome in the 
entire mTBI group, in the isolated mTBI group, again three predictive rules were 
designed (Table 6).
Table 4   Results of the multivariate analysis of the combined clinical and CT 
characteristics
Characteristic O.R. 99% C.I.
Multivariate analysis (n = 1069)
Agea 1.02 (1.01-1.03)
ISSeb 1.07 (1.04-1.1)
Ethanol intoxication 0.5 (0.3-0.8)
Number of hemorrhagic contusions 1.9 (1.2-3.1)
Facial fracture(s)c 1.5 (0.9-2.5)
aAge was computed per year; bcomputed per point on scale; cnot significant. 
CT, computed tomography; O.R., odds ratio; C.I., confidence interval; ISSe, Injury Severity Score 
extracranial; PTA, posttraumatic amnesia.
Table 5   Rules for predicting unfavorable outcome at six months after MTBI 
(n=1069)
A. Clinical variables A= -2.8 + 0.017*age + 0.30*AISH + 0.070*ISSe – 0.80*ethanol 
intoxication
B. CT characteristics B= -1.3 + 0.58*number of hem. contusions + 0.52*presence of 
facial fracture(s)
C. Combined C= -2.2 + 0.018*age + 0.065*ISSe + 0.65*number of hem. 
contusions – 0.75*ethanol intoxication
Age in years, ISSe and AISH in points, ethanol intoxication and presence of facial fracture(s): 1 present, 0 
absent. To calculate the probability of an unfavorable outcome the value of A, B or C has to be inserted in 
the formula: 1/ (1 + e- A, B or C). MTBI, mild traumatic brain injury; CT, computed tomography; AISH, 
Abbreviated Injury Scale Head score; ISSe, Injury Severity Scale extracranial; hem., hemorrhagic.
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The results of the ROC analysis showed that the predictive value of both CT models 
was limited, with AUCs of 0.57 and 0.56 (Fig. 2 and Table 7). The “clinical” models 
demonstrated the highest predictive values. Combination of clinical and CT 
predictors, so-called combination models, did not improve the performance of the 
“clinical” models. In the mTBI group the rule based on clinical variables had a higher 
AUC than the rule based on the combination of clinical and CT parameters. This 
seems to contradict the rule that states that a wider choice of variables always leads 
to an improved model. However, it is a result of missing values and of the variable 
selection procedure, which dictated that only significant variables could be used. 
We therefore reran the model with less strict criteria and found that, although the 
AUCs increased slightly, the AUC of the model including clinical and CT characteristics 
never showed any significant improvement over the model using clinical variables 
only.
 The 10% of the mTBI patients with the lowest scores (young, alcohol-intoxicated 
patients without extracranial injuries and no intraparenchymal contusions), when 
assessed with the “combination” model had a probability of an unfavorable outcome 
of 7.8%. On the other hand, in the mTBI patients with the highest scores (elderly 
patients with extracranial injuries and intraparenchymal contusions, without 
alcohol intoxication), or the lowest 10%, the probability of an unfavorable outcome 
was 49.5%.
Table 6   Rules for predicting unfavorable outcome at six months after isolated 
MTBI (n=669)
A. Clinical variables A = -3.1 + 0.017*age + 0.43*AISH – 1.1*ethanol intoxication
B. CT characteristics B = -1.7 + 0.90*number of hem. contusions 
C. Combined C = -3.0 + 0.018*age + 0.38*AISH – 1.11*ethanol intoxication 
Age in years, AISH in points, ethanol intoxication: 1 present, 0 absent. To calculate the probability of an 
unfavorable outcome the value of A, B or C has to be inserted in the formula: 1/ (1 + e- A, B or C). MTBI, mild 
traumatic brain injury; CT, computed tomography; AISH, Abbreviated Injury Scale Head score; hem., 
hemorrhagic.
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Figure 2   Receiver Operating Characteristic (ROC) curves of three prediction 
models in the entire MTBI group (A), and three analogous models in 
isolated MTBI patients (B)
MTBI, mild traumatic brain injury; iMTBI, isolated MTBI; CT, Computed Tomography; Comb., combination.
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Discussion
The main finding of this prospective cohort study is that of all demographic and 
acute injury characteristics studied, age, extracranial injury (as represented by the 
ISS or ISSe), and day-of-injury alcohol intoxication were the strongest independent 
predictors of functional outcome at 6 months after mTBI. The only CT characteristic that 
added marginally to the prediction of outcome was the number of intraparenchymal 
hemorrhagic contusions.
 Our finding of the predictive value of age and additional extracranial injuries are 
in accord with other results seen in the literature.41, 120, 134, 138, 215 Of the clinical variables, 
PTA (present in 61% of patients), and LOC (present in 41% of patients) did not show 
predictive value after univariate analysis. The percentage of our patients with LOC 
and/or PTA appears to be lower than that found in the literature, where LOC was 
present in 47.2–64.4%,69, 70, 188 and PTA was present in 69.2–73.7%214 of mTBI patients. 
One explanation for this discrepancy may be that we categorized patients in whom 
the presence of PTA and LOC was unclear (9% for PTA and 25% for LOC) as not 
experiencing these sequelae. However, in the logistic regression analysis we 
analyzed the ambiguous PTA and LOC scores both included in and excluded from the 
“present” group, and found no significant difference. Further, we deliberately included 
patients without PTA and LOC, since the absence of these factors in head-injured 
patients does not fully rule out mTBI.57, 58
Table 7   Area under the Receiver Operating Characteristic Curve (AUC) of  
six models, three predicting unfavorable outcome in MTBI and three 
in isolated MTBI
Model AUC C.I. (95%)
MTBI group (n=1069)
Clinical variables 0.71 (0.67-0.75)
CT parameters 0.57 (0.52-0.61)
Clinical and CT var. combined 0.69 (0.65-0.73)
Isolated MTBI group (n=669)
Clinical variables 0.69 (0.64-0.75)
CT parameters 0.56 (0.50-0.62)
Clinical and CT var. combined 0.70 (0.64-0.75)
MTBI, mild traumatic brain injury; C.I., confidence interval; CT, computed tomography.
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 The presence of day-of-injury alcohol intoxication was associated with favorable 
outcomes in our study. One explanation may be that alcohol intoxication can 
interfere with the initial assessment of injury severity, because it potentially affects 
the level of consciousness and post-acute cognitive and memory functioning.216-218 
Hence the attending physician may overestimate the effects of head injury in 
intoxicated patients, for instance due to a suboptimal GCS score (13–14), or the 
apparent presence of PTA as a result of diminished attention, and diagnose a mTBI 
when in fact the patient did not suffer any brain injury. Recent studies have shown 
no significant difference in short-term and long-term neuropsychological 
functioning between mTBI patients with and those without day-of-injury alcohol 
intoxication.219, 220 Nevertheless, alcohol intoxication should never lead to an under-
estimation of trauma severity. In intoxicated patients it may be necessary to exclude 
life-threatening intracranial injury first, before designating alcohol or drug use as 
the cause of impaired consciousness, amnesia, or behavioral disturbances.221
 The frequency of CT abnormalities in mTBI patients with hospital admission 
GCS scores of 13–15 seen in our study (19.5% intracranial abnormalities, and 20.7% 
when skull or skullbase fractures are included) is higher than that found in several 
other studies: 6%,194 7.5%,205 9.8%,69 12%,67 and 12.1%.70 There are, however, studies 
that support our data, showing comparable or even higher frequencies of CT 
abnormalities: 16.9%,202 17.2%,203 and 25.9%.189 A potential reason for these 
discrepancies concerns the inclusion criteria of the mTBI patients. Most studies 
included only patients with LOC and/or PTA. Head injury without LOC and PTA, 
however, does not preclude the presence of intracranial abnormalities, and they 
may be present in 0.5–4.9% of patients.57, 58 In our study head-injured patients 
without LOC and PTA were included, because our hospital protocol is based on the 
presence of risk factors rather than loss of or impairment of consciousness, which 
are part of the EFNS guidelines.46 These guidelines are derived in part from the 
Canadian67 and New Orleans66 CT prediction rules, and therefore lead to a higher 
frequency of CT abnormalities. Moreover, a recent study showed that when the 
EFNS head-CT guideline is directly compared to other protocols, the EFNS protocol 
has the highest sensitivity in detecting intracranial abnormalities in mTBI.68 Further, 
we included secondary referrals from level II and III centers, who by definition have 
intracranial abnormalities, and polytrauma patients with mTBI, who are more prone 
to having intracranial lesions than isolated head-injured patients.
 In our study, several individual CT characteristics, such as the status of the basal 
cisterns, and the presence of SAH, edema, and pneumocephalus were associated 
with worse outcome after mTBI. However, after multivariate logistic regression 
analysis, we found only two independent CT predictors of outcome (the presence of 
facial fractures and the number of intracranial hemorrhagic contusions). The 
negative influence of facial fractures on post-traumatic neuropsychological and 
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functional outcome after mTBI has been previously demonstrated.222, 223 The presence 
and size of hemorrhagic contusions, including traumatic intraparenchymal hemorrhages, 
have an adverse effect on outcome after TBI, particularly in severe TBI.153 The 
negative effect of hemorrhagic contusions on outcome has also been demonstrated 
in studies that incorporated more severely injured TBI patients.141, 142 In contrast to 
severe TBI, in mTBI the size of intracranial lesions has no influence on outcome.62
 From the independent predictors we composed three simple prediction models. 
The first model consisted of demographic and clinical variables, the second model 
of CT parameters, and the third model of combined clinical/demographic and CT 
characteristics. Whereas an AUC of 0.50 equals random guessing, and an AUC of 1.0 
is the best possible score, the CT model in the overall mTBI group had only limited 
predictive value (AUC 0.57), compared to the moderate AUC of 0.71 of the clinical 
model. Moreover, the CT characteristics did not add any predictive value, resulting in 
an AUC of 0.69 in the combined model. In isolated mTBI the AUC of the CT model 
(AUC 0.56; 95% CI 0.50, 0.62) did not reach statistical significance, and the AUC of 
the clinical model was only moderate, at 0.69. Of course CT remains an indispensable 
tool to identify patients in need of neurosurgical intervention. The presence of CT 
abnormalities might further delay recovery and influence short-term outcome, but 
the value of CT appears to be limited for the prediction of long-term outcome in 
mTBI patients.
 The importance of these findings is that contrary to intuitive beliefs, and unlike 
those with moderate to severe TBI, CT, demographic, and clinical characteristics are 
only modest predictors of outcome after mTBI. One reason for these findings may 
be that for prediction of outcome post-mTBI, factors other than age, clinical, and CT 
characteristics should be considered. Pre-existing physical comorbidities, severe 
post-concussion symptoms, and post-traumatic stress immediately after mTBI 
appear to affect the number or patients with post-concussional symptoms 6 months 
or more after mTBI.120 Further, the number of years of formal education, the presence 
of nausea or vomiting on ED admission, concurrently sustained extracranial injuries, 
and the pain levels seen early after injury, all appear to affect time to return to work 
after mTBI.120 A survey of U.S. Army infantry soldiers done after their return from Iraq 
demonstrated that post-traumatic stress disorder and depression are mediators of 
the relationship between mTBI and physical health problems more than 3 months 
post-injury.224 None of these factors, apart from additional extracranial injury, were 
included in the current study. We also did not investigate the roles of other potential 
predictors of outcome, including genetic polymorphisms and biomarkers of brain 
damage. Future predictive models might have stronger predictive power if these 
variables were added.
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Limitations 
This study has some limitations. First, only mTBI patients requiring neurological or 
neurosurgical consultation at the ED were included. Therefore patients seen only by 
the ED physician were not included, which may have caused inclusion bias. According 
to our hospital protocol, patients experiencing head injury without LOC or PTA, a GCS 
score of 15 or more, and no risk factors (i.e., not fulfilling the EFNS criteria described 
above),46 were not included. This category of patients, with slight head injury without 
mTBI, has an extremely low risk of having intracranial abnormalities, and thus they 
would contribute little to our predictive model. Moreover, these patients were 
excluded from most of the studies cited above, and they do not fulfill the criteria for 
mTBI as defined by the mTBI Committee of the Head Injury Interdisciplinary Special 
Interest Group of the American Congress of Rehabilitation Medicine.47
 Additionally, patient follow-up was of concern despite the prospective design of 
the study. In the CT-only group 46% patients were lost to follow-up, making extrapolation 
to our entire population more difficult. The low follow-up rate was partly caused by 
high rates of patients with alcohol and drug abuse problems, psychiatric patients, and 
homeless persons. A number of foreigners, who were visiting and thus unavailable for 
follow-up consultations, was also included. Furthermore, we suspect that mTBI 
patients with few complaints or symptoms are unlikely to visit the outpatient clinic. 
The high rate of loss to follow-up and the bias that may result has been described 
previously by others.225 Generalizability may also be limited by the fact that the patients 
included in the outcome analysis had a more severe injury profile, as demonstrated by 
GCS, AISH, and ISS scores, and CT characteristics. Our models may therefore have the 
most value for more severely injured mTBI patients, especially those that undergo a 
head CT scan. For less severely injured mTBI patients, a different type of prognostic 
model may yield better results.
 Third, although the patients were prospectively selected and included in the RUBICS 
database, the clinical data were collected from the patient charts by a research nurse, 
and many of the CT scans were reviewed within 24h post-injury. This may have given our 
study a partly retrospective nature, and may have led to missing data. The additional 
follow-up was nonetheless prospectively performed. A small proportion of the GOSE 
scores (n=53, 5.0%) were derived from patient charts using accessory queries that were 
previously formulated.178 When these questions could not be answered adequately 
using the available data, the patient was regarded as lost to follow-up. We therefore 
think it unlikely that invalid GOSE scores were used in this study. Nevertheless, we reran 
the various multivariate analyses without these 53 patients, and only minimal changes 
in the ORs and CIs were found. Thus we based the final prediction models on the results 
from the multivariate analyses performed on all 1069 patients.
 Finally, no external validation has been performed. The prediction models 
should be validated by a separate cohort study to determine its generalizability.
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Conclusion and future research 
Our study shows that age and extracranial injuries (high ISSe scores) are the 
strongest predictors of unfavorable outcome in mTBI, and they are stronger than 
admission CT characteristics. Further, the presence of day-of-injury alcohol intoxication 
is associated with favorable outcomes after mTBI, probably due to its interference 
with the initial assessment of injury severity. We propose a simple prediction model 
using these factors, and we believe that future prognostic models for mTBI should 
include these variables. To ensure its applicability, the validity of this prediction 
model is essential, and thus an external validation study is necessary.
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Aspect of cisterns and ventricles
Abstract
Computed tomography (CT) of the head has become the diagnostic tool of choice, 
particularly for moderate and severe traumatic brain injury (TBI). Various CT charac-
teristics are associated with outcome, and may therefore be used as outcome 
predictors. One of the most prominent predictors appears to be the status of the 
basal cisterns. This study describes the prognostic value of the appearance of 
individual cisterns and ventricles in relation to that of the basal cisterns. Further, we 
determine the interrater and intrarater reliability in the evaluation of the cisterns 
and ventricles. All consecutive moderate and severe adult TBI patients admitted to 
our hospital were included in this study as part of the prospective Radboud 
University Brain Injury Cohort Study (RUBICS). Outcome was assessed at 6 months 
post-trauma using the Glasgow Outcome Scale-Extended (GOS-E). The predictive 
value of cisterns and ventricles was determined using multivariate binary logistic 
regression analysis. We included 126 moderate and 574 severe TBI patients. Absence 
(complete obliteration), but also compression of the ambient cisterns and/or the 
fourth ventricle were strongly related to unfavorable outcome and death and 
emerged as the only significant outcome predictors after multivariate analysis. The 
assessment of the ambient cisterns and the fourth ventricle had a satisfactory inter- 
and intrarater reliability (kappa coefficients: 0.80-0.95). We conclude that, because 
obliteration of the ambient cisterns and the fourth ventricle both are better than 
the status of the basal cisterns as outcome predictors, they might be used in CT 
prediction models in cases of moderate and severe TBI.
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Introduction
Computed Tomography (CT) scanning of the head has become the principal 
diagnostic tool in traumatic brain injury (TBI) since its introduction in 1971.60 Today, 
a head CT scan is performed routinely, especially in the acute phase of moderate and 
severe TBI, but also in a large proportion of mild TBI patients. It is used to identify 
traumatic cranial and intracranial abnormalities requiring immediate neurosurgical 
intervention or extensive monitoring. Further, it has been acknowledged that CT 
characteristics are associated with outcome after moderate to severe TBI, and it 
may therefore be used to predict outcome.65, 153, 157
 One of the most prominent CT characteristics that has emerged as a powerful 
predictor of outcome is the appearance of the basal cisterns. Although most studies 
use the term “perimesencephalic cisterns” when referring to the basal cisterns, no 
clear definition exists to delineate the basal cisterns.65 Compression or absence of the 
basal cisterns is strongly associated with adverse outcome in severe TBI, resulting in a 
two- to fourfold increase in mortality or unfavorable outcome compared to patients 
with normal basal cisterns.153, 157, 226-231 Moreover, complete and partially obliterated 
basal cisterns are considered a sign of raised intracranial pressure (ICP).226, 230, 232 
However, in some studies of outcome in moderate and severe TBI, the status of the 
basal cisterns was not found to be an independent predictor.138, 233, 234 One explanation 
might be that in these studies absent pupil reactivity proved to be an outcome 
predictor, and a strong association has been found between the status of the basal 
cisterns and pupil reactivity.231, 232
 The status of the perimesencephalic cisterns is also used to classify TBI. In the 
widely recognized Traumatic Coma Data Bank (TCDB) CT classification it is an essential 
classification criterion.62 The TCDB CT classification categorizes TBI patients into six 
groups. The primary distinction is made between diffuse injury (category I-IV) and the 
presence of mass lesions (evacuated or non-evacuated). Within the diffuse injury 
category, patients are partially differentiated based on the presence, compression, or 
absence of the perimesencephalic cisterns. The TCDB CT classification is used to 
describe CT abnormalities and to stratify patients in research trials and prognostic 
studies. 29, 42, 145, 147, 151, 153, 235 Various authors have elaborated on the aspect of the basal 
cisterns, but to our knowledge, no systematic evaluation of the predictive value of the 
individual cisterns has been performed, as has been noted before.65
 Research on the predictive value of the cerebral ventricles in TBI has not been as 
extensive as that done on the basal or perimesencephalic cisterns. Studies focusing 
on the third ventricle showed an association between a compressed or absent third 
ventricle and raised ICP and adverse outcome after severe TBI.226, 232 Recently, 
obliteration of the third ventricle was identified as a prognostic variable (odds ratio 
of unfavorable outcome: 2.2) in a multivariate predictive model of TBI.41 Other 
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studies, however, did not select the status of the ventricles as an outcome predictor in 
a multivariable model,140, 231 or did not find predictive power for small or asymmetrical 
ventricles.227 Determining the status of the basal cisterns and ventricles on CT by visual 
inspection is susceptible to interobserver variation; however, adequate data on inter- 
and intrarater variability are not available.65
 The aim of this study is to determine the prognostic value of the status of the 
various individual cisterns and ventricles as identified with CT scanning in a prospective 
cohort of consecutive moderate and severe TBI patients. Furthermore, to select 
independent predictors of functional outcome, we compare the cisterns and ventricles 
in a multivariate analysis. Finally, we determine the interobserver variation and 
intrarater reliability in the assessment of the status of the cisterns and ventricles.
Methods
Subjects 
We obtained the data for this study from the Radboud University Brain Injury Cohort 
Study (RUBICS), which is an ongoing prospective observational cohort begun on 
January 1, 1998. All consecutive patients, including children, with a diagnosis of mild, 
moderate, and severe TBI admitted to the emergency department (ED) of the 
Radboud University Nijmegen Medical Centre, a level I trauma center in the eastern 
Netherlands, are included in the cohort. All patients with moderate and severe TBI, 
aged 16 years and older, admitted to the ED of our hospital between January 1998 
and January 2006 were selected from the RUBICS database. Moderate TBI was defined 
by a Glasgow Coma Scale (GCS) score in the ED of 9-12 after initial resuscitation, or 
an admission GCS of 9-12 followed by sedation and intubation during resuscitation 
for a non-neurological cause. Severe TBI was characterized by an ED GCS score of <8 
after resuscitation, preferably obtained before sedation and intubation. We focused 
on closed head injury cases, because penetrating head injuries may disturb the 
aspect of the cerebrospinal fluid (CSF) spaces too much to allow analysis. The RUBICS 
databank comprises demographic data, clinical and radiological injury variables, and 
outcome scores. Several CT characteristics and the TCDB CT classification are also 
recorded.62
Outcome assessment 
Outcome was assessed at 6 months post-injury using the Glasgow Outcome 
Score-Extended (GOS-E).178 The 6-month time-frame was chosen because a large 
majority of severe TBI patients improves to their final functional outcome level, as 
assessed using the GOS-E, during the first 6 months post-injury.118 The GOS-E is an 
8-point scale expressing functional outcome, ranging from 1: death, to 8: complete 
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recovery. GOS-E scores of =4 were considered unfavorable outcomes and were 
dichotomized as such. If no outcome could be obtained directly from the patient, 
charts and correspondence were reviewed to determine outcome and construct a 
GOS-E score. Patients with no outcome score or outcome data insufficient to 
determine the GOS-E score were considered lost to follow-up.
Computed tomography 
After initial resuscitation all patients underwent a CT scan of the head. Only the 
initial CT scans of patients admitted to the hospital within 24h after sustaining the 
head injury were analyzed in this study. CT was performed in the axial plane with 
slices scanned parallel to the orbito-meatal line. Before 2002 slice thickness was 
4.5mm infratentorial and 6.0mm supratentorial; from 2002 on 5.0mm reconstruc-
tions were made out of 0.75mm slices in both the supratentorial and infratentorial 
regions. Contrast-enhanced CT was not used on a routine basis. Each CT scan was 
scored by one of three raters (B.J., T.B., and P.E.V.), using a predefined structured format 
as previously described.236 In short, abnormalities like intracranial hematomas, traumatic 
subarachnoid hemorrhage, fractures, and the appearance of cisterns and ventricles 
were registered on data entry sheets and subsequently entered into the computer. 
In addition, all scans were classified according to the TCDB CT classification.62 For 
this study we used the data collected about the status (presence, compression, or 
absence) of cisterns and ventricles (Figure 1): foramen magnum, cerebello-medul-
lary cistern, fourth ventricle, prepontine cistern, chiasmatic or suprasellar cistern 
(pentagon), ambient cisterns (left and right), quadrigeminal cistern, third ventricle 
and lateral ventricles (left and right), and the sylvian fissures (left and right).
 All cisterns and ventricles were scored by visual inspection using a three point 
scale: 1=normal, indicating normal anatomy; 2=compressed, indicating unilateral 
narrowing of a cistern or ventricle (a slit-like appearance), but CSF still is visible; and 
3=absent, indicating no CSF is visible. In addition a binary score was computed for all 
cisterns and ventricles: “normal” or “abnormal.” The scores of the left and right 
ambient cistern were combined to form a comprised ambient cistern score, in which 
the worst score of the left or the right side was used as the new ambient cistern 
score. In addition, a basal mesencephalic cistern score was quantified by combining 
the scores for the ambient cisterns, the pentagon (suprasellar) cistern, and the 
quadrigeminal cistern. This definition of the basal cisterns has also been used by 
other authors.226, 237
Statistical analysis 
We used univariate and multivariate binary logistic regression analysis to identify 
the abnormalities in cistern and ventricle anatomy that were most strongly 
associated with an adverse outcome after moderate to severe TBI. Missing data 
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were excluded from the analysis. As a dependent variable we dichotomized the 
6-month GOS-E into unfavorable (GOS-E 1-4), and favorable (GOS-E 5-8), and also 
into death (GOS-E 1) or survival (GOS-E 2-8). First, all the variables (3-point scale 
scores and binary scores) were analyzed univariately to determine which of these CT 
characteristics was associated with unfavorable outcome and/or death. Second, 
significant predictors (p<0.01) were analyzed multivariately, using the forward 
stepwise likelihood ratio method, to determine which combination of these variables 
independently predicted adverse outcome at 6-months after moderate to severe 
TBI. We performed three successive multivariate analyses. One multivariate analysis 
was done using only the 3-point scale scores, one analysis included only the binary 
scores, and a third combined the 3-point scale and the binary scores. To determine 
which of these three combinations of predictors had the best performance, the 
C-statistic was calculated. In order to avoid having irrelevant differences be 
statistically significant due to the large number of observations, we used a two-sided 
p-value of 0.01 as the criterion for significance in the logistic regression analyses. 
 To determine the interrater reliability of the scoring of the cisterns and the 
ventricular system, we randomly selected 73 CT scans from the RUBICS database 
(including mild TBI) to be scored by two observers (B.J. and P.E.V.). The interobserver 
Figure 1   Normal cisterns and fourth ventricle
CT scan of the head in a 27-year-old patient that suffered a mild TBI. A. Fourth ventricle; B. Prepontine cistern; 
C. Pentagon (suprasellar) cistern; D. Right ambient cistern; E. Quadrigeminal cistern (lower portion).
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variation of the 3-point scale scores was determined using a linear weighted kappa 
analysis, and for the dichotomized scores we used the Cohen’s unweighted kappa 
method. Further, 68 CT scans were selected at random to determine the intrarater 
variation of one observer (P.E.V.), using the unweighted or linear weighted kappa 
analysis where applicable.
Results
We included 700 consecutive patients: 126 moderate and 574 severe TBI patients. 
Accurate CT data were available for 658 patients (121 moderate and 537 severe). 
Survival data were available for 605 patients, and data were available for 567 
patients about the prediction of unfavorable outcome (complete GOS-E data). The 
inclusion flow chart of the study and the reasons for exclusion are shown in Figure 2.
 Several demographic, clinical, and outcome characteristics of the patient 
sample (n=700) are shown in Table 1. Demographic and clinical data were missing in 
fewer than 0.5% of these patients. For all CT characteristics, fewer than 2.1% of the 
required values were missing. We studied a predominantly male population (71%) 
with a mean age of 43.8 years. The main cause of traumatic injury was a traffic-relat-
ed crash in severe TBI (70%) patients, and resulted from a fall in those with moderate 
TBI (40%). In 71 (12%) of the severe TBI patients, neurosurgical intervention (the 
placing of an ICP monitoring device was not regarded as such) was necessary 
(craniotomy for acute subdural hematoma [SDH], n=38; epidural hematoma [EDH], 
n=22; hemorrhagic contusion, n=7; compression fracture, n=4). In those with 
moderate TBI, 12 (10%) patients required neurosurgical intervention (SDH, n=6; 
EDH, n=5; hemorrhagic contusion, n=1). A total of 29 (23%) patients died after 
moderate TBI, and 222 patients died (39%) after severe TBI. 
 Table 2 shows the patient distribution over the different categories of the TCDB 
CT classification. Intracranial abnormalities were found in 433 (81%) of the severe 
TBI, and in 73 (60%) of the moderate TBI patients. In 47% of the severe TBI and 28% 
of the moderate TBI patients the basal mesencephalic cisterns were abnormal (i.e., 
compressed or absent).
 Univariate binary logistic regression analysis showed that the status of all 
cisterns and ventricles was significantly (p<0.01) associated with both unfavorable 
outcome and death after moderate to severe TBI (Tables 3A and B and 4A and B); the 
results of the cerebello-medullary cistern, left and right ambient cisterns, sylvian 
fissures, and the lateral ventricles are not shown.
 Univariate analysis of the GCS, one of the classical and established outcome 
predictors in TBI, resulted in an odds ratio (OR) of 0.8 (99% confidence interval [CI]: 
0.77-0.9; p<0.0001) in death, and 0.85 (99% CI: 0.8, 0.9) in unfavorable outcome.
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 First, multivariate logistic regression analysis (forward L.R. method) of all the 
3-point scale (normal, compressed, or absent) scores showed that the status of the 
fourth ventricle and the ambient cisterns were independent predictors of death 
after moderate to severe TBI (Tables 5A, B, and C). When the dichotomized (normal 
or abnormal) scores were analyzed, again obliteration of the fourth ventricle and 
ambient cisterns proved to be outcome predictors (Table 5B). After a multivariate 
test of all 3-point scales and dichotomized scores simultaneously, the dichotomized 
score of the fourth ventricle and the 3-point scale score of the ambient cisterns 
emerged as significant predictors of death (Table 5C). The same procedure was 
followed with unfavorable outcome instead of death as the dependent variable 
Figure 2   Diagram showing the inclusion and exclusion of the patients observed 
in the study
TBI, traumatic brain injury; RUBICS, Radboud University Nijmegen Brain Injury Cohort Study; MTBI, mild 
traumatic brain injury; GCS, Glasgow Coma Scale; CT, computed tomography; GOSE, Glasgow Outcome Scale-
Extended.
4188 TBI patients included in RUBICS database (1998-2005) 
Excluded  
  675 age < 16 yrs  
     12 penetrating TBI  
2801 MTBI   
126 moderate TBI (GCS 9-12)  574 severe TBI (GCS 3-8) 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
470 included in outcome analysis:  
 favorable versus unfavorable  
 
501  included in outcome analysis:  
 survival versus death  
  97 included in outcome analysis:  
 favorable versus unfavorable  
 
104 included in outcome analysis:  
 survival versus death  
18 died before head CT  
19 relevant CT data missing  
 
31 no GOSE score    
36 lost to follow-up  
 21 foreigners  
   1 homeless  
   3 died before head CT  
   2 relevant CT data missing  
 
  7 no GOSE score  
 
 
17 lost to follow-up  
5 foreigners  
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88
Ch
ap
te
r 4
.1
Table 1   Patient demographic and clinical characteristics at presentation
Characteristic Moderate TBI  
(n=126)
Severe TBI  
(n=574)
Male gender 77 (61.1) 419 (73.0)
Agea 47.7 (22.3) 42.9 (19.9)
Trauma mechanism
Traffic-related crash 60 (47.6) 403 (70.2)
Fall 50 (39.7) 123 (21.4)
Sports-related 3 (2.4)  12 (2.1)
Violence 5 (4.0)  11 (1.9)
Suicide 4 (3.2)    7 (1.2)
Other/ missing 4 (3.2)  18 (3.1)
GCS at EDb 11 (9-12) 3 (3-8)
AIS heada 3.5 (1.1) 4.3 (4.1)
ISSa 20.5 (12.6) 31.6 (14.8)
Hypotensive episode  7 (5.6) 133 (23.2)
Hypoxic episode 12 (9.5) 165 (28.7)
Pupillary respons 
- present 117 (92.9) 374 (65.2)
- one absent 6 (4.8)   74 (12.9)
- bilateral absent 3 (2.4) 126 (22.0)
Neurosurgical intervention 12 (9.5) 71 (12.4)
Outcome 
Death (GOSE score 1) 29 (23.0) 222 (38.7)
- missing 16 (12.7) 39 (6.8)
Unfavorable (GOSE score 1-4) 39 (31.0) 289 (50.3)
- missing 25 (19.8)   71 (12.4)
aMean (sd); bmedian (range); all other variables: n and (%).
MTBI, mild traumatic brain injury; GCS, Glasgow Coma Scale; ED, emergency department; AIS, Abbreviated 
Injury Scale; ISS, Injury Severity Score; GOSE, Glasgow Outcome Scale-Extended; sd, standard deviation.
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(Tables 6A, B, and C). The results were comparable to a large extent, but there was 
with one exception. In the multivariate analysis of the 3-point scale scores only the 
status of the ambient cisterns was associated with an unfavorable outcome (Table 
6A). The GCS did not show a significant relation with outcome when we finally 
re-ran the different multivariate analyses of the cistern and ventricle scores including 
the GCS. The ORs of the fourth ventricle and ambient cistern scores were therefore 
not altered.
 Figure 3 depicts the mortality rates in the various patient categories with normal, 
compressed, or absent fourth ventricle, ambient cisterns, and basal cisterns.
 The C-statistics of the three combinations were comparable in both dead -three- 
 point scales: 0.80; dichotomous scores: 0.79; combined: 0.80, and unfavorable 
outcome - trichotomous variables: 0.77; dichotomous variables: 0.76; and combined: 
0.76.
 The interrater kappa coefficients of the status of the fourth ventricle were 0.93 
(normal versus abnormal), and 0.95 (normal, compressed, or absent), and of the 
ambient cisterns (0.80 and 0.81, respectively). The intrarater analysis showed kappa 
coefficients of the dichotomized fourth ventricle score (normal versus abnormal) of 
0.89; of the 3-point scale (normal, compressed, or absent): 0.80; and of the ambient 
cisterns, normal versus abnormal: 0.83, and normal, compressed, or absent: 0.80.
Table 2   Incidence of CT abnormalities on initial head CT and distribution of 
patients according to the Traumatic Coma Data Bank CT classification
CT characteristics Moderate TBI 
(n=121)
Severe TBI 
(n =537)
Intracranial abnormalities 73 (60.3) 433 (80.6)
CT abnormalities (intracranial & fractures) 75 (62.0) 439 (81.8)
TCDB-classification
Diffuse Injury I  48 (39.7) 104 (19.4)
Diffuse Injury II  38 (31.4) 156 (29.1)
Diffuse Injury III  5 (4.1)   88 (16.4)
Diffuse Injury IV  0 (0.0) 17 (3.2)
Evacuated mass lesion/ neurosurgical 
intervention
12 (9.9)   71 (13.2)
Non-evacuated mass lesion   18 (14.9) 101 (18.8)
All variables n (%). CT, computed tomography; TBI, traumatic brain injury; TCDB, Traumatic Coma Data Bank.
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Table 3A   Association of cistern and ventricle status (trimodal) with death  
(n = 605) after univariate analysis
Cistern/ ventricle (n) O.R. 99% C.I. p Value
Foramen magnum 
- Normal (474) ref.
- Compressed (72)   5.8 (2.9 - 11.7) < 0.0001
- Absent (47) 24.5 (7.0 - 85.4) < 0.0001
Fourth ventricle 
- Normal (459) ref.
- Compressed (87) 10.0 (5.0 - 20.0) < 0.0001
- Absent (46) 27.6 (7.9 - 96.8) < 0.0001
Prepontine cistern 
- Normal (404) ref.
- Compressed (116)   6.4 (3.6-11.5) < 0.0001
- Absent (73) 18.7 (8.0-43.8) < 0.0001
Pentagon 
- Normal (388) ref.
- Compressed (89)   3.3 (1.7-6.2) < 0.0001
- Absent (116) 17.3 (8.6-34.5) < 0.0001
Cisterna ambiens 
- Normal (343) ref.
- Compressed (132)   4.3 (2.4-7.8) < 0.0001
- Absent (118) 26.2 (12.5-54.9) < 0.0001
Quadrigeminal cistern 
- Normal (392) ref.
- Compressed (88)   5.1 (2.7-9.6) < 0.0001
- Absent (112) 12.1 (6.3-23.1) < 0.0001
Third ventricle 
- Normal (402) ref.
- Compressed (63)   1.9 (0.9-3.9)  0.032
- Absent (128) 11.8 (7.9-96.8) < 0.0001
Basal mesencephalic cisterns 
- Normal (323) ref.
- Compressed (120)   2.8 (1.5-5.3) < 0.0001
- Absent (150) 16.7 (8.9-31.4) < 0.0001
O.R., odds ratio; C.I., confidence interval; ref., reference.
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Table 3B   Association of cistern and ventricle status (bimodal) with death  
(n = 605) after univariate analysis
Cistern/ ventricle (n) O.R. 99% C.I. p Value
Foramen magnum – abnormal (119)   9.1 (4.9 - 16.7) < 0.0001
Fourth ventricle – abnormal (133) 13.2 (7.1 - 24.7) < 0.0001
Prepontine cistern – abnormal (189)   9.1 (5.4 - 15.4) < 0.0001
Pentagon – abnormal (205)   7.6 (4.6 - 12.6) < 0.0001
Cisterna ambiens – abnormal (250)   9.0 (5.4 - 15.0) < 0.0001
Quadrigeminal cistern – abnormal (200)   8.0 (4.8 - 13.2) < 0.0001
Third ventricle – abnormal (191)   6.0 (3.6 - 9.8) < 0.0001
Basal mesencephalic cisterns – abnormal (270)   7.2 (4.4 - 11.9) < 0.0001
O.R., odds ratio; C.I., confidence interval.
Table 4A   Association of cistern and ventricle status (trimodal) with  
unfavorable outcome (n = 567) after univariate analysis
Cistern/ ventricle (n) O.R. 99% C.I. p Value
Foramen magnum
- Normal (439) ref.
- Compressed (71)   7.6 (3.1 - 18.2) < 0.0001
- Absent (47) 31.2 (4.8 - 203.9) < 0.0001
Fourth ventricle 
- Normal (425) ref.
- Compressed (85) 11.1 (4.5 - 27.5) < 0.0001
- Absent (46) 21.3 (4.5 - 101.2) < 0.0001
Prepontine cistern 
- Normal (369) ref.
- Compressed (115)   5.9 (3.1 - 11.2) < 0.0001
- Absent (73) 14.1 (5.2 - 38.5) < 0.0001
Pentagon 
- Normal (354) ref.
- Compressed (87)   2.9 (1.5 - 5.5) < 0.0001
- Absent (116) 24.1 (9.0 - 64.7) < 0.0001
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Table 4B   Association of cistern and ventricle status (bimodal) with  
unfavorable outcome (n = 567) after univariate analysis
Cistern/ ventricle (n) O.R. 99% C.I. p Value
Foramen magnum – abnormal (118) 11.2 (5.0-24.8) < 0.0001
Fourth ventricle – abnormal (131) 13.5 (6.1-29.8) < 0.0001
Prepontine cistern – abnormal (188)   7.9 (4.5-13.8) < 0.0001
Pentagon – abnormal (203)   7.1 (4.1-12.0) < 0.0001
Cisterna ambiens – abnormal (246)   7.5 (4.6-12.5) < 0.0001
Quadrigeminal cistern – abnormal (198)   7.8 (4.5-13.5) < 0.0001
Third ventricle – abnormal (189)   6.1 (3.6-10.4) < 0.0001
Basal mesencephalic cisterns – abnormal (265)   5.9 (3.6-9.5) < 0.0001
O.R., odds ratio; C.I., confidence interval.
Table 4A   Continued
Cistern/ ventricle (n) O.R. 99% C.I. p Value
Cisterna ambiens 
- Normal (311) ref.
- Compressed (129)   3.7 (2.1 - 6.5) < 0.0001
- Absent (117) 34.2 (11.9 - 97.8) < 0.0001
Quadrigeminal cistern 
- Normal (358) ref.
- Compressed (87)   4.5 (2.3 - 8.7) < 0.0001
- Absent (111) 14.8 (6.4 - 34.2) < 0.0001
Third ventricle 
- Normal (368) ref.
- Compressed (63)   2.0 (1.0 - 4.1)    0.0100
- Absent (126) 15.5 (6.8 - 35.5) < 0.0001
Basal mesencephalic cisterns 
- Normal (292) ref.
- Compressed (116)   2.2 (1.2 - 3.9)    0.0010
- Absent (149) 22.0 (9.8 - 49.8) < 0.0001
O.R., odds ratio; C.I., confidence interval; ref., reference.
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Table 5A   Association of cistern and ventricle status (trimodal) with death  
(n = 605) after multivariate analysis
Cistern/ ventricle O.R. 99% C.I. p
Fourth ventricle 
- normal ref.
- compressed  3.3 (1.4 - 7.6) < 0.0001
- absent  4.5 (1.0 - 20.5)    0.0110
Ambient cisterns 
- normal ref.
- compressed  3.5 (1.9-6.6) < 0.0001
- absent 10.1 (3.9-26.4) < 0.0001
O.R., odds ratio; C.I., confidence interval; ref., reference.
Table 5B   Association of cistern and ventricle status (bimodal) with death 
(n = 605) after multivariate analysis
Cistern/ ventricle O.R. 99% C.I. p
Fourth ventricle - abnormal 5.7 (2.8-11.6) < 0.0001
Ambient cisterns - abnormal 4.5 (2.5-8.1) < 0.0001
O.R., odds ratio; C.I., confidence interval.
Table 5C   Association of cistern and ventricle status (bi- and trimodal) with 
death (n = 605) after multivariate analysis
Cistern/ ventricle O.R. 99% C.I. p
Fourth ventricle - abnormal 3.4 (1.5 - 7.8) < 0.0001
Ambient cisterns
- normal ref.
- compressed 3.5 (1.9 - 6.5) < 0.0001
- absent 10.8 (4.3 - 27.1) < 0.0001
O.R., odds ratio; C.I., confidence interval; ref., reference.
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Table 6A   Association of cistern and ventricle status (trimodal) with 
unfavorable outcome (n = 567) after multivariate analysis
Cistern/ ventricle O.R. 99% C.I. p
Ambient cisterns 
- normal ref.
- compressed   4.5 (2.5-8.1) < 0.0001
- absent 36.6 (11.9-112.7) < 0.0001
O.R., odds ratio; C.I., confidence interval; ref., reference.
Table 6C   Association of cistern and ventricle status (bi- and trimodal) with 
unfavorable outcome (n = 567) after multivariate analysis
Cistern/ ventricle O.R. 99% C.I. p
Fourth ventricle - abnormal   3.0 (1.1 – 8.2)    0.006
Cisterna ambiens
- normal ref.
- compressed  3.6 (2.0 - 6.7) < 0.0001
- absent 16.3 (4.4 - 60.8) < 0.0001
O.R., odds ratio; C.I., confidence interval; ref., reference.
Table 6B   Association of cistern and ventricle status (bimodal) with 
unfavorable outcome (n = 567) after multivariate analysis
Cistern/ ventricle O.R. 99% C.I. p
Fourth ventricle - abnormal 6.0 (2.2-13.5) < 0.0001
Ambient cisterns - abnormal 4.6 (2.5-8.4) < 0.0001
O.R., odds ratio; C.I., confidence interval.
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Discussion
This study shows that from all cisterns, ventricles, and the sylvian fissures, as 
visualized by head CT scanning, the status of the fourth ventricle and the ambient 
cisterns are independent predictors of death and unfavorable functional outcome 
at 6 months post-trauma in moderate and severe TBI patients. We also demonstrate 
that the interobserver agreement and intrarater reliability for these CT characteris-
tics are adequate.
 The findings of our study are consistent with present knowledge that the status 
of the basal, in other studies referred to as perimesencephalic, cisterns is an 
important aspect of the head CT exam, and is a predictor of functional outcome in 
moderate and severe TBI patients.153, 157, 226-231 Absent basal cisterns, as opposed to a 
normal aspect of the basal cisterns, increased mortality in our study almost fivefold: 
76.7% versus 16.4% (Fig. 3). However, when the basal cisterns were analyzed 
multivariately, simultaneously with the other cisterns and ventricles, they did not 
emerge as an independent outcome predictor. In our study the ambient cisterns, a 
part of the basal perimesencephalic cisterns, were the strongest predictor of 
Figure 3   Distribution of mortality rate differentiated for the status of the fourth 
ventricle, ambient cisterns and the basal cisterns
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outcome. The predictive value of these cisterns has not been examined as a sole 
entity in detail before. The same holds true for the fourth ventricle, the second 
independent predictor we identified. The strong association of the fourth ventricle 
with outcome might be explained by the fact that as a midline structure, compression 
indicates more brain shift due to a higher ICP, or the presence of a larger intracranial 
mass lesion, than that seen with unilateral obliteration of other cisterns or ventricles. 
Alternatively, when contusion, hematoma, or edema are present within the 
brainstem, narrowing of the fourth ventricle may occur before obliteration of, for 
example, the perimensencephalic or prepontine cisterns. Finally, compression of the 
fourth ventricle will frequently be accompanied by deformation of the brainstem, 
probably more often than (unilateral) compression of the perimesencephalic 
cisterns. A deformed brainstem is associated with increased mortality compared to a 
normal brainstem with obliteration of the perimesencephalic cisterns.228 Analogous 
to this, when the fourth ventricle is compressed, the brainstem is likely to be deformed 
as well: the status of the fourth ventricle may thus be considered a surrogate marker 
for brainstem integrity.
 In our study, the status of the third ventricle was univariately associated with 
outcome; however, it proved to be one of the weakest predictors. After multivariate 
analysis, the third ventricle lost its predictive value, confirming findings by others,140, 
231 but contradicting studies that emphasize the predictive value of the third 
ventricle.41, 226, 232 Interestingly, in those studies accentuating the contribution of the 
third ventricle, the status of the basal cisterns and third ventricle were combined to 
form one single characteristic. Therefore the individual contribution of the third 
ventricle in the prediction of outcome is not clear, and may be inferior to that of the 
basal cisterns.
 Whereas the mortality rate (39%) and proportion of severe TBI patients with an 
unfavorable outcome (50%) is largely in line with reports in the literature,28, 29 the 
death rate of the moderate TBI patients (23%) is relatively high. Several studies 
demonstrated lower mortality rates of 3–13%,28, 33, 54, 109, 110, 238 save for one recent 
study that found a higher rate of 33%.30 One possible explanation for the high 
mortality rate in our moderate TBI patients might be the secondary and tertiary 
referral function of our level I trauma center. This results from the transfer from 
adjacent hospitals of more severely injured moderate TBI patients, for instance 
patients with severe CT abnormalities at risk for deterioration or needing immediate 
neurosurgical intervention (and surgical intervention in cases of polytrauma). Also, 
some of the studies that found a lower mortality rate in moderate TBI included 
patients with a hospital admission GCS score of 13. It is well known that the case 
fatality rate in GCS 13 patients is lower than in GCS 9–12 patients. Although still 
debated, in many other studies of TBI, also from our institution, patients with a GCS 
score of 13 were classified as having mild TBI.69, 109, 134, 238
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 Notwithstanding the fact that CT is already the diagnostic tool of choice in 
moderate and severe TBI, and that its prognostic value has been well established, 
the relative importance of CT in the prediction of outcome may have increased in 
recent years. This is related to the observed loss of predictive power of the GCS as a 
classic outcome predictor and determinant of TBI severity.44 Intensified prehospital 
treatments, comprised of early sedation and intubation, of trauma patients hampers 
valid neurological examination and results in erroneously low GCS scores.44 
Nevertheless, in our study, the GCS was univariately associated with both death and 
unfavorable outcome. In the multivariate analyses this association was, however, 
lost.
 Formal data on the inter- and intraobserver reliability of scoring individual 
cisterns and ventricles, particularly in TBI, are absent.65 In a previous study we 
described the interrater and intrarater coefficients for the TCDB CT classification, 
but not for the individual CT characteristics, and demonstrated high reliability in the 
scoring of the different TCDB categories.176 Considering the significant role of the 
appearance of the basal cisterns in the TCDB CT classification, one might assume 
that the reliability of scoring the basal cisterns would show comparable coefficients. 
Nonetheless, both the interrater and intrarater kappa coefficients found in our 
current study are more than adequate.239
Limitations 
We are aware of some limitations of our study. The first limitation is due to the 
missing data in this prospective study. Because of missing relevant CT data, 21 
patients (3.0%) had to be excluded. Moreover, for some of the CT characteristics the 
percentage of missing values was up to 2.1% (aspect of the fourth ventricle, 
quadrigeminal cistern, sylvian fissures, and lateral ventricles). Additionally, not all 
included patients could be used for outcome prediction analysis. In the severe TBI 
group of 31 patients (5.4%), only data on survival, but no adequate GOS-E scores 
were available, and 36 patients (6.3%) were completely lost to follow-up, mainly due 
to the inclusion of patients from abroad that were unable to be present for follow-up 
consultations. For the moderate TBI patients, loss to follow-up was 13.5% (n=17), and 
for 7 patients (5.6%) insufficient outcome data were registered to ascertain the 
GOS-E. The rate of loss to follow-up for the entire study was 7.6%. In a recent review 
of prognostic models of TBI, less than 10% was considered an acceptable rate of loss 
to follow-up.144
 Secondly, this study was based on the acute CT characteristics of TBI (i.e., the 
first CT scan only). Severe, and to a lesser extent also moderate TBI, however, are 
dynamic pathological processes in which CT scans show changes that take place 
over time post-trauma. This has been demonstrated for traumatic intracerebral 
hematomas, brain swelling and edema, midline shift, and post-traumatic cerebral 
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infarction;240-244 however, this has not been shown specifically for the status of 
cisterns and ventricles. The eventual outcome is more accurately predicted using 
data from sequential rather than initial CT scans.242 Nevertheless, we think the 
findings of the initial CT scan remain important in clinical decision making and for 
prognostic purposes. Furthermore, these findings are also strongly associated with 
outcome after TBI.153, 157
Conclusion
In moderate and severe TBI, a combination of the status of ambient cisterns, as 
assessed with a simple 3-point score (normal, compressed, or absent), and the status 
of the fourth ventricle, described as either normal or abnormal, proved the most 
powerful predictors of outcome at 6 months post-injury. The currently most widely 
used parameter, the status of the basal perimesencephalic cisterns, was surpassed 
in predictive value, and therefore the ambient cisterns and the fourth ventricle may 
be considered good alternatives for use in CT prediction models. The assessment of 
the ambient cisterns and the fourth ventricle also had sufficient interrater and 
intrarater reliability.
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Abstract
Intracranial lesion volume and midline shift are powerful outcome predictors in 
moderate and severe traumatic brain injury (TBI), and therefore they are used in TBI 
and computed tomography (CT) classification schemes, like the Traumatic Coma 
Data Bank (TCDB) classification. In this study we aimed to explore the prognostic 
value of lesion volume and midline shift in moderate and severe TBI as measured 
from acute cranial CT scans. Also, we wanted to determine interrater reliability for 
the evaluation of these CT abnormalities. We included all consecutive moderate 
and severe TBI patients admitted to our hospital who were aged >16 years, over an 
8-year period, as part of the prospective Radboud University Brain Injury Cohort 
Study. Six months post-trauma we assessed outcomes using the Glasgow Outcome 
Scale-Extended (GOS-E). We analyzed 605 patients and found an association of 
both lesion volume and midline shift with outcome; increases were associated with 
a higher frequency of patients with an unfavorable outcome or death. A cut-off 
value, such as that used in the TCDB CT classification (lesion volume 25mL and 
midline shift 5mm), was not found. The average interrater difference in volume 
measurement was 6.8mL, and it was 0.2mm for the determination of degree of shift. 
Using lesion volume and midline shift as continuous variables in prognostic models 
might be preferable over the use of threshold values, although an association of 
these variables with outcome in relation to other CT abnormalities was not tested. 
The data provided here will be useful for stratification of patients enrolled in clinical 
trials of neuroprotective therapies.
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Introduction
Traumatic brain injury (TBI) is a common neurological disorder, with an incidence of 
235-556/100,000 persons.2, 4 Overall, 80% are classified as mild based on a Glasgow 
Coma Scale (GCS) score of 13-15 at hospital admittance, having a mortality rate of 
0.1%.106 Up to 10% are graded as moderate (GCS score 9-12), and 10% as severe TBI (GCS 
score <8),4 with fatality rates in the latter category of 35-40%.29, 32, 33 For survivors of 
severe TBI the disability rate is 55–77%.32, 33 Computed tomographic (CT) scanning of 
the head, performed after respiratory and hemodynamic stabilization of the patient, 
is the diagnostic tool of choice in the acute phase of moderate and severe TBI, and is 
primarily used to detect life-threatening abnormalities requiring urgent neurosurgical 
intervention or monitoring in an intensive care unit. Knowledge of CT parameters 
related to adverse outcomes is useful for optimal treatment, clinical decision-making, 
and prognostic purposes. In addition, validated scales for rating CT scans acutely after 
TBI will be helpful in clinical research for the selection of patients for enrollment in 
trials, as well as for stratifying participants by injury severity.169
 The presence of an intracranial mass lesion, compression of the perimesencephalic 
cisterns, midline shift, and traumatic subarachnoid hemorrhage, have all been 
associated with unfavorable outcomes after TBI.41, 42, 65, 149, 153, 157 From prognostic studies, 
including two recently published prognostic models based on large international 
patient cohorts,41, 42 the type of intracranial lesion, and particularly intracranial 
hematoma size, have emerged as two of the most powerful outcome predictors.65, 153, 
157, 245, 246 Another important CT predictor is the shift of the cerebral midline structures.41, 
65 Controversy remains about how best to introduce these parameters into a prognostic 
scheme, and whether to use threshold values or continuous variables.
 Numerous studies have yielded a wide variety of threshold values, ranging from 
5-150mL, to ascertain the relationship between hematoma volume and outcome.65, 
247, 248 Indeed, internationally acknowledged injury severity models use different 
cut-off values to classify trauma victims with multiple (systemic) injuries, or isolated 
head injuries. The Abbreviated Injury Scale (AIS) and the Injury Severity Score (ISS) 
score both use threshold values of 15, 30, and 50mL, to estimate the probability of 
survival after TBI (Table 1).174, 249 A recent study re-evaluated the odds ratios (OR) for 
mortality according to hematoma size based on the AIS head score (Table 1).250
 The Traumatic Coma Data Bank (TCDB) CT classification is widely used to 
categorize moderate and severe TBI patients, and primarily discriminates between 
diffuse injury and mass lesions, based on the presence of focal lesions with a volume 
larger than 25mL (Table 2).62, 157
 There is a strong association between outcome and the initial CT scan diagnosis 
according to the TCDB CT classification.62 It is also used to categorize patients in 
research trials and prognostic studies.29, 42, 145, 147, 149, 151, 153, 157
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Table 1   Volume cut-offs in official head injury classification systems and scores
Classification/ 
scoring system Location Type
Volume 
dominant 
lesion (ml)
Classification 
score
Unadjusted 
O.R. for 
mortalityb   
(95% C.I.)
AIS-heada  Infratentorial Contusion    < 15            3 Not performed
   15 - 30            4 Not performed
   > 30            5 Not performed
Parenchymal 
hematoma
   < 15            4 Not performed
   > 15            5 Not performed
Epidural    < 30            4 Not performed
   > 30            5 Not performed
Subdural    < 30            4 Not performed
   > 30            5 Not performed
Supratentorial Contusion  
(single)
   < 30            3 Not performed
   30 - 50            4 Not performed
   > 50            5 Not performed
Contusion 
(multiple)
   < 30            3 Not performed
   30 - 50            4 Not performed
   > 50            5 Not performed
Parenchymal 
hematoma
   < 30            4 0.88 (0.65-1.19)
   > 30            5 4.19 (3.46-5.06)
Epidural    < 50            4 0.57 (0.43-0.74)
   > 50            5 1.61 (1.29-2.01)
Subdural    < 50            4 1.31 (1.13-1.53)
   > 50            5 6.30 (5.50-7.21)
TCDBc Any Any    < 25 ml       2 - 4 -
Any    > 25 ml       5 - 6 -
RCTSd Any All, except 
epidural
   All sizes            1 -
Epidural    < 25 ml            1 -
Epidural    > 25 ml            0 -
aIn this study all patients > were 10 years old. bFrom Perel et al., 2009.250 cFrom Marshall et al., 1991.62 dFrom 
Maas et al., 2005.157
O.R., odds ratio; C.I., confidence interval; CT, computed tomography; AIS, Abbreviated Injury Scale; TCDB, 
Traumatic Coma Databank CT classification; RCTS, Rotterdam CT Score.
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 Although a nearly linear and significant relationship between midline shift and 
outcome has been found in severe TBI patients,153, 227 various cut-off values, ranging 
from 3.0–20.0mm, have been tested for their association with outcome, and have 
demonstrated an inverse correlation with prognosis.62, 153, 227, 231, 248, 251-255 The TCDB CT 
classification uses a shift cut-off value of 5mm (Table 1).62
 The objective of this study was to determine the prognostic value and the 
significance of the threshold values for hematoma volume and midline shift as used 
in the TCDB CT and the ISS classification systems, which may eventually result in 
refinements of classification and prognostication of TBI patients. A secondary 
objective was to assess interobserver variation in the assessment of hematoma 
volume and degree of shift.
Methods
Subjects 
The data for this study were obtained from the Radboud University Brain Injury 
Cohort Study (RUBICS), a prospective observational cohort study that explores 
demographic, clinical, and radiological predictors of outcome. RUBICS includes all 
Table 2   Traumatic Coma Databank (TCDB) CT classification of severe TBI 
patients based on abnormalities visualized on head CT scan 
Category Definition
Diffuse injury I (no visible 
pathology)
No visible intracranial pathology seen on CT scan
Diffuse injury II Cisterns are present with midline shift 0-5 mm and/ or:
Lesion densities present
No high- or mixed-density lesion > 25 ml
May include bone fragments and foreign bodies
Diffuse injury III (swelling) Cisterns compressed or absent with midline shift 0-5 
mm, no high or mixed-density lesion > 25 ml
Diffuse injury IV (shift) Midline shift > 5 mm, no high- or mixed-density lesion 
> 25 ml
Evacuated (mass) lesion Any lesion surgically evacuated
Non-evacuated mass lesion High- or mixed-density lesion > 25 ml, not surgically 
evacuated
CT, computed tomography; TBI, traumatic brain injury.
From Marshall et al., 1991.62
107
4
Intracranial lesion volume and midline shift revisited
consecutive patients with a diagnosis of TBI admitted to the emergency department 
(ED) of our university medical center, a level I trauma center. Review by our local 
ethics committee was not required for the anonymous registration of demographic, 
clinical, and radiological data acquired during regular daily clinical practice. The local 
ethics committee approved contact with patients to gather information on 
outcomes that was outside that usually collected for quality control purposes. From 
the RUBICS database we selected all patients who were >16 years of age, with 
moderate and severe TBI, admitted between January 1998 and January 2006. 
Moderate TBI was defined by an ED GCS score of 9-12 after initial resuscitation, or an 
admission GCS score of 9-12, followed by sedation and intubation during resuscitation 
for a non-neurological cause. We defined severe TBI by an ED GCS score of <8 after 
resuscitation. Those suffering from penetrating head injury, who constitute a 
separate category within TBI patients, were excluded. For the present study 700 
consecutive TBI patients were eligible for inclusion: 126 with moderate injury, and 
574 with severe injury. Data from the RUBICS have been published previously.256, 257
Computed tomography 
After initial resuscitation, a CT scan of the head was performed in all patients using 
a four-slice (until 2002), or a 16-slice CT scanner (after 2002). CT scanning was 
generally carried out in the axial plane with slices scanned parallel to the 
orbito-meatal line. Before 2002, slice thickness was 4.5mm infratentorial and 6.0mm 
supratentorial; from 2002 on, 5.0-mm reconstructions were made out of 0.75-mm 
slices in both the supra- and infratentorial regions. Only initial CT scans obtained 
within 24h after sustaining the head injury were used. Each CT scan was scored by 
one of three raters (B.J., T.B., or P.V.). The three observers performed joint readings to 
get and to stay familiar with the scoring format, and to maintain interobserver 
consensus. Traumatic CT abnormalities and the TCDB CT classification score.62 were 
recorded on standardized data sheets.256 The presence, type, location, number, and 
dimensions were recorded separately for subdural hematomas (SDH), epidural 
hematomas (EDH), intraparenchymal hematomas, and hemorrhagic contusions. 
Intraparenchymal high-density lesions were considered hematomas, and mixed- 
density lesions hemorrhagic contusions, and focal mass-occupying low-density 
lesions were considered contusions, particularly when no suspicion of an alternative 
diagnosis existed. These three subtypes of intraparenchymal lesions were grouped 
together, because they belong to the same category of traumatic lesions: 
contusions. The volumes (in milliliters) of all lesions mentioned above were 
calculated using the ellipsoid method described previously.176, 177 The largest lesion 
was considered the dominant lesion, and was used for categorization according to 
the TCDB CT classification. When multiple intracranial lesions were present, the 
total volume was calculated. Punctate or petechial hemorrhages, defined as 
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hyperdense lesions with a maximum diameter <5mm, were recorded as separate 
entities concomitant with diffuse axonal injury, but were not analyzed in this study. 
Midline shift was defined as displacement of the septum pellucidum, being a 
reproducible landmark, in relation to the midline, and was registered in millimeters 
as described by others.65
Outcome assessment 
The Glasgow Outcome Scale-Extended (GOSE) was assessed at 6 months post-
injury.114 This time frame was chosen because at that point most TBI patients have 
reached their final functional outcome level.118 The GOSE is an eight-point scale 
expressing functional outcome ranging from 1 = death, to 8 = complete recovery. 
Patients with no outcome score or insufficient outcome information were considered 
lost to follow-up.
Statistical analysis 
Different cut-off values, derived from the literature, for the dominant hematoma 
volumes and midline shift were evaluated for their predictive value. The dependent 
outcome variable was dichotomized as dead versus alive, and as unfavorable (GOSE 
score 1-4) versus favorable outcome (GOSE score 5-8). For each of the cut-off values 
we calculated the mortality rate and the percentage of patients with an unfavorable 
outcome. We used univariate binary logistic regression analysis to further establish 
the association between hematoma volume and shift, both as a continuous and as 
a nominal variable (e.g., presence versus absence), and dichotomized outcome. To 
explore the relation between midline shift and hematoma volume, we calculated 
the Spearman’s correlation coefficient. Finally, the area under the receiver operating 
characteristic curve (AUC) was computed to compare the predictive power of 
midline shift, dominant hematoma volumes, and total lesion volumes.
 The interrater reliability of the hematoma and midline shift measurements was 
estimated by calculating the differences between the scores of the two main 
observers (B.J. and P.V.), who were blinded to each other’s scores, on a subset of 73 
randomly-selected CT scans. A linear weighted kappa analysis was performed to 
determine the interobserver variation of the CT diagnosis, according to the TCDB CT 
classification, of the detection of hematomas >25mL, and midline shift >5mm.
Results
Complete CT data were available for 658 (94%) of the 700 patients. At 6 months, 
survival data were available for 605 (92%) patients, and a GOSE score for 567 (86%) 
patients. The study flow chart is shown in Figure 1.
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 Demographic, clinical, and outcome characteristics of all patients (n=700) are 
shown in Table 3. Less than 0.5% of the demographic and clinical data were missing. 
In 12 (10%) of the moderate TBI patients neurosurgical intervention (ICP monitoring 
was not regarded as such) was necessary (craniotomy for acute SDH in 6, EDH in 5, 
and hemorrhagic contusion in 1 patient), and in the severe TBI patients 71 (12%) 
underwent neurosurgery (SDH in 38, EDH in 22, hemorrhagic contusion in 7, and 
depressed skull fracture in 4 patients). Twenty-nine (23%) patients died after 
moderate and 222 (39%) after severe TBI.
Figure 1   Diagram showing the inclusion and exclusion criteria of patients in  
this study
TBI, traumatic brain injury; RUBICS, Radboud University Nijmegen Brain Injury Cohort Study; MTBI, mild 
traumatic brain injury; GCS, Glasgow Coma Scale; CT, computed tomography; GOSE, Glasgow Outcome Scale-
Extended.
4188 TBI patients included in RUBICS database (1998-2005) 
Excluded  
  675 age < 16 yrs  
     12 penetrating TBI  
2801 MTBI   
126 moderate TBI (GCS 9-12)  574 severe TBI (GCS 3-8) 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
470 included in outcome analysis:  
 favorable versus unfavorable  
 
501  included in outcome analysis:  
 survival versus death  
  97 included in outcome analysis:  
 favorable versus unfavorable  
 
104 included in outcome analysis:  
 survival versus death  
18 died before head CT  
19 relevant CT data missing  
 
31 no GOSE score    
36 lost to follow-up  
 21 foreigners  
   1 homeless  
   3 died before head CT  
   2 relevant CT data missing  
 
  7 no GOSE score  
 
 
17 lost to follow-up  
5 foreigners  
 3 homeless  
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 Table 4 shows the incidence of the major CT characteristics. Less than 2.5% of all 
CT characteristics was missing.
 More detailed results were obtained from analyses of the TBI patients for whom 
outcome data (survival, n=605), or GOSE scores (n=567) were available. An intracranial 
Table 3   Patient demographic and clinical characteristics at presentation
Characteristic Moderate TBI (n=126) Severe TBI (n=574)
Male gender  77 (61.1) 419 (73.0)
Agea 47.7 (22.3) 42.9 (19.9)
Trauma mechanism
Traffic 60 (47.6) 403 (70.2)
Fall 50 (39.7) 123 (21.4)
Sports 3 (2.4)  12 (2.1)
Violence 5 (4.0)  11 (1.9)
Suicide 4 (3.2)    7 (1.2)
Other/ missing 4 (3.2)  18 (3.1)
GCS at EDb 11 (9-12) 3 (3-8)
AIS heada 3.5 (1.1) 4.3 (4.1)
ISS * 20.5 (12.6) 31.6 (14.8)
Hypotensive episode  7 (5.6) 133 (23.2)
Hypoxic episode 12 (9.5) 165 (28.7)
Pupillary respons 
- present 117 (92.9) 374 (65.2)
- one absent 6 (4.8)   74 (12.9)
- bilateral absent 3 (2.4) 126 (22.0)
Neurosurgical intervention 12 (9.5) 71 (12.4)
Outcome 
Death (GOSE 1) 29 (23.0) 222 (38.7)
- missing 16 (12.7) 39 (6.8)
Unfavorable (GOSE 1-4) 39 (31.0) 289 (50.3)
- missing 25 (19.8)   71 (12.4)
aMean (sd); bmedian (range); all other variables: number (%).
TBI, traumatic brain injury; GCS, Glasgow Coma Scale; ED, emergency department; AIS, Abbreviated Injury 
Scale; ISS, Injury Severity Score; GOSE, Glasgow Outcome Scale-Extended; sd, standard deviation.
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hematoma or contusion was found in 314 (52%) patients, and midline shift in 221 
(37%) patients. Of the patients with an intracranial lesion, 202 out of 314 (64%) also 
had a midline shift. In most patients with a midline shift, an intracranial hematoma 
Table 4   Incidence of CT abnormalities on initial head CT, and distribution  
of patients according to the Traumatic Coma Data Bank (TCDB) CT 
classification
CT characteristics Moderate TBI  
(n=121)
Severe TBI            
(n =537)
Intracranial CT abnormalities 73 (60.3) 433 (80.6)
CT abnormalities (intracranial and fractures) 75 (62.0) 439 (81.8)
TCDB-classification
Diffuse injury I 48 (39.7) 104 (19.4)
Diffuse injury II 38 (31.4) 156 (29.1)
Diffuse injury III  5 (4.1) 88 (16.4)
Diffuse injury IV  0 (0.0) 17 (3.2)
Evacuated mass lesion/ neurosurgical intervention 12 (9.9) 71 (13.2)
Non-evacuated mass lesion 18 (14.9) 101 (18.8)
(Mass) lesion
- No (mass) lesion 69 (57.0) 244 (45.4)
- One (mass) lesion 24 (19.8) 148 (27.6)
- Multiple (mass) lesions 28 (23.1) 136 (25.3)
- Missing -   9 (1.7)
Volume dominant (mass) lesion, mla 48.6 (51.4) 61.3 (90.8)
Total volume (mass) lesions, mla 67.8 (69.1) 69.7 (96.7)
Dominant (mass) lesion 
- EDH 7 (5.8) 34 (6.3)
- SDH 20 (16.5) 145 (27.0)
- Hemorrhagic contusion 25 (20.7) 104 (19.4)
- Missing - 11 (2.0)
Midline shift 
- Presence 23 (19.0) 213 (39.7)
- Mean, mma 7.1 (3.8) 8.2 (6.4)
aMean (sd); All other variables: number (%). 
CT, computed tomography; TBI, traumatic brain injury; TCDB, Traumatic Coma Databank; EDH, epidural 
hematoma; SDH, subdural hematoma.
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was found as well (202 out of 221, 91%). The correlation between dominant hematoma 
volume and midline shift was 0.73 (p<0.0001). Patients who died had a significantly 
(p<0.0001) larger lesion volume (mean 87.0mL, SD 108.4mL), and midline shift 
(mean 10.1mm, SD 7.0mm), than surviving patients (lesion volume: mean 33.7mL, SD 
43.0mL; degree of midline shift: mean 5.4mm, SD 3.9mm). Lesion volumes (mean 
75.7mL, SD 99.4mL), and degree of midline shift (mean 9.4mm, SD 6.7mm), in 
patients with unfavorable outcomes were significantly (p<0.0001) larger than those 
in patients with favorable outcomes (lesion volume: mean 30.9mL, SD 39.6mL; 
degree of midline shift: mean 4.9mm, SD 3.5mm).
 The rate of loss to follow-up was higher in moderate than in severe TBI patients. 
No GOSE and no survival information data were available for 19% (moderate) and 
12% (severe) of the patients. However, we found no relevant differences between 
the patients included in the outcome analysis and those lost to follow-up for GCS 
score, ISS, pupillary reactivity, hypotension, hypoxia, volume of dominant lesion, and 
age. Only midline shift was different; in included patients midline shift was 1.4mm 
(mean), whereas none of the patients lost to follow-up showed midline shift on 
their initial head CT.
 The interrater kappa coefficient of classification according to the TCDB CT 
classification was high: 0.92 (95% CI=0.84,1.0). The CT scans studied for this purpose 
resulted in the detection of 45 intracranial hemorrhagic lesions (EDH, SDH, and 
contusions) that both observers agreed on. The mean difference in the measured 
volumes between the raters (B.J. versus P.V.) was -6.8mL (median -4.0mL; range 
-44.5 to 15.2mL). The median difference was 39% (range -85 to 88%). The kappa 
coefficient for the identification of lesions larger than 25mL was substantial: 0.74 
(95% CI=0.55,0.93). In 17 CT scans both raters agreed on the presence of midline 
shift. On average the difference in degree of midline shift between both raters (B.J. 
versus P.V.) was -0.2mm (range -4.0mm to 3.0mm). The kappa coefficient for the 
recognition of midline shift larger than 5mm was substantial: 0.82 (95% CI=0.50,1.00).
 Figure 2a shows the mortality rate of patients with at least one (mass) lesion on 
CT (n=314) per cut-off value; a correlation between increasing death rate and 
increasing lesion volume can be seen. This correlation was also found between 
increasing rates of unfavorable outcomes and increasing lesion volumes (Fig. 2b). In 
the patients with midline shift (n=221) comparable results were found for death and 
unfavorable outcome (Fig. 2c and 2d).
 In those with lesion sizes above 100mL, the odds ratios for death (cut-off 150mL), 
and unfavorable outcome (cut-offs 100 and 150mL), were increased twofold compared 
to the lesion volume cut-offs below 50mL, such as those used for head injury classifi-
cations and scores (Table 1). The same was true for midline shift, for which there was 
a fourfold increase in death and unfavorable outcome at the 15mm cut-off (Fig. 3).
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Figure 2   (a) Patient mortality rate per cut-off value of lesion volume.  
(b) Percentage of patients with an unfavorable outcome per cut-off 
value of lesion volume. (c) Patient mortality rate per cut-off value of 
midline shift. (d) Percentage of patients with an unfavorable outcome 
per cut-off value of midline shift.
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Figure 2 Continued
Numbers of patients in each category are shown in the table (top line shows numbers of patients equal to or 
below cut-off; bottom line shows numbers of patients above each cut-off). 
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Figure 3   Odds ratios for death (a and c) and unfavorable outcomes (b and d). 
Error bars indicate 95% confidence intervals. Odds ratios are depicted 
per cut-off value for lesion volume (a and b) and midline shift (c and d).
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Figure 3 Continued
Pres. = presence.
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 The results of the univariate logistic regression analysis of total and dominant 
lesion volume and midline shift as continuous variables, and types and numbers of 
hematomas, are shown in Table 5.
Table 5   Results of the univariate binary logistic regression analysis for several 
CT characteristics and death and unfavorable outcome
Death (n=605) Unfavorable outcome (n=567)
CT characteristic O.R. 95% C.I. p O.R. 95% C.I. p
(Mass) Lesions
- No lesions present ref. - - ref. - -
- One lesion present 3.6 2.3-5.5 <0.0001 4.1 2.7-6.3 <0.0001
-  Multiple lesions 
present
6.1 3.9-9.4 <0.0001 6.0 3.9-9.4 <0.0001
Type of dominant lesion
- No lesion present ref. - - ref. - -
- EDH 1.3 0.6-3.0 0.474 1.5 0.7-3.1 0.253
- SDH 5.7 3.7-8.8 <0.0001 6.3 4.0-9.8 <0.0001
-  Hemorrhagic 
contusion
5.0 3.1-8.0 <0.0001 5.5 3.4-8.9 <0.0001
Number of lesions (per type)
- EDH 0.7 0.4-1.2 0.205 0.8 0.5-1.4 0.450
- SDH 2.7 2.0-3.7 <0.0001 2.7 2.0-3.8 <0.0001
-  Hemorrhagic 
contusion
2.2 1.8-2.8 <0.0001 2.3 1.8-2.9 <0.0001
Lesion volume (per ml)
Volume dominant 
lesion
1.020 1.015-1.025 <0.0001 1.023 1.017-1.030 <0.0001
Total volume lesions 1.018 1.014-1.022 <0.0001 1.019 1.014-1.025 <0.0001
Dominant lesion diameters (per mm)
- Anteroposterior 1.15 1.11-1.18 <0.0001 1.15 1.11-1.19 <0.0001
- Transverse 1.22 1.12-1.32 <0.0001 1.36 1.21-1.54 <0.0001
- Cranial-caudal 1.24 1.17-1.32 <0.0001 1.23 1.16-1.32 <0.0001
Midline shift
Shift - presence 4.0 2.8-5.7 <0.0001 4.1 2.8-5.8 <0.0001
Degree of shift (mm) 1.2 1.15-1.25 <0.0001 1.2 1.16-1.29 <0.0001
CT, computed tomography; O.R., odds ratio; C.I., confidence interval; ref., reference; EDH, epidural 
hematoma; SDH, subdural hematoma.
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 The last tables show the AUCs of dominant lesion volume, total volume of all 
visible lesions, and degree of midline shift, with death (Table 6A) and unfavorable 
outcome (Table 6B) as dependent variables. The AUCs of the dominant and total 
volumes were identical, and therefore these parameters are interchangeable. 
Midline shift proved a less powerful predictor, as demonstrated by a lower AUC.
Discussion
Our study shows an association between increasing hematoma volume and degree 
of midline shift with poor outcomes in those with moderate and severe TBI. We 
could not reproduce the predictive ability of hematoma volume and shift threshold 
values described in the literature or those used in currently utilized injury severity 
scales and CT classifications.62, 174, 249 Although we appreciate the use of these 
thresholds from a practical standpoint in the literature and daily clinical practice, we 
Table 6A   Area under the Receiver Operating Characteristic Curve (AUC) for 
lesion volume and midline shift and death (n=605)
CT characteristic AUC 95% C.I. p
Volume of dominant lesion (ml)         0.75    0.71-0.79    < 0.0001
Total volume of lesions (ml)         0.75    0.71-0.80    < 0.0001
Midline shift (mm)         0.70    0.65-0.75    < 0.0001
CT, computed tomography; C.I., confidence interval.
Table 6B   Area under the Receiver Operating Characteristic Curve (AUC) for 
lesion volume and midline shift and unfavorable outcome (n=567)
CT characteristic AUC 95% C.I. p
Volume of dominant lesion (ml)         0.74    0.70-0.78    < 0.0001
Total volume of lesions (ml)         0.74    0.70-0.78    < 0.0001
Midline shift (mm)         0.69    0.64-0.73    < 0.0001
CT, computed tomography; C.I., confidence interval.
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believe that injury classification and outcome prediction can be improved when 
continuous values instead of absolute thresholds are used, as our study shows.
Intracranial lesions 
This study confirms the predictive value of the type of intracranial lesion. In general, 
patients with an EDH have a better post-traumatic outcome than patients suffering 
from an SDH or contusion.153, 157, 245, 246, 258 The association of adverse outcomes with 
SDH and contusions was significantly stronger than that with EDH, resulting in 
increased odds of death (OR 5.7 for SD and 5.0 for contusion), and unfavorable 
outcomes (OR 6.3 for SDH and 5.5 for contusion), compared to patients with no 
intracranial hematomas or contusions. In addition, in accordance with findings of 
previous studies we also found a strong relationship between the number of 
intracranial lesions and outcomes.246, 247, 259, 260 The presence of multiple lesions (>2) 
had a higher OR (death: 6.1; unfavorable outcome: 6.0) than the presence of just one 
lesion (death: 3.6; unfavorable outcome: 4.1), regardless of lesion type.
Lesion volume 
In our study, the mortality rate and the percentage of patients with unfavorable 
outcomes increased as hematoma volume increased (Fig. 2a and b). We did not find 
a clear cut-off value such as that suggested by other authors,62, 227, 247, 248, 252, 254 although 
the ORs of the various cut-off values (Fig. 3a and 3b) suggest a threshold of 150mL 
for predicting death, and 100mL for predicting unfavorable outcome. However, 
patient numbers decreased considerably above the higher thresholds (Fig. 2), 
warranting caution in interpreting these results.
 To improve the accuracy of prognostic models and TBI classifications, the 
incorporation of lesion volume as a continuous variable is preferable to the application 
of a strict threshold value, such that used in the TCDB CT classification.62 The use of 
different cut-off values in a single model, such as is the case for the AIS-head score, 
might be an adequate compromise.174, 249 Though the exact lesion volume must be 
determined for classification according to, for instance, the TCDB CT classification and 
ISS (i.e., to determine if a lesion’s volume meets a given threshold), no additional 
calculations have to be made.
 When using the volume of the dominant hematoma or the total volume of all 
hematomas for a prognostic model or CT classification, one must keep in mind that 
these variables are interchangeable, as shown by ROC curve analysis in our study. To 
simplify a model or classification scheme, we propose the use of the volume of the 
dominant (largest) hematoma.
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Midline shift 
Analogously to hematoma volume, a cut-off value for the degree of midline shift in 
relation to outcome could not be demonstrated, and a continuous association was 
found (Fig. 2c and d), confirming earlier findings.153, 227, 261 The ORs of the different 
shift thresholds found in this study, however, might indicate a possible cut-off value 
of 15mm for both death and unfavorable outcome (Fig. 3c and 3d), although the 
numbers of patients with a shift above a particular threshold decreased in the 
higher categories. The widespread use of thresholds for midline shift such as those 
suggested by other authors,153, 227, 231, 248, 251-255 and as applied in the TCDB CT 
classification,62 may therefore not yield accurate results. In a recent study the 
authors recommended the use of midline shift as a continuous variable for outcome 
prediction.133 In addition, results of that study indicated that hematoma volumes can 
be substituted for midline shift in CT scoring systems.133 To the contrary, we found a 
higher discriminative value of hematoma volume than of midline shift for death and 
unfavorable outcomes, as demonstrated by the superior AUCs for hematoma 
volume (Tables 6a and 6b).
Interobserver reliability 
Formal data on the interobserver reliability of the measurement of intracranial 
hematomas and midline shift by visual assessment are scarce.65, 262, 263 One study 
compared the mean volume of traumatic lesions as measured by three readers and 
found an average difference of less than 1.5mL when an ellipsoid method, comparable 
to the method used in this study, was applied; the limits of agreement of the 
computed volumes ranged from -32.6 to 37.6mL.263 In our study the difference in 
volume of the computed lesion volumes was larger (mean 6.8mL); the limits of 
agreement (-44.5 to 15.2mL), however, were more or less equal. More recently, good 
interobserver reproducibility could be demonstrated for most traumatic head CT 
features, although the average Bland and Altman coefficients of variation, 
particularly for SDH and contusion volume measurements, were high, indicating 
that difficulties might be encountered in such volume calculations.262
Limitations 
Due to missing CT data, 21 patients (3.0%) had to be excluded before analysis. For 
the CT characteristics of the included patients, the rate of missing individual values 
was less than 2.5%. This may have influenced the results, mainly leading to a weaker 
association of these variables with outcome, although this effect was likely small.
 Also, in the severe TBI group, for 31 patients (5.4%) no adequate GOSE score was 
available, and 36 patients (6.3%) were completely lost to follow-up, mainly due to the 
inclusion of patients from abroad, for whom we were unable to obtain follow-up 
results. Of the moderate TBI group, 13.5% (17) were lost to follow-up, and in 5.6% (7) 
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patients the GOSE score was missing. The overall rate of loss to follow-up, including 
patients with no GOSE scores and those completely lost to follow-up, was 13%. 
The overall rate of loss to follow-up with regard only to the survival data was 7.6%. A 
recent review of prognostic models of TBI found that less than 10% was an acceptable 
rate of loss to follow-up.144 Relatively more moderate than severe TBI patients were lost 
to follow-up (in total 19% versus 12%). This may have introduced a potential bias, but 
we believe that any influence on the results was limited, because the rate of moderate 
TBI patients lost to follow-up, except for midline shift, did not differ from that of the 
included patients. However, this is not definitive proof of an absence of bias.
 Furthermore, this study was based on the acute CT characteristics found on the 
initial CT scan. However, severe, and to a lesser extent moderate, TBI causes dynamic 
processes to commence, and CT scans may reveal these changes with increasing time 
post-injury.240-243, 264 Long-term TBI outcomes can be more accurately predicted using 
data from sequential rather than just initial CT scans.242 Nevertheless, we believe that 
the findings of the initial head CT scan are essential for clinical decision making, and are 
important for prognostic purposes. Further, for patients enrolled in clinical trials, the use 
of the initial CT to identify injury subtypes and for prognostic determination requires 
validated scales and quantitative measures such as those presented in this study.
 Not all CT abnormalities, including traumatic SAH or punctuate hemorrhages 
indicating diffuse axonal injury, and their effects on outcomes are addressed in this 
study.133, 264, 265 For a full appreciation of the prognostic power of the initial head CT in 
TBI patients, all CT parameters with predictive value should be considered. Only 
after a multivariate analysis can a comprehensive CT prediction model be constructed. 
Definitive proof of the validity of our findings would require comparing a CT model 
based on hematoma volume and midline shift to the existing TCDB CT classification 
and Rotterdam CT score.
 Joint CT readings were performed to acquire a high-quality CT database; 
however, this may have reduced interobserver variation to a lower level than that 
seen without these dual readings. Finally, the interobserver agreement analysis of 
the degree of midline shift were calculated on 23% of the CTs, which were selected 
for this purpose. This relatively small number may have influenced the statistical 
power of this result.
Conclusion
In moderate and severe TBI the presence, type, and volume of intracranial (mass) 
lesions such as EDHs, SDHs, and contusions, and midline shift were associated with 
functional outcome at 6 months post-injury. Whereas various studies have used 
thresholds of lesion volumes and midline shift to predict outcomes, we demonstrate 
here that the quantification of exact volumes and shifts may be more accurate for 
predicting outcomes.
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Abstract 
Introduction: With this study we aimed to design validated outcome prediction 
models in moderate and severe traumatic brain injury (TBI) using demographic, 
clinical and radiological parameters.
Methods: Seven hundred consecutive moderate or severe TBI patients were 
included in this observational prospective cohort study. After inclusion, clinical 
data were collected, initial head CT scans were rated, and at six months outcome 
was determined using the extended Glasgow Outcome Scale. Multivariate binary 
logistic regression analysis was applied to evaluate the association between 
potential predictors and three different outcome endpoints. The prognostic models 
that resulted were externally validated in a national Dutch TBI cohort.
Results: In line with previous literature we identified age, pupil responses, Glasgow 
Coma Scale score and the occurrence of a hypotensive episode post-injury as 
predictors. Furthermore, several CT characteristics were associated with outcome; 
the aspect of the ambient cisterns being the most powerful. After external validation 
using Receiver Operating Characteristic (ROC) analysis our prediction models 
demonstrated adequate discriminative values, quantified by the area under the 
ROC curve, of 0.86 for death versus survival and 0.83 for unfavorable versus favorable 
outcome. Discriminative power was less for unfavorable outcome in survivors: 0.69.
Conclusions: Outcome prediction in moderate and severe TBI might be improved 
using the models that were designed in this study. However, conventional demo - 
graphic, clinical and CT variables proved insufficient to predict disability in surviving 
patients. The information that can be derived from our prediction rules is important 
for the selection and stratification of patients recruited into clinical TBI trials.
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Introduction
The accuracy of prognostic models in moderate and severe traumatic brain injury 
(TBI) has risen during recent years, especially with the study of large patient cohorts 
within the IMPACT (International Mission on Prognosis and Clinical Trial Design in 
TBI) project159 and MRC CRASH study.41 Knowledge on the prognosis of a head injured 
patient in the early phase post-injury is essential to optimize treatment, for the 
possible withdrawal of treatment if an unfavorable outcome is anticipated, and to 
inform patients and their next-of-kin. Prognostic models may also be helpful to 
stratify patients for research purposes. Although literature on prognostic modeling 
is extensive and highly relevant, the methodological quality is subject to discussion 
and questions have been raised on the applicability, validity and generalizability of 
current models.144, 146, 147, 158
 Most studies on outcome prediction in TBI investigated the combination of 
demographic, clinical and radiological characteristics.29, 41, 42, 144, 146, 149 Age, total 
Glasgow Coma Scale (GCS) score or GCS-motor score, pupil reactivity and the 
occurrence of a post-injury hypotensive and/ or hypoxic period, proved the most 
powerful clinical predictors.29, 41, 42, 146, 148, 149, 151 
 Various individual head computed tomography (CT) abnormalities have 
emerged as significant radiological outcome predictors after multivariable analyses, 
also including demographic and clinical covariates, such as: midline shift, 
compression of perimesencephalic cisterns, traumatic subarachnoid hemorrhage 
(SAH), and the presence and type of intracranial (mass) lesions.41, 138, 140, 148, 149, 151, 153 
Several studies used the Traumatic Coma Databank (TCDB) CT classification62 to 
incorporate CT characteristics in their prediction models.29, 42, 149, 151, 153 Although widely 
used and acknowledged, the TCDB CT classification is criticized for being partly 
retrospective in nature and not addressing all radiological elements with prognostic 
value, in particular the presence of traumatic SAH.65, 133, 153, 157 To meet this criticism the 
Rotterdam CT classification was introduced a few years ago157 and more recently the 
Stockholm prediction score.133 Combinations of individual CT characteristics, 
including intraventricular and traumatic subarachnoid hemorrhage, demonstrated a 
better discriminative performance than the original TCDB classification. Therefore, 
it has been suggested to use individual CT predictors instead of the TCDB 
classification for prognostic purposes in TBI.157
 In this prospective cohort study in moderate and severe TBI we aimed to develop 
and externally validate new prognostic models, incorporating demographic, clinical 
and radiological variables for the prediction of death and unfavorable outcome, the 
latter also in the TBI survivors. A newly developed CT prediction rule was compared 
to the existing TCDB and Rotterdam CT classifications. 
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Methods
The present study is part of the Radboud University Brain Injury Cohort Study 
(RUBICS), an ongoing prospective observational cohort study that started on 
January 1st, 1998. The Radboud University Nijmegen Medical Centre (RUNMC) is a 
level I trauma centre in the Netherlands with a referral area of 2.5 million inhabitants. 
All consecutive patients with a TBI diagnosis, including children, admitted to the 
emergency department (ED) of the RUNMC are included. The RUBICS databank 
comprises demographic data, various clinical and radiological injury variables, and 
outcome scores. The institutional ethics committee of the RUNMC waived the need 
for informed consent. 
 Moderate TBI was defined by a GCS score of 9-12 after initial resuscitation at 
the ED or an admission GCS of 9-12 followed by sedation and intubation during 
resuscitation for a non-neurological cause. Severe TBI was characterized by an ED 
GCS score of <8 after resuscitation, preferably obtained before sedation and 
intubation. Patients suffering from penetrating head injury were excluded.
Subjects
For the current study, all patients, aged above 16, with moderate and severe TBI, 
admitted to the ED of our hospital between January 1998 and January 2006, were 
selected from the RUBICS database. Patient characteristics that were selected 
included: Mechanism of injury, presence of hypotension (systolic RR < 90 mmHg, 
equal to shock class III-IV173 or hypoxia (O2 saturation < 90%, measured with pulse 
oximeter) during the pre-hospital period or at the ED. Furthermore, we included the 
GCS score, pupil responses, the Abbreviated Injury Scale score of the Head (AISH) 
and the Injury Severity Score (ISS).174 Finally, our study incorporated information on 
the clinical suspicion of day-of-injury alcohol intoxication or definite day-of-injury 
intoxication, when blood alcohol level (BAL) exceeded 0.1 promille (equal to >100 
mg/l), and the use of oral anticoagulants. To adequately quantify additional 
extracranial injuries we calculated an alternative modified ISS score based on the 
three most severely injured body areas excluding the head: the ‘ISS-extracranial 
score’ (ISSe). 
Computed tomography
All patients underwent CT scanning of the head after initial (surgical) resuscitation. 
Only the initial CT scans of patients admitted to the hospital within 24 hours after 
sustaining the head injury were analyzed in this study. Each CT scan was scored, 
based on visual inspection, by one of three raters (B.J., T.B. and P.V.) using a predefined 
structured format, published previously.256 All scans were classified according to the 
TCDB classification and Rotterdam CT score.62, 157 Based on the results of two of our 
128
Ch
ap
te
r 5
earlier reports the following CT outcome predictors were preselected: the status of 
the fourth ventricle and ambient cisterns - the status of the perimesencephalic or 
basal cisterns was not included,257 lesion (hematoma) volume and midline shift. 
The latter two were considered as continuous variables instead of using cutoff 
values.266 To eventually design straightforward prediction models, i.e. to prevent 
selection of predictors subject to possible high interrater disagreement, we primarily 
used a binary – present versus absent – score of several variables, e.g. SAH, petechial 
hemorrhages, edema and skull(base) fracture. 
 We have described the results of various interobserver and intraobserver 
variability analyses of two of the raters (B.J. and P.V.) before: concerning ventricles 
and cisterns,257 and regarding hematoma volume, midline shift and the TCDB CT 
classification.266
Outcome assessment
Outcome was assessed at six months post injury according to the Glasgow Outcome 
Score Extended (GOSE) using a structured interview during regular visits to the 
out-patient clinic or during consultation by telephone.112, 178 The GOSE is an eight 
point scale expressing functional outcome ranging from 1: death to 8: complete 
recovery. Patients not visiting the outpatient clinic were sent a GOSE questionnaire 
by regular mail, and when not returned a reminder was sent.115 Finally, we attempted 
to reach all non-responding patients by telephone to acquire an outcome score. 
Outcomes obtained within a three months range were also accepted if no outcome 
at exactly six months was available. When a patient was dismissed from follow-up 
before six months because of a favorable GOSE score of 7 or 8, this observation was 
carried forward and considered a definitive outcome. 
Statistical analysis
We used binary logistic regression analysis to evaluate the univariate relationship 
between the demographic, clinical and CT characteristics and: 1) death (GOSE 1); 2) 
unfavorable outcome including death (GOSE: 1-4); and 3) unfavorable outcome 
excluding death (GOSE 2-4). Age was analyzed per year; GCS, AISH, ISS and ISSe per 
point scored on each scale. Concerning the CT parameters midline shift was analyzed 
per millimeter (mm), the volume of the dominant intracranial lesions per milliliter 
(ml) and the number of hematomas/ contusions per individual patient. Subsequently, 
the variables significantly associated with outcome were analyzed per category - 
demographic and clinical parameters combined, and CT characteristics - using 
multivariable logistic regression analysis with forward variable selection to derive 
prediction rules for the different outcome scores. Both the AISH and ISS were not 
included in the multivariable analyses since they are based on a combination of 
clinical and CT information. To finish, the demographic, clinical and CT predictors 
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were combined and their predictive value was subsequently re-determined to 
design ‘combination’ models. 
 Throughout the binary logistic regression analysis, both uni- and multivariable, 
we used a two-sided p-value of 0.01 as criterion for significance. This in order to 
avoid that irrelevant differences would be statistically significant due to the large 
number of observations. 
 The discriminative power of the prediction rules was calculated using Receiver 
Operating Characteristic (ROC) analysis and quantified by the area under the receiver 
operating curve (AUC). We compared the AUCs of our CT rules with the AUCs of the 
TCDB CT classification and Rotterdam CT score.62, 157 
 Our prediction models were also externally validated in a population of 442 
moderate and severe TBI patients from a recent Dutch multicenter observational 
cohort study: The Prospective Observational COhort Neurotrauma (POCON) study, 
executed in 5 out of 11 specialized (Level I) trauma centers in the Netherlands.267 
Results
Figure 1 shows the in- and exclusion flow-chart of this study: 700 Consecutive 
patients were included; 126 moderate and 574 severe TBI patients. Sufficient head 
CT data were available for 658 patients and of 605 patients survival data was known. 
 The demographic, acute clinical, radiological and outcome characteristics of 
all included patients are represented in Table 1. Demographic and clinical data were 
missing in less than 0.5% of these patients. In 81% (433) of the severe and 60% (73) 
of the moderate TBI patients CT abnormalities were found. Less than 4% of all 
individual CT characteristics was missing. 
 Neurosurgical intervention (placement of an intracranial ICP monitoring device 
was not regarded as such) was performed in 12 (9.5%) moderate TBI patients 
(craniotomy for acute SDH: n=6; EDH: n=5; hemorrhagic contusion: n=1) and in 71 
(12%) of the severe TBI patients (SDH: n=38; EDH: n=22; hemorrhagic contusion: 
n=7; depressed skull fracture: n=4). In our moderate TBI patients death rate was 
23% (n=29) and 222 (39%) patients died after severe TBI.
 After univariate binary logistic regression analysis all demographic and clinical 
variables but gender, extracranial trauma (represented by ISSe) and day-of-injury 
alcohol intoxication, were associated with death at six months post-injury (data not 
shown). Furthermore, all CT characteristics, except for the presence and type of 
petechial hemorrhages and the presence of facial fractures, demonstrated a 
relationship with mortality at six months (not shown). Associations were also found 
between clinical, demographic and CT variables and unfavorable outcome, comparable 
to those found for death. The presence of punctuate hemorrhages was merely 
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moderately associated with unfavorable outcome (data not shown). Remarkably, the 
GCS score and pupillary responses were not associated with unfavorable outcome in 
the survivors.
 Age, GCS score at the ED, occurrence of a hypotensive episode and pupil reactivity 
surfaced as independent outcome predictors of both death and unfavorable outcome 
after multivariate analysis. Unfavorable outcome in surviving patients was only 
associated with age and the occurrence of a hypotensive episode. 
 Multivariate analysis of the CT characteristics identified five predictors of death 
- aspect of ambient cisterns, number of contusions, aspect of the fourth ventricle, 
presence of intraventricular or subarachnoid hemorrhage and volume of the largest 
intracranial lesion -, three predictors of unfavorable outcome (GOSE 1-4) - aspect of 
Figure 1   Diagram showing the inclusion and exclusion of patients in this study
TBI, traumatic brain injury; RUBICS, Radboud University Nijmegen Brain Injury Cohort Study; yrs, years; MTBI, 
mild traumatic brain injury; GCS, Glasgow Coma Scale; CT, computed tomography; GOSE, Glasgow Outcome 
Scale Extended.
4188 TBI patients included in RUBICS database (1998-2005) 
Excluded  
  675 age < 16 yrs  
     12 penetrating TBI  
2801 MTBI   
126 moderate TBI (GCS 9-12)  574 severe TBI (GCS 3-8) 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
470 included in outcome analysis:  
 favorable versus unfavorable  
 
501  included in outcome analysis:  
 survival versus death  
  97 included in outcome analysis:  
 favorable versus unfavorable  
 
104 included in outcome analysis:  
 survival versus death  
18 died before head CT  
19 relevant CT data missing  
 
31 no GOSE score    
36 lost to follow-up  
 21 foreigners  
   1 homeless  
   3 died before head CT  
   2 relevant CT data missing  
 
  7 no GOSE score  
 
 
17 lost to follow-up  
5 foreigners  
 3 homeless  
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Table 1   Demographic, clinical and CT characteristics of the included moderate 
and severe TBI patients (n = 700)
Characteristic Moderate TBI (n=126)a Severe TBI (n=574)a
Gender - male 77 (61) 419 (73)
Age b 47.7 (22.3) 42.9 (19.9)
Trauma mechanism
Traffic 60 (48) 403 (70)
Fall 50 (40) 123 (21)
Other/ missing 16 (12)    48 (8.4)
GCS at ED - median 11 3
AIS head b 3.5 (1.1) 4.3 (4.1)
ISS b   20.5 (12.6) 31.6 (14.8)
ISSe b  7.2 (8.2) 14.3 (14.1)
Multitrauma patients 73 (58) 427 (74)
Hypotensive episode   7 (5.6) 133 (23)
Hypoxic episode 12 (9.5) 165 (29)
Hypotensive and hypoxic   2 (1.6)   69 (12)
Pupil reactivity - normal 117 (93) 374 (65)
- one abnormal pupil     6 (4.8)   74 (13)
- both pupils abnormal     3 (2.4) 126 (22)
Intoxication Ethanol 39 (31) 99 (17)
Ethanol ‰ at ED b  2.5 (1.2) 2.1 (3.8)
Use of Anticoagulants 7 (5.6) 46 (8.0)
Neurosurgical intervention 12 (9.5) 71 (12)
Outcome 
Death (GOSE 1) 29 (23) 222 (39)
- missing 16 (13)    39 (6.8)
Unfavorable (GOSE 1-4) 39 (31) 289 (50)
Unfavorable within survivors 
(GOSE 2-4)
10 (7.9)   67 (12)
- missing 25 (20)   71 (12)
TCDB-classification n=121 n=537
Diffuse Injury I  48 (40) 104 (19)
Diffuse Injury II  38 (31) 156 (29)
Diffuse Injury III    5 (4.1)   88 (16)
Diffuse Injury IV -    17 (3.2)
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ambient cisterns, presence of intraventricular or subarachnoid hemorrhage and 
dominant lesion type - and merely two CT predictors - aspect of ambient cisterns 
and dominant lesion type - of GOSE 2-4.
 Table 2 shows the results of the final multivariable analysis combining the 
demographic, clinical and CT predictors that constituted the ‘clinical’ and ‘CT’ 
prediction models mentioned above. Based on these predictors three prognostic 
models were designed for each endpoint. 
 The discriminative values (AUC) of the various prognostic models are presented 
in Table 3, next to the results of the external validation in the POCON data set. Of 
the 442 patients from the POCON database we eventually included in the external 
validation analysis, due to missing data, 333 patients with outcome data available at 
six months. The discriminative power of the TCDB classification and Rotterdam CT 
score in the RUBICS and POCON studies was computed for mutual comparison with 
our ‘CT’ models (Table 3). 
 For a more easy use of our models in daily clinical practice a web-based calculator, 
that is available at: http://www.tbi-prognosis.com/, was built.
Table 1   Continued
Characteristic Moderate TBI (n=126)a Severe TBI (n=574)a
Evacuated mass lesion/ 
Neurosurgical intervention
  12 (9.9)    71 (13)
Non-evacuated mass lesion   18 (15) 101 (19)
- missing 0 0
a All variables expressed in number (percentage), except for b Mean (sd). CT, computed tomography; TBI, 
traumatic brain injury; sd, standard deviation; GCS, Glasgow Coma Scale; ED, emergency department; AIS, 
Abbreviated Injury Scale; ISS, Injury Severity Score; ISSe, Injury Severity Scale extracranial injuries; GOSE, 
Glasgow Outcome Scale Extended; TCDB, Traumatic Coma Databank. 
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Table 2   Association of demographic, clinical and CT variables and death  
(2a.; n=605), unfavorable outcome including death (2b.; n=567) and 
unfavorable outcome within survivors (2c.; n=567) in moderate and 
severe TBI: Results of multivariate binary logistic regression analysis 
2a. Characteristic O.R. (99% C.I.) Coefficient a
Ambient cisterns - normal ref. -
- compressed 2.1 (1.0-4.5) 0.741
- absent 7.0 (2.2-22.0) 1.943
Age 1.05 (1.03-1.07) 0.047
Pupil reactivity - normal ref. -
- one abnormal pupil 1.4 (0.5-3.6) 0.321
- both pupils abnormal 6.0 (2.3-15.9) 1.795
Number of contusions 1.7 (1.1-2.4) 0.501
Hypotensive episode 2.9 (1.3-6.4) 1.067
Fourth ventricle - abnormal 2.9 (1.1-7.6) 1.065
Constant -4.795
a The probability of death (GOSE 1) at six months can be calculated with the formula: 1/(1 + e-y). Y = -4.795 
+ (0.741 x ambient cisterns compressed) + (1.943 x absent ambient cisterns) + (0.047 x age) + (0.321 x one 
abnormal pupil) + (1.795 x both pupils abnormal) + (0.501 x number of contusions) + (1.067 x hypotensive 
episode) + (1.065 x abnormal fourth ventricle)
2b. Characteristic O.R. (99% C.I.) Coefficient b
Ambient cisterns - normal ref. -
- compressed   2.1 (1.03-4.3) 0.744
- absent 19.9 (6.0-65.7) 2.989
Age 1.04 (1.03-1.06) 0.043
Hypotensive episode 3.7 (1.7-8.3) 1.311
Dominant lesion (type) - none ref. -
- epidural hematoma 0.7 (0.2-2.5) -0.343
- acute subdural hematoma 2.3 (1.04-5.0) 0.823
- hemorrhagic contusion 3.2 (1.5-6.9) 1.153
Pupil reactivity - normal ref. -
- one abnormal pupil 1.2 (0.5-2.9) 0.147
- both pupils abnormal 4.2 (1.4-12.9) 1.436
Constant -3.269
b The probability of unfavourable outcome (GOSE 1-4) at six months can be calculated with the formula: 1/(1 + e-y). 
Y = -3.269 + (0.744 x ambient cisterns compressed) + (2.989 x absent ambient cisterns) + (0.043 x age) + 
(1.311 x hypotensive episode) + (-0.343 x EDH dominant lesion) + (0.823 x SDH dominant lesion) + (1.153 x 
contusion dominant lesion) + (0.147 x one abnormal pupil) + (1.436 x both pupils abnormal)
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Table 2   Continued 
2c. Characteristic O.R. (99% C.I.) Coefficient c
Ambient cisterns - normal ref. -
- compressed 1.3 (0.5-3.1) 0.223
- absent 5.9 (1.5-23.5) 1.779
Dominant lesion (type) - none ref. -
- epidural hematoma 1.5 (0.3-6.2) 0.372
- acute subdural hematoma 4.1 (1.6-10.7) 1.415
- hemorrhagic contusion 3.7 (1.4-10.1) 1.320
Hypotensive episode 3.3 (1.3-8.7) 1.198
Constant -2.213
c The probability of unfavourable outcome (GOSE: 2-4) at six months can be calculated with the formula: 1/(1 + 
e-y). Y = -2.213 + (0.223 x ambient cisterns compressed) + (1.779 x absent ambient cisterns) + (0.372 x EDH 
dominant lesion) + (1.415 x SDH dominant lesion) + (1.320 x contusion dominant lesion) + (1.198 x hypotensive 
episode). 
CT, computed tomography; TBI, traumatic brain injury; O.R., odds ratio; C.I. confidence interval; ref., reference; 
GOSE, Glasgow Outcome Scale Extended.
Table 3   Area Under the receiver operating characteristic curve (AUC) of 
different models for three outcome scores in RUBICS and POCON
Model RUBICS
(AUC)
External validation POCON 
(AUC [95% C.I.])
Death
Clinical 0.84  0.82 (0.78-0.87)
CT 0.85  0.79 (0.74-0.84)
TCDB CT 0.79  0.76 (0.71-0.82)
RCTS 0.81  0.79 (0.74-0.84)
Combination 0.90  0.86 (0.82-0.90)
Unfavorable outcome (incl. death)
Clinical 0.82  0.81 (0.76-0.86)
CT 0.82  0.78 (0.73-0.83)
TCDB CT 0.79  0.77 (0.72-0.83)
RCTS 0.77  0.79 (0.75-0.84)
Combination 0.87  0.83 (0.79-0.88)
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 Discussion
This prospective cohort study in unselected moderate and severe TBI patients 
introduces new outcome prediction rules. Although the demographic and clinical 
predictors we identified are in line with previous research, we found several new CT 
outcome predictors. In addition to the conventional dichotomized outcome 
endpoints, death and unfavorable outcome, we also evaluated unfavorable outcome 
in surviving patients as an outcome of interest.
 Not surprisingly, pupil reactivity, age, GCS and the presence of a hypotensive 
post-injury event surfaced as predictors for both death and unfavorable outcome 
after multivariate analysis consistent with literature.29, 41, 42, 138, 146, 148, 149, 151, 152 We used 
the complete GCS score instead of merely the GCS-motor score because we think 
the eye and verbal scores of the GCS also contain prognostic information as has 
been demonstrated before,149 although the additive prognostic value of these scores 
to the GCS-motor score was probably higher in moderate than in severe TBI patients. 
Interestingly, neither the GCS score nor the pupillary responses were predictors of 
unfavorable outcome in survivors, and therefore may be only relevant to predict 
death versus survival.    
 The presence of extracranial injuries, as represented by an extracranial ISS (ISSe) 
score, was not associated with outcome in contrast to a recently published prediction 
model.41 This may be caused by the fact that around 30% of the patients included in 
that study suffered from mild TBI. And, as we have shown before, specifically in mild 
TBI patients recovery and six months outcome is to a large part determined by 
extracranial injuries.134, 256 In moderate and severe TBI the extent of the brain damage 
by itself may be sufficient to determine, and explain differences in functional 
outcome and return to work. 
Table 3   Continued
Model RUBICS
(AUC)
External validation POCON 
(AUC [95% C.I.])
Unfavorable outcome (excl. death)
Clinical 0.65 0.61    (0.52-0.70)
CT 0.71 0.71    (0.62-0.79)
Combination 0.74 0.69    (0.61-0.78)
AUC, Area Under the Curve; RUBICS, Radboud University Brain Injury Cohort Study; POCON, Prospective 
Observational COhort Neurotrauma; C.I., confidence interval; CT, computed tomography; TCDB CT, 
Traumatic Coma Databank CT classification; RCTS, Rotterdam CT Score; incl., including; excl., excluding.
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 Consistent with previous studies demonstrating the value of CT characteristics 
in prediction models,29, 151, 153, 157 both in our and in the POCON cohort the TCDB CT 
classification showed strong predictive power (AUCs 0.76-0.79, Table 3). Other 
authors have suggested that the prognostic power of the head CT scan is not fully 
utilized with the TCDB CT classification.133, 149, 153, 157 Despite of its shortcomings the 
TCDB classification performed only slightly worse than the Rotterdam CT score 
(AUCs 0.77-0.81, Table 3) and our CT prognostic models (AUCs 0.78-0.79, Table 3), 
challenging those statements. The discriminative power of our ‘CT’ models predicting 
unfavorable outcome in the surviving patients was somewhat disappointing (AUC 
0.71), suggesting that CT characteristics are more important for the prediction of 
death and survival than of disability.
 The discriminative abilities of our ‘combination’ models were highly adequate 
even after external validation for both death (AUC: 0.86, Table 3) and unfavorable 
outcome (AUC: 0.83, Table 3), also when compared to recently published outcome 
prediction studies.29, 41, 42, 151 In the surviving patients the predictive power of these 
models was limited (AUC 0.69, Table 3), again suggesting that disability is probably 
predicted by other variables than is death. 
 Two recent studies: IMPACT and MRC CRASH, introduced several prognostic 
models for mortality and unfavorable outcome in moderate and severe TBI.41, 42 And 
although they are the two largest studies in moderate and severe TBI, some aspects 
need to be considered. The prognostic models resulting from these studies are 
largely based on patients enrolled in clinical trials and not on prospective observational 
cohort studies alone.145, 160 Furthermore the IMPACT database exists of studies 
executed between 1984 and 1997:145 The last patient was enrolled in these studies 
more than fifteen years ago. Finally, both studies, and this is true for most studies on 
outcome prediction in moderate and severe TBI, aimed at the prediction of death 
and unfavorable outcome, but not at favorable versus unfavorable outcome in the 
surviving patients.41, 42  
 The prediction models described in this study still rely on conventional 
demographic and clinical parameters, and a number of CT characteristics. Though 
certainly adequate, the discriminative values (AUCs) of our prediction rules are still 
not reaching the maximum of 1.0. Hence we think that there is room for improvement 
and new outcome predictors are ready to hand. First, laboratory parameters have 
been found to add prognostic value. Serum glucose, platelet count and hemoglobin 
levels proved independent predictors after multivariate analysis.42, 149, 233, 268 In the 
widely applied intensive care prognostic system APACHE, laboratory parameters are 
of great importance in predicting mortality for critically ill adult patients.269 Further, 
various biomarkers, like the brain specific proteins GFAP and S100B, in cerebrospinal 
fluid and serum have been identified as parameters associated with outcome after 
TBI.161, 270 Genetic polymorphisms, for example the apolipoprotein E4 polymorphism, 
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are also considered to play a role in the prognosis of TBI outcome.172 Finally, most 
current prognostic models are designed to predict death or unfavorable outcome 
(including death).29, 41, 42, 151 We found that the predictors constituting these models 
are insufficient for the prediction of severe disability in survivors. Research on more 
relevant predictors is warranted.
Limitations
We recognize some limitations of this study. Missing data in this prospective study 
may have weakened the association of these variables with outcome. Furthermore, 
not for every included patient outcome data was available. Of 31 (5.4%) severe TBI 
patients only information on survival was available and 36 (6.3%) patients were lost 
to follow-up. The main reason for this was the inclusion of patients from abroad, 
unable to be present at follow-up consultation. In the moderate TBI group 17 (13.5%) 
patients were lost to follow-up, whereas in 7 (5.6%) patients insufficient data to 
determine the GOSE score were available. For the complete study the loss to 
follow-up rate was 7.6%, which is still less than the 10% considered an acceptable 
loss to follow-up rate in a review on prognostic models in TBI.144
 The generalizability of our prognostic models may be impeded by the fact that 
the derivation part of this study was executed in a single centre and the external 
validation was performed using an exclusive Dutch cohort. On the other hand, in 
contrast to earlier studies we investigated an unselected cohort consisting of a 
heterogeneous and realistic patient population which minimized potential selection 
bias.41, 42, 149, 151
 Brain damage after severe and moderate TBI is a dynamic pathological process 
in which clinical and CT variables may change over time. This is best illustrated for 
the GCS score where a prediction model based on the best GCS-motor score within 
the first 24 hours post-trauma demonstrated superior accuracy over the worst GCS 
score.29 Progression of traumatic intracerebral hematomas and contusions, brain 
swelling and edema, midline shift and post-traumatic cerebral infarction after the 
initial CT scan is common.240-244 Prediction of eventual outcome becomes more accurate 
using information from sequential rather than initial CT scans.242 Nevertheless, we 
used the clinical parameters at the ED and the information obtained from initial CT 
scans, while we think that indices of the primary injury are most essential in clinical 
decision making and for prognostic purposes in daily practice.
 An inclusion bias may have been introduced because of the GCS score we applied to 
define TBI severity. We used the GCS score after initial resuscitation or the admission 
GCS score before intubation and sedation if these procedures were performed 
during resuscitation. However, a large proportion of especially the severe TBI 
patients was already intubated, and possibly also sedated, at the moment of clinical 
evaluation, as a result of pre-hospital management, complicating a reliable neurological 
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assessment. We did not correct for GCS scores determined at the injury scene, of 
which the reliability has been questioned before.271 Hence, it is possible that a less 
severely injured TBI patient was wrongly categorized as severe due to a falsely low 
GCS score.  
 Finally, the number of surviving patients with an unfavorable outcome (GOSE 
2-4) was relatively small (n=77), especially when compared to the number of patients 
that died (n=251), which may have influenced model derivation and validation for 
this outcome category. 
Conclusion
With this study of an unselected cohort of moderate and severe TBI patients we 
introduce several new and externally validated outcome prediction rules. We also 
evaluated unfavorable outcome in surviving patients as an outcome of interest 
besides the conventional dichotomized outcome endpoints, death and unfavorable 
outcome.
 The information our prediction models provide, will be helpful in clinical research 
for selection of patients for enrollment in clinical trials for example on neuroprotective 
therapies, as well as for stratifying participants by injury severity. To further improve 
the discriminative abilities of outcome prediction models in TBI, future research 
should focus on the identification of new potential outcome predictors, like serum 
or cerebrospinal fluid biomarkers of brain damage or genetic polymorphisms. 
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Serum biomarkers GFAP and S100B in moderate and severe TBI
Abstract
Background: Biomarker levels in blood after traumatic brain injury (TBI) may offer 
diagnostic and prognostic tools in addition to clinical indices. This study aims to 
validate glial fibrillary acidic protein (GFAP) and S100B concentrations in blood as 
outcome predictors of TBI using cutoff levels of 1.5 µg/L for GFAP and 1.13 µg/L for 
S100B from a previous study. 
Methods: In 79 patients with TBI (Glasgow Coma Scale score [GCS] <12), serum, 
taken at hospital admission, was analyzed for GFAP and S100B. Data collected 
included injury mechanism, age, gender, mass lesion on CT, GCS, pupillary reactions, 
Injury Severity Score (ISS), presence of hypoxia, and hypotension. Outcome was 
assessed, using the Glasgow Outcome Scale Extended (dichotomized in death vs 
alive and unfavorable vs favorable), 6 months post injury. 
Results: In patients who died compared to alive patients, median serum levels were 
increased: GFAP 33.4-fold and S100B 2.1-fold. In unfavorable compared to favorable 
outcome, GFAP was increased 19.8-fold and S100B 2.1-fold. Univariate logistic 
regression analysis revealed that mass lesion, GFAP, absent pupils, age, and ISS, but 
not GCS, hypotension, or hypoxia, predicted death and unfavorable outcome. 
Multivariable analysis showed that models containing mass lesion, pupils, GFAP, 
and S100B were the strongest in predicting death and unfavorable outcome. S100B 
was the strongest single predictor of unfavorable outcome with 100% discrimination. 
Conclusion: This study confirms that GFAP and S100B levels in serum are adjuncts 
to the assessment of brain damage after TBI and may enhance prognostication 
when combined with clinical variables. 
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Introduction
Accurate determination of the initial brain damage after severe traumatic brain 
injury (TBI) is crucial in establishing a neurologic prognosis and to balance risks and 
benefits of treatment options. Prognostic models, created from cohort and 
randomized controlled studies in more than 10,000 patients, confirm that age, 
extracranial injury, and brain damage indices including the Glasgow Coma Scale 
(GCS), GCS motor score, pupillary reactivity, and intracranial hemorrhage consistently 
predict death and unfavorable outcome.41, 42 The accuracy of models amounts to 
0.70-0.84, providing solid grounds for estimation of probabilities of outcome 
categories, yet is considered still insufficiently sensitive and specific as a diagnostic 
and prognostic tool in individual patients.29, 41, 42 
 Another line of TBI research therefore emphasizes enlarging knowledge on 
biochemical markers of injury as levels in serum or CSF may indicate the extent of 
brain damage or neurologic decline.169 Cohort studies (n=10-100) have yielded 
biomarkers that can be measured in blood including glial fibrillary acidic protein 
(GFAP),162 neuron-specific enolase,163 S100B,164-166 myelin basic protein,167 and cleaved 
tau.168 However, due to variation in methods, cutoff levels, sampling time, and 
comparison with clinical predictors, currently, biomarkers are considered insufficient 
to serve as a classification tool, prognostic factor, or surrogate outcome marker.169
 In this study, we validate the predictive value of biomarkers for outcome after 
moderate/severe TBI by comparing serum levels of GFAP and S100B with demographic 
and clinical indices. Previously, we showed that GFAP (cutoff value 1.5 µg/L) and 
S100B (cutoff value 1.13 µg/L) predict death (sensitivity 0.85-1.0, specificity 0.41-0.52) 
and unfavorable outcome (sensitivity 0.8-0.88, specificity 0.43-0.59).161
Methods
Since 1998, patients admitted to the emergency department (ED) of the Radboud 
University Nijmegen Medical Centre (RUNMC), a level I trauma center, with mild, 
moderate, or severe TBI are included in the Radboud University Brain Injury Cohort 
Study (RUBICS). RUBICS is an observational study on the association between 
demographic and clinical variables, imaging, posttraumatic complaints, genetic 
factors, and clinical outcome. In the current study, patients with moderate/severe 
TBI admitted between October 2004 and March 2006 were eligible for inclusion. 
Exclusion criteria were no blood sample taken, age <18 years, no informed consent, 
hospital admission more than 24 hours after the accident, alcohol or drug abuse or 
dementia, no possibility of follow-up, and inability to speak Dutch. 
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Standard protocol approvals, registrations, and patient consents
Approval for this study was obtained from the ethical standards committee of our 
hospital. Written informed consent was obtained from all patients (or guardians of 
patients) participating in the study. 
 TBI classification was based on the hospital admission GCS, defined as moderate 
(GCS 9-12) or severe (GCS 3-8). Multiple injuries were not excluded. Overall injury 
severity, including the presence of multiple injuries, was measured using the Injury 
Severity Score (ISS). If intubated or sedated at the trauma scene, the last known GCS 
was taken as the qualifier to classify brain injury severity. All patients were scheduled 
to undergo a head CT scan immediately after resuscitation. CT scans were classified 
by 2 investigators (P.E.V., B.J.) according to the Traumatic Coma Databank (TCDB) 
criteria.161 Treatment, according to international guidelines, was targeted at a normal 
intracranial pressure and cerebral perfusion pressure. Data recorded were age, 
gender, GCS, pupillary reactions, ISS, TCDB classification, the occurrence of hypoxia 
(PaO2 <8 kPa or SaO2 <90%), and hypotension (systolic blood pressure <90 mm Hg). 
Outcome was assessed (blinded for serum levels) using the Glasgow Outcome Score 
Extended (GOSE)114 at 6 months using a structured interview during regular patient 
visits to the clinic or by telephone. 
 Samples were allowed to clot and, after centrifugation (1,000g, 10 minutes), 
stored at -70°C. The GFAP and S100B assays are 2-site luminometric immunoassays 
with 1 incubation step performed on the STAT IntraOperative platform (Future 
Diagnostics, Wijchen, Netherlands). The assays cover a concentration range up to 18 
µg/L (S100B) and 30 µg/L (GFAP) with a typical intra-assay precision <5% and an 
interassay precision <10%. The analytical sensitivity of these assays is 0.02 µg/L. No 
high-dose hook effect exists up to 1,000 µg/L. The GFAP assay was performed as 
described.272 In short, 100 µL serum was added to anti-GFAP–coated wells and 50 µL 
polyclonal tracer antibody (Future Diagnostics: 10F-2214) labeled with N-(4-
Aminobutyl)-N-ethylisoluminol (ABEI; Sigma-Aldrich, St. Louis, MO) was added. 
Samples (incubated for 20 minutes at RT, 14,000 rpm) with GFAP values higher than 
the highest standard were diluted with the zero standard and reassayed. Normal 
controls (n = 46) showed nondetectable GFAP with a 99% upper limit of <0.04 µg/L. 
 In the S100B STAT assay, 100 µL serum samples were added to wells coated with 
2 monoclonal antibodies against S100B and contained the monoclonal tracer 
antibody labeled with ABEI in the form of a lyophilized particle. After incubation (20 
minutes at RT, 14,000 rpm), the strips were washed. The chemiluminescent signal 
was measured in the STAT plate luminometer. 
Statistical methods
Group differences in biomarker levels were tested for significance with the Mann- 
Whitney U test (2 groups) or the Kruskal-Wallis test (3 or more groups). Median 
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values and 90% reference (5th to 95th percentile) intervals are presented. Spearman 
correlations were calculated to explore the relationship between clinical variables 
and the biomarkers. 
 Univariate logistic regression analysis was used to evaluate the prognostic 
ability of the clinical and biochemical variables, separately, to predict the probability 
of death (GOSE = 1) or unfavorable outcome (GOSE = 1-4) 6 months after injury. The 
Nagelkerke R2 indicates the percentage explained variance in outcome by each 
variable. Because the brain-specific proteins were to be nonlinearly related to the 
log-odds for each outcome, cutoff values from a previous study were used: for GFAP 
1.5 µg/L and for S100B 1.13 µg/L. Because the TCDB classification is nonlinear we 
constructed an alternative CT score defined as the presence or absence of a mass 
lesion (contusion, intraparenchymal hematoma, subdural or epidural hematoma) 
with a volume >25 mL. The sensitivity, specificity, positive/negative predictive values, 
and false-positive/false-negative rates of the biomarker cutoffs were calculated. 
 Variables associated with outcome in the univariate analysis (p <0.05) were included 
in additional multivariable logistic regression procedures. Because of colinearity of 
candidate variables, several models were considered using forward selection to 
explore if biomarkers enhance prognostication when combined with clinical 
variables. Predictive accuracy of the models (or rules), i.e., the accuracy of selected 
variables to distinguish between death or alive and unfavorable vs favorable 
outcome, was assessed using the area under the receiver operating characteristic 
curve (AUC). The AUC is a measure of predictive discrimination: 0.5 is equivalent to 
random guessing and 1 is perfect prediction.273, 274
Results
During the inclusion period, 943 patients with TBI were seen at the ED. Not eligible 
were patients with mild TBI (n = 771), no blood sample taken (n = 25), age below 18 
(n = 39), dementia (n = 1), alcohol or drug abuse (n = 4), or inability to speak Dutch (n 
= 7). Of the 96 eligible patients, 17 were excluded (no consent, n = 7; no follow-up, n 
= 10). Clinical and demographic data are summarized in table 1. Table 2 shows higher 
median GFAP and S100B serum concentrations in severe as compared to moderate 
TBI and in the presence of hypoxia, hypotension, and absent pupillary reactions. 
GFAP and S100B concentrations were higher (p <0.001) in patients who died 
compared to alive patients and in patients with unfavorable outcome compared to 
favorable outcome (p <0.01, table 2). 
 The correlation between time to sample withdrawal and S100B or GFAP level 
was less than 0.2. Levels of GFAP did not correlate with GCS and ISS (Spearman 
correlation coefficients <0.3) but correlated weakly with age (correlation coefficient 
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Table 1   Characteristics of 79 patients with moderate and severe traumatic  
brain injury
Variables Values
 Age, y, median (range) 47.0 (18.0 – 91.0)
 Gender, n (%)
Men
Women
57 (72)
22 (28)
Type of accident, n (%)
Traffic accident 
Falls
Violence
42 (53)
34 (43)
   3 (4)
Median (p5-p95) time to sample withdrawal, min. 61 (30 – 300)
GCS, median (range)
     GCS 3-8, n (%)
     GCS 9-12 n (%)
  3 (3 – 12)
57 (73)
22 (27)
Pupillary reactions, n (%)
Present
One absent
Bilateral absent
Unknown
54 (68)
  5 (6)
18 (23)
  2 (3)
ISS, median (range) 25.0 (5.0 – 75.0)
Multiple trauma,a n (%) 53 (67)
Hypotension,b n (%)
No
Suspected
Present
61 (77)
  3 (4)
15 (19)
Hypoxia,c n (%)
No
Suspected
Present
44 (56)
11 (14)
24 (30)
Alcohol intoxication, n (%)
No
Yes
Unknown
57 (72)
19 (24)
  3 (4)
TCDB CT classification, n (%)
1
2
3
4
5
6
Not performed
12 (15,2)
29 (36,7)
  7 (8,9)
  -
  7 (8,9)
21 (26,6)
  3 (3,8)
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= 0.30, p = 0.007). The brain-specific proteins were moderately correlated (correlation 
coefficient 0.53, p <0.0001). S100B serum levels correlated with the GCS (correlation 
coefficient = -0.18, p = 0.006) and ISS (correlation coefficient = 0.29, p = 0.009). 
 Table 3 shows sensitivity, specificity, and positive and negative predictive values 
for the brain-specific proteins, pupillary reactions, and presence of mass lesion. 
Compared to the clinical variables, the specificity of the proteins was better in 
predicting death or unfavorable outcome at 6 months (0.93-0.95 for GFAP and 
0.95-1.0 for S100B). 
 Table 4 shows crude odds ratios with 95% confidence intervals of serum brain- 
specific proteins (dichotomized, using the cutoff values), GCS, ISS, and intracranial 
mass lesion for the prediction of either death (GOSE = 1) or unfavorable outcome 
(GOSE = 1-4). Nagelkerke R2 were higher for the biomarkers compared to the clinical 
variables and comparable to the presence of a mass lesion on head CT.
 All variables were considered in a multivariable logistic regression analysis to 
test if outcome prediction could be improved when combined with clinical variables. 
Because of colinearity of variables, several models were considered. The best-fitting 
models, based on the AUC for death vs alive including 2 variables contributing 
independently to the probability of being deceased at 6 months postinjury, consisted 
of pupillary reactions and mass lesion (AUC = 0.93), GFAP with pupillary reactions 
(AUC = 0.92), and GFAP with mass lesion (AUC = 0.92). S100B serum level and mass 
Table 1   Continued
Variables Values
Outcome GOSE, n (%)
Unfavorable outcome
1
2
3
4
Favorable outcome
5
6
7
8
36 (46)
24 (30)
  0 (0)
  7 (9)
  5 (6)
43 (54)
  8 (10)     
12 (15)
  7 (9)
16 (20)
aMultiple trauma was defined as an ISS >16. bHypotension was defined as follows: no = none; suspected = 
on clinical grounds; yes = definite hypotension (systolic blood pressure <90 mmHg). cHypoxia was defined 
as follows: no = no SaO
2 
<85% or PaCO
2 
>8 kPa; suspected = on clinical grounds; yes = any SaO
2 
<85% or 
PaCO
2 
>8 kPa. Abbreviations: GCS = Glasgow Coma Scale score; GOSE = Glasgow Outcome Score Extended; 
ISS = Injury Severity Score; TCDB = Trauma Coma Databank.
149
6
Serum biomarkers GFAP and S100B in moderate and severe TBI
Table 2   Median (p5-p95) serum concentrations (μg/l) of GFAP and S100B  at the 
time of hospital admission by clinical variables and outcome in patients 
with moderate/ severe TBI
Variable   No. GFAP S100B
Gender
     Male
     Female
57
22
0.46 (0.02-21)
0.21 (0.02-5.27)
0.38 (0.12-2.6)
0.21 (0.07-0.69)*
Hypoxiaa
     No
     Yes
44
35
0.38 (0.02-8.39)
0.73 (0.02-21)
0.25 (0.07-1.58)
0.44 (0.14-2.6)*
Hypotensionb
     No
     Yes
61
18
0.52 (0.02-9.38)
0.1 (0.02-9.81)*
0.26 (0.09-1.45)
0.47 (0.13-3.7)*
Pupilsc
     No
     Yes
24
55
1.53 (0.05-21)
0.19 (0.02-4.76)***
0.6 (0.09-2.61)
0.27 (0.09-1.77)*
GCS
    3-8
    9-12
57
22
0.52 (0.02-21)
0.37 (0.02-4.59)
0.43 (0.12-2.6)
0.22 (0.07-0.48)**
CT
   TCDB = 1
   TCDB = 2-4
   TCDB = 5-6
12
35
29
0.02 (0.02-1)
0.1 (0.02-1.25)
2.17 (0.15-21)***
0.22 (0.07-2.6)
0.29 (0.12-1.77)
0.38 (0.09-1.58)
Deceased (GOSE 1) 24 4.67 (0.29-21) 0.54 (0.13-2.61)
Alive (GOSE 2-8) 55 0.14 (0.02-3.13)*** 0.26 (0.09-1.77)***
Unfavorable outcome 36 1.79 (0.05-21) 0.51 (0.13-2.61)
Favorable outcome 43 0.09 (0.02-1.44)*** 0.24 (0.09-0.69)**
Overall 79 0.43 (0.02 – 21) 0.32 (0.06 – 3.7)
aHypoxia is categorized as follows: no = no SaO
2 
<85% or PaCO
2 
>8 kPa; yes = suspected on clinical grounds 
or definite (any SaO
2 
<90% or PaCO
2 
>8 kPa). bHypotension is categorized as follows: no = none; or yes = 
suspected on clinical grounds or definite hypotension (systolic blood pressure <90 mmHg).  cPupils: yes = 
both present, no = one or both absent.  Unfavorable outcome: GOSE 1-4; Favorable outcome: GOSE 5-8.
* p <0.05, ** p <0.01, *** p <0.001,  p values of the Mann-Whitney U test in case of two groups and 
Kruskal-Wallis test in case of three groups.
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lesion (AUC = 0.85) yielded the best results for the prediction of unfavorable outcome. 
Close alternative models in predicting unfavorable outcome were the combination 
of GFAP with mass lesion (AUC = 0.8), pupillary reactions with mass lesion (AUC = 0.81), 
and S100B with GFAP (AUC = 0.79). 
 Finally, the figure clearly demonstrates the increased mortality risk and probability 
of unfavorable outcome in those patients with high biomarker levels at the time of 
hospital admission. 
Table 4   Crude odds ratios (O.R.) of demographic, clinical, and biochemical 
variables for deceased and unfavorable outcome at 6 months after 
moderate/ severe traumatic brain injury
Deceased (GOSE = 1) Unfavorable outcome (GOSE = 1-4)
Variable OR (95% CI) p R2, % AUC OR (95% CI) p R2, % AUC
Age,a y 1.05 (1.02-1.08) 0.003 17 0.7 1.03 (1.01-1.06) 0.015 10 0.65
GCS 0.9 (0.77-1.07) 0.249  2.5 0.57 0.90 (0.77-1.04) 0.137  4 0.56
Pupillary reactions
     Present
     Both absent
1.0
17.85 (4.86–65.6)
Ref.
<0.001 36 0.76
1.0
6.21 (1.81 – 21.18)
Ref.
0.004 16 0.65
ISSa 1.04 (1.00-1.07) 0.031  9 0.66 1.03 (0.99-1.06) 0.075  6 0.63
CT mass lesion    
     No
     Yes
1.0
29.4 (7.93-108.8)
Ref.
0.001 66 0.84
1.0
13.44 (4 -42.6)
Ref.
<0.001 36 0.76
Hypotensionc    
     No
     Yes
1.0
1.19 (0.36 – 3.99)
Ref.
0.77  1 0.51
1.0
1.44 (0.46 – 4.47)
Ref.
0.53  1 0.53
Hypoxiac            
     No
     Yes
1.0
1.33 (0.45 – 3.91)
Ref.
0.6  1 0.53
1.0
1.70 (0.63 – 4.65)
Ref.
0.30  2 0.56
GFAP     
     <1.5 μg/l
     >1.5 μg/l
1.0
30.96 (8.06-118.9)
Ref.
<0.001 49 0.82
1.0
22.9 (4.80-109.3)
Ref.
<0.001 37 0.74
S100B      
     <1.13 μg/l
     >1.13 μg/l
1.0
5.78 (1.30-25.53)
Ref.
0.021 10 0.6
1.0
14.33 (1.72-¥)b
Ref.
0.002 24 0.63
aPer point on scale. bNot estimable, exact lower bound confidence estimate is presented. cPatients with 
suspected hypotension or hypoxia were excluded from the analysis. 
Abbreviations: AUC = area under the receiver operating characteristic curve; O.R. = odds ratio; C.I. = confidence 
interval; GCS = Glasgow Coma Scale score; GFAP = Glial Fibrillary Acidic Protein; GOSE =  Glasgow Outcome 
Scale Extended; ISS = Injury Severity Score; Ref = reference; R2 = total rescaled R-square indicating the percentage 
explained variance. 
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Discussion
This study confirms that outcome prediction after TBI can be improved with 
determination of serum levels of GFAP and S100B at the time of hospital admission. 
Serum concentrations above 1.5 µg/L (GFAP) and 1.13 µg/L (S100B) were stronger 
predictors of death or unfavorable outcome than age, ISS, pupillary reactions, and GCS 
score. GFAP and S100B levels were higher in patients who died compared to those who 
remained alive. Similarly, patients with unfavorable functional outcome (GOSE 1-4) 
had higher levels than patients with favorable outcome (GOSE 5-8). These results are 
in line with previous studies showing increased S100B serum concentrations in the 
first hours postinjury in patients dying166, 275-277 or with unfavorable outcome.276-281
 S100B correlated best with the ISS, indicating that S100B also reflects overall 
extracranial injury severity.165, 282, 283 GFAP serum levels correlated best with mass 
lesion on CT. The good correlation between GFAP serum levels and mass lesion 
(r = 0.73) is noteworthy. Interestingly, after stroke increased serum GFAP values 
were found within 6 hours after symptom onset in intracerebral hemorrhage but 
not ischemic stroke.284 Hence lesion type or etiology may influence release of 
brain-specific markers through the blood–brain barrier into the circulation. GFAP 
serum levels are higher in the presence of mass lesions and raised intracranial 
pressure but GFAP is not released after multiple trauma without brain injury.162, 285 
S100B is a Ca2+-binding protein of astrocytes, oligodendrocytes, and Schwann 
cells.286 Although, contrary to GFAP, S100B is not entirely brain-specific and serum 
Figure   Proportion of death and unfavorable outcome in relation to glial fibrillary 
acidic protein (GFAP) and S100B cut-off levels
Proportion of patients with traumatic brain injury deceased (A) and with unfavorable outcome (B) in relation 
to GFAP and S100B serum level at the time of hospital admission.
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levels are also increased after extracranial injuries without brain injury, S100B 
predicts unfavorable outcome after severe TBI.165, 275, 276, 279, 280, 282
 Previous studies showed that GFAP and S100B serum concentrations change 
with time.162, 166, 275, 287, 288 The median time to withdrawal in our study was short, 61 
minutes, and no interaction with serum levels was found. Since GFAP has a higher 
molecular weight than S100B, it is possible that release of the proteins into the 
circulation differs over time. Interestingly, when GFAP and S100B were repeatedly 
measured in 92 patients with TBI, the accuracy of GFAP serum levels to predict 
mortality decreased, while the accuracy of S100B increased over time.162
 Data from the univariate analyses reveal that GFAP, S100B, age, ISS, pupillary 
reactions, and mass lesion but not GCS, hypoxia, and hypotension predict death 
(GOSE 1) or unfavorable outcome (GOSE 1-4). The R2 were in general higher for the 
biochemical determinants compared to the clinical and CT injury indices. 
 When combinations of clinical variables with the biomarkers were tested, only 
models containing GFAP, S100B, pupillary reactions, and mass lesion contributed 
independently to the probability of death or unfavorable outcome. The combination 
of pupillary reactions and mass lesion predicted mortality best, while GFAP with 
pupillary reactions and GFAP with mass lesion were good alternatives. The predictive 
accuracy of these models, i.e., the accuracy to distinguish between death or survival, 
was high between 0.92 and 0.93. For unfavorable outcome, the combination of S100B 
with mass lesion, GFAP with S100B, and GFAP with mass lesion yielded the highest 
predictive accuracy, although lower than for mortality, varying between 0.8 and 0.85. 
 We found no correlation between protein levels and hospital admission GCS. 
Although some authors demonstrated a correlation of S100B and GFAP with the 
GCS,289, 290 others did not.291 The absence of a correlation with the GCS may be due to 
loss of predictive strength of the GCS and GCS motor score as classic outcome 
predictors of TBI.44 Intensified prehospital treatments, comprising early sedation 
and neuromuscular blockade, hampers neurologic examination and may result in 
erroneous low GCS scores.44  A clinical implication of the current study might be that 
when the GCS cannot be reliably obtained, biomarker levels in blood may still be 
good indicators of brain damage. 
 A general limitation of studies like ours is that S100B in blood is not exclusively 
from cerebral origin and may be released into the circulation from injury to fat 
tissue, muscle, or bone marrow.165, 282 In our study, in which 67% sustained multiple 
injuries, serum-S100B levels were probably derived from both cerebral and 
extracerebral sources. The brain damage and systemic injuries together in general 
determine global functional outcome after TBI. A tentative explanation for the 
predictive strength of S100B for outcome (all patients with S100B above cutoff level 
had unfavorable outcome) may be that trauma to other body parts than the head 
accounted largely for the unfavorable outcome. The source of origin problem probably 
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does not exist for GFAP. GFAP is a specific marker of a monomeric intermediate 
filament protein of differentiated astrocytes in the CNS and indeed, GFAP was not 
released after multiple trauma without brain injury.285
 Another limitation is that the S100B ELISA measures 2 different isoforms, 
S100A1B and S100BB, that may be derived from different sources. A study in 59 samples 
comparing total S100B with S100A1B and S100BB found equal high specificities for 
unfavorable outcome with different cutoff values.281 Serum S100B correlates with the GCS, 
absent pupillary reactions, contusion volume, and subarachnoid hemorrhage.275, 288, 292-294 
Insufficient power may explain why established predictors like GCS, hypoxia, and 
hypotension did not reach significance in our study. 
 The cutoff values for GFAP (1.5 µg/L) and S100B (1.13 µg/L) used in this study 
match well with other studies. Depending on the time of sample withdrawal and 
chosen endpoints, published cutoff values vary between 0.53 and 2.5 µg/L for S100B 
and 1.5 and 6.98 µg/L for GFAP.162, 276, 278, 295 Also the sensitivities and specificities show 
variation and the lower the chosen cutoff value the higher the sensitivity and the 
less specific a biomarker becomes. In 59 patients with severe TBI, serum GFAP peak 
levels above 6.98 µg/L in the first 2 weeks post-injury predicted 100% of cases with 
unfavorable functional outcome.295 For a variable (clinical or laboratory) to be a good 
predictor in clinical practice, it is important to know what type of decisions will be 
taken on the biomarker result at the emergency room or the intensive care unit. 
When treatment limitation or withdrawal is considered, physicians and individual 
patients and their relatives must be confident that a biomarker test result, on which 
the final decision will be based, is highly specific for a particular outcome category 
(death or vegetative state) and that the number of false-positives is extremely low 
to avoid unjustified treatment restrictions. Hence, predictive values and confidence 
intervals of false-positive predictive values are important. GFAP and S100B clearly 
fulfilled this criterion, as demonstrated by a false-positive rate for unfavorable 
outcome below 5%. But is this specific enough? 
 In this respect, a parallel can be drawn with the accurate assessment of neurologic 
prognosis in patients in coma after cardiopulmonary resuscitation. The guideline on the 
prediction of recovery from coma after cardiopulmonary resuscitation has accepted 
that in addition to clinical indices, a biomarker, in this case, serum neuron-specific 
enolase (cutoff level 33 µg/L, measured in the first 3 days), can reliably assist in accurately 
predicting unfavorable outcome with a 95% confidence level of the false positive rate of 
0% to 3%.296, 297 Based on the results of our study, we hypothesize that it is possible to 
obtain cutoff levels for GFAP and S100B in TBI with a similar small false-positive rate for 
death or unfavorable outcome. To achieve this goal, larger (multicenter) studies are 
needed to establish precise threshold values and to demonstrate that information 
obtained from biomarkers in addition to clinical variables indeed allows for sufficient 
accurate outcome prediction in individual patients. 
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The studies presented in this thesis focused on outcome predictors and prognostic models 
in mild, moderate and severe traumatic brain injury (TBI), and are part of the prospective 
observational Nijmegen based Radboud University Brain Injury Cohort Study (RUBICS). TBI 
is a frequent and heterogeneous neurological disorder. It yearly affects more than 35,000 
patients in the Netherlands, predominantly children and young adults. 
 First of all the patient and his or her next-of-kin, but also physicians and other 
professionals involved in the treatment of a TBI patient, irrespective of severity, have a 
need for information on the prognosis of that patient. The correctness of this 
information is, of course, of the utmost importance. With the studies in this thesis we 
intended to contribute to the development of accurate prognostic models and to 
provide helpful tools that can be used in daily clinical practice. 
 In this chapter the results of our studies are recapitulated and discussed. First, the 
development and the external validation of a new scale to optimize post-traumatic 
amnesia (PTA) assessment are described. Subsequently, our findings on the prognostic 
value of demographic and clinical parameters in mild to severe TBI are discussed, 
followed by a review of the role of CT characteristics in TBI outcome prediction in 
relation to our results. Finally, the results of our biomarker (GFAP and S100B) study are 
summarized. This chapter is concluded with several ideas on further research 
perspectives, to answer the important question: How to proceed from here?
7.1 Post-traumatic amnesia assessment (Chapter 2)
The importance of PTA in TBI and its role as an outcome predictor has been shown in 
different studies in mild, moderate and severe TBI.46, 55, 66, 68, 84-91, 91-96 Accurate assessment 
of PTA presence and duration is essential to preserve and further enhance its status as a 
reliable prognostic factor. In order to simplify and therefore perpetuate PTA assessment 
in clinical practice and also for research purposes we developed and externally validated 
a new PTA scale consisting of seven objective items: age, name of hospital, time, day of 
week, month, mode of transport and recall of three words. The discriminative capacity of 
our scale proved comparable to that of existing PTA scales. Nevertheless, it has the 
advantage of being more practical, less time consuming and examiner independent. To 
evaluate anterograde memory we have included a three-word memory test instead of 
using pictures as memory items like is done in the MOPTAS100 and (R-)WPTAS scales,101, 102 
because the specificity of words as memory items was not inferior to pictures but had a 
higher sensitivity, confirming earlier findings.180 Besides, the use of words for instance at 
an ED setting is far more practical. 
 To study the discriminative value of our scale, i.e. the mutual relation of 
sensitivity and specificity, also in relation to existing PTA scales, we used ROC 
analysis across three consecutive PTA assessments. On all these three test moments 
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our proposed PTA scale showed significant discriminative values (AUCs: 0.77, 0.85 
and 0.89), and even the highest AUC of all tested scales at the second moment of 
PTA assessment (one hour after initial administration). Additionally, we calculated 
correlation coefficients to examine the association between performances of TBI 
patients on our PTA scale and performances on the GOAT,99 MOPTAS100 and (R-)
WPTAS scales101, 102 serving as surrogate gold standards: We found correlations of 
>0.70 indicating that performance on our PTA scale was in good agreement with 
currently used assessment scales. Furthermore, a recent study on the accuracy of 
the R-WPTAS in mild TBI demonstrated similar discriminative values (AUC) as we 
found for our PTA scale.183 
7.2  Prognosis of TBI: Role of demographic and clinical 
parameters (Chapters 3 and 5)
Age is an indisputable outcome predictor in moderate and severe TBI.41, 42, 152 The role 
of age in mild TBI prognosis is less apparent, but several studies suggest a relation 
between age and outcome as well.117 Not remarkably, we also found an association 
between age and outcome after multivariate analysis: In all TBI categories a higher 
age was associated with a worse outcome. Here all parallels between mild and 
moderate/ severe TBI regarding outcome prediction cease.
 An interesting finding concerned the prognostic value of extracranial injury, in 
our studies represented by the extracranial ISS score (ISSe). We showed that in mild 
TBI, outcome is partly determined by the presence and severity of extracranial 
injuries and the ISSe score was therefore included in a prediction rule. This association 
has also been found in mild TBI studies using other outcome scores than the GOSE.120, 
134 However, in moderate and severe TBI, extracranial injury was not an outcome 
predictor. Comparable findings have also been published by others.43, 298 Presumably, 
the extent of the brain damage by itself is sufficient to determine, and explain 
differences in functional outcome and for example return to work in moderate and 
severe TBI patients. Extracranial injury was not associated with TBI outcome and 
consequently not included in the MRC CRASH prognostic model.41 This may result 
from the fact that about 30% of the patients included in that study suffered from 
mild TBI. 
 In mild TBI, day-of-injury alcohol intoxication was associated with favorable 
outcome. It was part of a prediction rule composed of age and extent of extracranial 
injuries, which provided the best prognostic value in our study (AUC: 0.71). On the 
other hand, recently no significant differences were found in short-term and 
long-term neuropsychological functioning between mild TBI patients with and 
those without alcohol intoxication at the time of the injury.219, 220 Patients with mere 
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head injury might be diagnosed as suffering from TBI, because alcohol (intoxication) 
potentially affects the level of consciousness (suboptimal GCS score of 13 or 14) and 
post-acute cognitive and memory functioning resembling PTA.216-218 
 With regard to the assessment of outcome one might argue that the GOSE is an 
inappropriate outcome score with too little detail for mild TBI, explaining the 
modest prognostic value of demographic and clinical parameters. Other, more 
differentiated outcome measures, like the Rivermead post-concussional questionnaire 
or comprehensive neuropsychological tests might do more justice to the outcome 
after mild TBI. On the other hand, additional (pre-)injury factors might be more 
important for prognosis after mild TBI than the variables we included in our study, 
for instance pre-existing physical comorbidities.120
 Not surprisingly and largely consistent with the literature, in moderate and 
severe TBI, next to age, pupil reactivity, GCS score and the occurrence of hypotensive 
events post-injury were identified as predictors for both death and unfavorable 
outcome after multivariate analysis of demographic and clinical variables.29, 41-43, 138, 144, 
146-148, 150, 151, 154, 235 Contrary to several other studies29, 42, 151, 235 we used the full GCS score 
instead of merely the GCS-motor score because we think the eye and verbal scores 
of the GCS also contain prognostic information as has been demonstrated before.235 
The added prognostic value of these subscores to  the GCS-motor score was probably 
higher in moderate than in severe TBI patients. However, when demographic and 
clinical variables were combined with CT characteristics, the GCS score was not 
included in the resulting prognostic model. This might imply a smaller role of the 
GCS score in multivariable prognostics in moderate and severe TBI, than previously 
suggested. 
 We did not find additional predictive value for post-injury hypoxia after 
multivariate analysis, and this contrasts other prediction models,42, 149, 151 although it 
was associated with outcome after univariate analysis in our study. The reason 
might be that, in contrast to other studies, we added a ‘clinically suspected’ hypoxic 
event not confirmed by blood oxygen saturation or PaO2 levels to the ‘no hypoxia’ 
category. This may have weakened the predictive power of hypoxia in our study. On 
the other hand, hypoxia has not emerged as outcome predictor in all multivariate 
prognostic studies.29, 138
 Unfavorable outcome - vegetative state and severe disability - in the surviving 
patients was associated with higher age and post-traumatic hypotension, but not 
with the GCS score and pupillary reactivity. Probably the latter two variables are 
more related to death than to poor survival. 
 In short, for predicting outcome in mild TBI using demographic and clinical 
variables, age and the severity of extracranial injuries were the only relevant factors, 
confirming earlier findings.117, 134 Also, the results of our studies in moderate and 
severe TBI strengthen previous observations:29, 41, 42, 147, 151, 235 Age, pupil reactivity, the 
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GCS score and a post-traumatic hypoxic episode were the major clinical predictors 
of outcome, especially death, at six months post-injury. 
7.3 Prognosis of TBI: Role of cranial CT (Chapters 3, 4 and 5)
As discussed before, cranial CT scanning in the management of TBI patients is 
currently considered indispensable. Its role in the prognosis of mild TBI patients has 
been demonstrated, although not as comprehensively compared to moderate and 
severe TBI.29, 41, 42, 117, 133, 149, 151, 153, 157 We studied in detail more than 1,500 CT scans to 
investigate the association of various CT characteristics with outcome after TBI. 
Mild traumatic brain injury
In our mild TBI study, several CT characteristics, for example presence of SAH or 
edema, were individually associated with worse outcome. The best univariate 
predictor proved the number of parenchymal (hemorrhagic) contusions. Combinations 
of possible predictors did not improve the results. The AUC after ROC analysis, i.e. 
the discriminative or predictive value, of a prediction rule designed from demographic 
and clinical variables (AUC 0.71) did not increase when this CT characteristic was 
added, suggesting no extra value of CT above clinical and demographic predictors. 
Nevertheless, CT remains an essential tool to identify the individual mild TBI patient 
which requires neurosurgical intervention or is at risk for deterioration. CT 
abnormalities might delay recovery and influence the short term outcome, but for 
the prediction of long term outcome in mild TBI the value of CT seems restricted, 
somewhat contrary to intuitive beliefs. 
 Few other studies on, or including, mild TBI have compared the prognostic value 
of CT characteristics with demographic and acute clinical variables in a multivariate 
analysis.41, 117, 120, 133, 135, 138, 140, 142 Traumatic SAH,133, 140 presence of a traumatic hematoma,133, 
138 midline shift,133 signs of DAI,133 but also less specific characteristics - ‘presence of 
acute CT abnormalities’135 and ‘overall CT appearance’140 - have emerged as outcome 
predictors from these studies. Except for one study135 these studies included more 
severely injured patients.133, 138, 140 The same is true for the MRC CRASH study in which 
compression of the basal cisterns and third ventricle, SAH, midline shift and the 
presence of a non-evacuated hematoma were identified as independent CT 
predictors.41 The question arises if the predictive value of the CT variables as found 
in these studies is actually true for TBI of all severity categories or merely based on 
their predictive power in the most severely affected patients. 
 Other studies could not demonstrate an association between CT abnormalities 
and outcome after TBI120, 142, 143 or found only an association between traumatic CT 
lesions and outcome after univariate analysis.136, 137, 139, 141 Hence, in mild TBI different 
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studies have lead to conflicting results regarding the association of CT and outcome 
thus far. 
 What might explain our findings of the limited predictive value of CT charac-
teristics in mild TBI? Again, the GOSE might not be the most suitable outcome score 
for mild TBI. Still, studies with other outcome measures were unable to demonstrate an 
association between outcome and CT characteristics after multivariate analysis.120, 299 
An international workgroup on outcome and TBI suggested a core set of different 
outcome measures, assessing TBI-related symptoms and disabilities on different 
domains exceeding mere global functioning, to be used in future studies on TBI 
outcome.300 Furthermore, the low prevalence of individual CT abnormalities, i.e. they 
are only found in a minority of mild TBI patients, may limit the predictive value.43 
For prognostic studies on imaging in mild TBI a combination of CT, MRI and MRI 
related techniques (DWI) might be preferable above CT alone.301 Concluding, our 
findings are largely in line with earlier studies: Individual CT characteristics are 
associated with outcome after mild TBI, but they are inferior to demographic and 
clinical parameters, contrary to moderate and severe TBI.
Moderate and severe traumatic brain injury
The prognostic value of CT characteristics in moderate and severe TBI has been 
recognized by numerous authors.29, 41, 42, 62, 133, 138, 140, 149, 151, 153, 157, 227 Several individual CT 
variables associated with outcome, including intraventricular and traumatic SAH, 
have been combined to form the Rotterdam CT score (RCTS).157 And although it 
largely elaborates further on the older TCDB CT classification and its separate 
discernible elements,62 the RCTS demonstrated a better discriminative performance 
than the original TCDB CT classification.157 Similarly, we designed CT prediction rules 
combining several individual CT variables which showed good prognostic values in 
an external validation cohort (AUC: 0.79 [death] and 0.78 [unfavorable outcome]), 
largely comparable to the RCTS (AUCs: 0.79 and 0.79), and performed to some 
extent better than the original TCDB CT classification (AUCs: 0.76 and 0.77). For the 
prediction of unfavorable outcome within the population of survivors at six months 
the conventional CT characteristics proved less suitable as demonstrated by an AUC 
of 0.71. Our findings challenge the suggestion of other authors that the prognostic 
power of the head CT scan is currently not fully utilized when the TCDB CT 
classification is used or incorporated in a prediction model.133, 149, 153, 157 
 We found that a combination of the following CT characteristics performed 
best in the prediction of mortality in moderate and severe TBI: aspect of the ambient 
cisterns - part of the basal cisterns - and the fourth ventricle, presence of SAH or in-
traventricular hemorrhage, the volume of the dominant (largest) hematoma and the 
number of contusions (AUC: 0.79). For the prediction of unfavorable outcome the 
aspect of ambient cisterns, presence of SAH or intraventricular hemorrhage and the 
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type of the dominant (largest) hematoma showed the best prognostic performance 
(AUC: 0.78). The combination of the aspect of the ambient cisterns and the type of 
the dominant (largest) hematoma demonstrated the highest discriminatory value 
for unfavorable outcome within the group of surviving patients (AUC 0.71).  
 Where various studies, classifications and scores have used thresholds of lesion 
volumes to study association with outcome,41, 42, 62, 153, 157, 174, 249, 250 we have demonstrated 
that the quantification of exact volumes may give a more accurate outcome 
prediction probability. A stringent cut-off value such as used for example in the 
TCDB CT classification (lesion volume 25mL),62 was not found. Rather noteworthy is 
our finding that apparently lesion size (volume) is codecisive for death after TBI but 
when unfavorable outcome - also including surviving patients with poor outcome - 
is concerned the type of hematoma - i.e. EDH, SDH or (hemorrhagic) contusion - is 
more important to determine TBI prognosis.
 Two of our CT models incorporate the aspect of ambient cisterns and the 
presence of SAH or intraventricular hemorrhage. Most CT prediction models include 
a variable based on the status of basal or perimesencephalic cisterns,62, 153, 157 but not 
all.133 We showed that the assessment of the ambient cisterns and the fourth 
ventricle had a satisfactory inter- and intrarater reliability (kappa coefficients: 
0.80–0.95). The association of traumatic SAH and TBI outcome, and its additive 
prognostic value has been appreciated extensively before.133, 140, 148, 153, 157, 302
 CT remains to play an important role in outcome prediction in moderate and 
severe TBI. Although the discriminative performance of the criticized TCDB CT 
classification was slightly worse than the RCTS and our models, the use of a 
combination of individual CT characteristics is probably preferable. From our studies 
the question rises if CT variables, like is the case with the currently used conventional 
demographic and clinical parameters, aren’t more relevant for the prediction of 
death than for unfavorable survival even though we have chosen combinations of 
predictors with the highest discriminative value for our different models (death, 
unfavorable outcome, and unfavorable outcome within surviving patients). 
7.4  Prognosis of TBI: RUBICS prediction models 
(Chapters 3 and 5)
We combined demographic, clinical and radiological characteristics with potential 
predictive value to develop prognostic models suitable for daily practice and similar 
to the models resulting from the IMPACT and CRASH studies.41, 42
 In mild TBI an exact prediction of outcome at six months proved not feasible 
when only demographic, clinical and CT variables available at the ED were concerned. 
The most accurate prediction models we were able to design, showed only a 
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moderate predictive value (maximal AUC 0.71) and were based on age and two 
clinical parameters. As discussed above (7.3), CT characteristics had no added value. 
In view of the already limited AUCs of the prediction rules in the derivation cohort 
we decided not to perform external validation analyses. The limited association of 
conventional variables with outcome emphasizes the individualized approach the 
physician has to take where the prognosis of a mild TBI patient is concerned.  
 In moderate and severe TBI combinations of age, clinical and CT variables yielded 
good prognostic properties after external validation in a new cohort, both for the 
prediction of death (AUC: 0.86) and unfavorable outcome (AUC: 0.83). The prognostic 
models for these outcome categories were to a large extent identical; both models 
included age, pupil reactivity, the occurrence of a hypotensive episode and the 
aspect of the ambient cisterns. For the prediction of death two CT variables were 
added: the number of parenchymal contusions and the aspect of the fourth 
ventricle; the type of the dominant (largest) intracranial hematoma proved the 
additional CT predictor for unfavorable outcome. Compared to the CRASH41 and 
IMPACT42 prediction models several similarities exist: All models included age and 
pupil reactivity as predictors, next to different CT characteristics with at least some 
information on the aspect of the basal cisterns. A remarkable difference on the 
other hand is that CRASH and IMPACT have incorporated the GCS score as predictor 
in their final models. Possible explanations might be the inclusion of mild TBI 
patients (GCS score 13 and 14) in the original CRASH study and the suggested 
decrease in prognostic power of the GCS score in more recent TBI populations.44  
 We also developed a prognostic model to estimate the probability of unfavorable 
outcome within TBI survivors at six months post-injury. However after multivariable 
analysis, in contrast to the models for death and unfavorable outcome (including 
death), merely three variables surfaced as outcome predictors: the occurrence of a 
hypotensive episode, the aspect of the ambient cisterns and the type of the 
dominant (largest) intracranial hematoma. Furthermore, this model demonstrated 
limited discriminative properties after external validation (AUC: 0.69). From these 
findings one might conclude that the (conventional) predictors of death, and 
therefore also for unfavorable outcome including death, are probably not the best 
predictors for disability in moderate and severe TBI survivors. 
7.5 Prognosis of TBI: Role of biomarkers (Chapter 6)
Notwithstanding the good performance of our prognostic models for death and 
unfavorable outcome in moderate and severe TBI (AUCs 0.83-0.86), they still are 
imperfect. In addition to demographic, clinical and CT variables we also investigated 
the additional prognostic value of two biomarkers. We looked at serum levels of the 
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brain specific proteins GFAP (cutoff level 1.5 µg/L) and S100B (1.13 µg/L) and showed 
that concentrations above the previously defined thresholds161 at the time of hospital 
admission were strongly associated with death and unfavorable outcome after 
moderate and severe TBI. In all patients who died or had an unfavorable outcome at 
six months post-injury we found both GFAP and S100B serum levels above the cutoff 
values. Of both biomarkers GFAP was the most powerful in predicting death, 
whereas S100B showed the strongest association with unfavorable outcome. 
 When we performed multivariable analyses combining the biomarkers with 
age, different clinical variables and the radiological parameter ‘intracranial mass 
lesion’, prognostic rules containing GFAP, S100B, pupillary reactions, and the 
presence of a mass lesion demonstrated the highest predictive values. The 
combination of pupillary reactions and mass lesion showed the best predictive 
accuracy for death (AUC 0.93), while GFAP with pupillary reactions (AUC 0.92) and 
GFAP with mass lesion (AUC 0.92) were good alternatives. For unfavorable outcome, 
the combination of S100B with mass lesion (AUC 0.85), GFAP with mass lesion (AUC 
0.80) and GFAP with S100B (AUC 0.79) yielded the highest prognostic value, although 
the AUCs were lower than for mortality. Our study suggests that the biomarker 
proteins GFAP and S100B serum levels may contribute to outcome prediction in TBI 
and might even enhance prognostication given the high discriminative values.
 In this study the GCS score, hypotension and hypoxia were not associated with 
outcome, in contrast to our own findings as described before and the previous 
literature.29, 41, 42, 149, 151 This is probably partially due to the relatively small sample size 
of 79 patients. Also, the high proportion of patients with a GCS score of 3 (median 
GCS = 3) may have negatively influenced the predictive value of the GCS score as has 
been shown before.44
7.6 Future research perspectives
This thesis is an advancement in the complex and fast expanding field of prognostic 
model development in TBI. Nonetheless, further improvement is necessary and 
therefore the following is suggested. 
PTA assessment
Despite our study which enables at least a more straightforward evaluation of PTA, 
its assessment can be further improved, especially in patients with MTBI at an ED 
setting. To improve the sensitivity but preserving specificity of PTA scales, studies 
on a more demanding memory task might be performed, introducing for instance 
four184 or five303 word memory tests. The diagnostic accuracy of the three-word 
memory test we used in our PTA scale also deserves additional examination, 
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particularly concerning different short time intervals for recall testing, like ten to 
thirty minutes after initial assessment. Additionally, a future PTA study might focus 
on the development of stricter criteria on the basis of which a patient can be 
considered as emerged from PTA. It would also be interesting to study if a structured 
PTA questionnaire performs better in daily clinical practice than the more subjective 
professional opinion of an attending physician not using a scale. Finally, this study 
was not designed to study the association of PTA, as tested for with our new scale 
and compared to currently acknowledged PTA scales, with TBI outcome. In the light 
of the main subject of the current thesis this would a valuable addition.
Predicting outcome in mild TBI
What may be the main reasons for the moderate results in our search for mild TBI 
outcome predictors and the modest performance of the prognostic rules we 
developed? First, as discussed before, we used the GOSE to determine outcome. The 
GOSE might not be the appropriate outcome assessment tool for mild TBI. On the 
other hand, have we studied the right potential predictors? Probably, other factors 
than demographic, acute clinical and CT characteristics have to be taken into 
account in mild TBI. An extensive review of literature by the WHO collaborating 
centre for neurotrauma task force showed the wide variety of outcome measures 
(ranging from neurological limitations at discharge to detailed cognitive tests) and 
(potential) predictors in mild TBI of the last decades (from pre-injury health to 
financial incentives).117 
 It has been demonstrated that severe post-concussional symptoms and post- 
traumatic stress both early after injury and preexisting physical comorbidities are 
associated with the presence of post-concussional symptoms 6 months after mild 
TBI.120, 120 Additionally, the number of years of formal education, nausea or vomiting 
on ED admission, concomitantly sustained extracranial injuries and pain levels early 
after injury, predicted return to work 6 months after mild TBI.120 Also, post-traumatic 
stress disorder and depression were shown to mediate the relationship between 
mild TBI and physical health problems more than 3 months post-injury in a survey 
amongst U.S. Army infantry soldiers after their return from Iraq.224 This may partly 
also apply to civilians. Apart from concurrently sustained extracranial injury, we did 
not include all these factors in our current mild TBI study. We neither investigated 
the role of genetic polymorphisms and biomarkers of brain damage as other possible 
predictors of outcome. Future prediction models might show a stronger predictive 
power when these variables are added.
 Although the research of biochemical markers and genetic polymorphisms has 
been extensive during recent years in both mild versus moderate and severe TBI, at 
this moment results are most promising in moderate/ severe TBI. In mild TBI the 
biomarker protein S100B has been most extensively studied.304 Until now, different 
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biochemical markers have not consistently shown a relation with post-concussion 
syndrome/ symptoms in mild TBI.304 Interestingly, a number of studies have looked at 
the relation between serum levels of S100B and the presence of CT abnormalities; there 
was a tradeoff between a reasonable specificity but a low sensitivity, rendering S100B 
not the most useful tool to value the necessity for a head CT after mild TBI.305-307
 In mild TBI genetic studies on the association of genetic polymorphisms and 
outcome are limited. An association between the presence of the APOE-ε4 allele, in 
severe TBI related to poor outcome, has not been found in mild to moderate TBI. 172, 
308, 309 Poorer cognitive performance after mild TBI was associated with the Dopamine 
D2 receptor T allele in a small (n=39) patient sample,310 although more recently this 
finding was subsided by the same research group.311
 Finally, CT scanning might have limited prognostic value in mild TBI, studies of 
MRI and new imaging modalities - e.g. DTI and perfusion CT - and their relation with 
outcome show promising results, although not all techniques are suited for the 
acute post-trauma stage.60 Abnormalities, i.e. a decreased cerebral blood flow and 
cerebral blood volume, detected with perfusion CT scanning performed in the acute 
stage after mild TBI were associated with worse outcome compared to patients 
with normal perfusion CT scans.312
In conclusion, outcome in mild TBI is determined by a highly heterogeneous palette 
of factors of which only a part is elucidated. Apparent demographic, clinical and 
radiological parameters have been studied extensively but proved insufficient. 
Maybe it is not even possible to capture outcome prediction in mild TBI in faultless 
clear-cut prognostic models. Studies on new potential outcome predictors, new 
imaging techniques and preferably biochemical markers and genetic polymorphisms, 
are nevertheless warranted to improve mild TBI patient management. Moreover, 
these studies, but also physicians in daily clinical practice, should assess outcome 
after mild TBI in more detail: Next to functional outcome as determined with the 
GOSE and return to work, surveys on post-traumatic emotional and behavioral 
disturbances, and on more physical complaints – for instance fatigue and pain - like 
the Rivermead questionnaire, have to be incorporated as well, without losing sight 
of clinical applicability. 
Prognostic models and CT imaging in moderate and severe TBI
The models to predict outcome in moderate and severe TBI described in this thesis 
fundamentally rely on conventional demographic (age) and clinical parameters, and 
a number of CT characteristics, similar to most prognostic models based on large 
patient cohorts that have been published during previous years.29, 41, 42, 151 All include 
age, and the clinical predictors GCS(-motor) score and pupillary reactivity. Post- 
trauma hypotension29, 42, 151 and/ or hypoxia42, 151 complete these different models. 
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Only the CRASH study has included ‘(major) extra-cranial injury’ as an outcome 
predictor in its model.41 One could argue that this variable also includes for example 
a hypotensive period in case of hemorrhagic shock. 
 Some models show strong resemblance on the radiological predictors because 
they use the TCDB CT classification exclusively29 or combined with an extra individual 
CT characteristic like traumatic SAH.42, 151 To design our prediction models we chose 
to combine individual CT characteristics in an attempt to further improve the 
prognostic value of CT. Focused CT prediction studies applied analogous strategies 
and confirm our finding that the use of CT characteristics in prognostic models can 
be optimized.133, 149, 153, 157 From the MRC CRASH study a multivariable prognostic model 
was derived including individual CT predictors as well.41 And although the TCDB CT 
classification is simple and comprehensive, for prognostic models a combination of 
individual CT parameters have been shown to perform better. The individual CT 
predictors selected in the different studies vary. Nevertheless there are several 
similarities between the prognostic models: All include information on the aspect of 
cisterns and/ or ventricles, on the presence of SAH and on the presence or volume of 
an intracranial (mass) lesion, like a SDH. CT remains an important outcome predictor 
in moderate and severe TBI in the near future, since CT scanning is widely available 
and easy to obtain. Also, as we have shown, rating CT scans can be done reliably and 
with low interobserver variability. Finally, CT may become even more important 
because the GCS score loses predictive power due to intensified prehospital 
management.44
For future prognostic studies in moderate and severe TBI a strong foundation, with 
adequate but imperfect prognostic models, has been provided by the studies 
presented in this thesis and the various studies discussed above. The conventional 
demographic, clinical and CT variables have been studied thoroughly during recent 
years and new ground-breaking findings in this respect are not to be expected. 
Perfect prognostic models are needed, especially when treatment limitation or 
withdrawal are concerned, and advocated.169 Consequently, we have to adopt a new 
approach to improve outcome prediction in moderate and severe TBI. 
 First, prognostic models are ideally derived from large and multicenter observational 
cohort studies, e.g. the recent Prospective Observational Cohort Neurotrauma 
(POCON) study executed in five level I trauma centers in the Netherlands.267 For the 
studies discussed in this thesis patient data from the RUBICS study were used: An 
observational but single center cohort study, contrary to the large and multicenter 
designs of the IMPACT and CRASH studies. On the other hand, the IMPACT study was 
for the most part based on smaller clinical trials whereas the data from the CRASH 
study were derived from a randomized medication trial. Patients included in 
(randomized) trials are not representative of the patient population seen in regular 
170
Ch
ap
te
r 7
practice. Due to more or less strict in- and exclusion criteria only a proportion of the 
usual population, less heterogeneously than a cohort of consecutive TBI patients, is 
selected resulting in inclusion bias. This may have repercussions for the applicability 
of prognostic models based on the studies in daily clinical practice. 
 Second, it may be preferable to develop a single prognostic model for TBI of all 
severity categories. The model based on data from the CRASH trial can be applied to 
TBI patients with an initial GCS score of 3-14, therefore including mild, moderate and 
severe TBI.41 On the other hand, the studies described in this thesis show that mild 
versus moderate/ severe TBI have little in common regarding their outcome 
predictors, except for age. Though one comprehensive and relevant prognostic 
model is preferable, it will probably not result in the most accurate model for each 
of the severity categories separately.  
Third, different laboratory parameters have been found to add prognostic value to 
conventional predictors. Serum glucose, platelet count and hemoglobin levels 
proved predictors after multivariate analysis in various prognostic studies.42, 149, 155, 233, 
268 Laboratory variables are also of great importance in predicting mortality for 
critically ill adult patients within the widely applied intensive care prognostic system 
APACHE.269 Accordingly future prognostic studies in TBI should include more 
information on potential laboratory predictors.
 Fourth, next to CT scanning more and more imaging modalities are becoming 
available to determine the extent of the injury inflicted to the brain. The association 
of abnormalities detected using these techniques with the patient’s prognosis is 
being investigated, as described in the introduction. MRI, especially the T2* gradient 
echo and SWI sequences, may improve outcome estimation above all in patients 
with diffuse TBI (TCDB CT classification of diffuse injury 1-4) due to its superior 
sensitivity in detecting abnormalities related to DAI. Recently, it was demonstrated 
that 75% of moderate and severe TBI patients have DAI, including patients with 
intracranial mass lesions (TCDB 5-6) as detected with CT.26 The presence of DAI in TBI 
is relevant to the patient’s prognosis since DAI is known to be associated with 
cognitive, behavioral and motor sequellae.51, 79, 313-315 And although better than CT, 
conventional MRI, even with T2* gradient echo and SWI sequences, is surpassed by 
DTI when the visualization of damage to axons is concerned.313, 316 These modalities 
might contribute to determining prognosis of moderate and severe TBI as is 
expected also in mild TBI. A recent study on DTI tractography, an MRI technique 
where white matter structures are reconstructed to assess structural connectivity, 
found that longitudinal changes in DTI tractography results were associated with 
long-term outcome: Progressive damage to different anatomic white matter 
pathways from the (sub)acute to the chronic phase was related to poor performance 
on cognitive tests.316 While obtaining an MRI scan might be practically not always 
feasible in the acute - ED or intensive care unit - phase, it is desirable to use MRI 
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scanning not only for research purposes, but also in the more early stages after TBI 
than is currently customary. MRI and related techniques imply to be of value in the 
prognosis of TBI and therefore may be added in future prognostic models. Ultimately, 
multimodality imaging might be introduced: Combining DTI (structural integrity) 
and functional MRI (function).313
 Fifth, we have also investigated the discriminative abilities of different prognostic 
models (demographic/ clinical variables, CT characteristics and a combination model) in 
moderate and severe TBI survivors. The results were somewhat disappointing (AUC: 
0.61-0.71), nevertheless they suggest that prognosis in this patient category probably 
depends on other variables than the conventional demographic, clinical and radiological 
parameters. Therefore, more research on variables specifically associated with 
disability in TBI survivors is strongly advised.
 Finally, TBI is a dynamic process. Both the CRASH and IMPACT studies,41, 42 but 
also the studies described in this thesis, have used data attained at the ED to design 
their prognostic models, consequently not including the sequential TBI dynamics. 
For instance, different studies have shown progression of CT abnormalities with 
time post-injury: These changes have been demonstrated for traumatic intracerebral 
hematomas, brain swelling and edema, midline shift, and post-traumatic cerebral 
infarction.240-244, 264 Long-term outcome after TBI can be predicted more accurately 
using data from sequential rather than just the initial CT scan.242 It was found that 
the worst CT was most strongly correlated with outcome.244 Next to sequential CT 
scanning, monitoring of ICP is a potential instrument to observe some of the 
dynamics taking place in the (sub)acute post-injury phase. For a more accurate 
outcome prediction it might be necessary to include information on these early 
changes in prognostic models of TBI.43 Nevertheless, the findings of the initial head 
CT scan, similar to information on clinical variables like the GCS score and pupillary 
responses, are essential for clinical decision making in the acute post-traumatic 
period and important for prognostic purposes.     
 An important new and promising approach to improve outcome prediction in 
TBI are the studies on the prognostic value of neural and glial cell specific proteins as 
(serum) biochemical markers, and the study of possible association between genetic 
factors and TBI outcome.
Biomarkers and genetic factors in moderate and severe TBI
Evidence is growing that next to conventional TBI severity indices and outcome 
predictors, biochemical markers may play an important role in TBI prognosis, 
complementary to but possibly also as a substitute for acknowledged variables. The 
latter might be the case for the GCS score. Its association with outcome has 
weakened during recent years due to the increased use of prehospital sedation and 
intubation.44  
172
Ch
ap
te
r 7
 Most appealing are the brain specific proteins that appear in the systemic 
circulation through blood brain barrier leakage as opposed to biomarkers that have 
to be measured in the CSF. Our validation study (described in chapter 6 of this thesis) 
already demonstrated the prognostic characteristics of GFAP and S100B serum 
levels in moderate and severe TBI. One of the latest and most interesting studies on 
biomarkers investigated the prognostic value of two promising biomarkers: First, 
GFAP, reflecting injury to astrocytes (glial cells) and second, ubiquitin carboxy-termi-
nal hydrolase L1 (UCH-L1), reflecting injury to neurons. Serum UCH-L1 levels were 
found to be increased in diffuse injuries (according to the TCDB CT classification), 
where GFAP serum levels were in particular increased in the presence of focal mass 
lesions. UCH-L1, age and the GCS score showed a high predictive value for mortality 
at six months post-injury, rather similar to a combination of GFAP and UCH-L1.317 A 
limitation of the study was the relative small study population of 81 patients, which 
is the case in most TBI-biomarker studies at this moment.
 It is time to study the various biomarkers available, preferably a combination of 
neuronal and glial cell proteins, in larger (multicenter) studies to establish exact 
threshold values and to demonstrate that biomarkers, in addition to clinical variables 
or perhaps independently, indeed allow for accurate outcome prediction in individual 
TBI patients. When biomarkers and/ or prognostic models are utilized in end-of-life 
decisions, avoiding false-positive rates are essential. Parallel to TBI in this respect, 
the use of biochemical markers for an accurate assessment of neurologic prognosis 
has been studied in comatose patients after cardiopulmonary resuscitation. NSE 
measured in serum during the first three days post-resuscitation accurately 
predicted unfavorable outcome with a 95% CI of the false positive rate of 0% to 
3%.296 This additional prognostic value of NSE has been included in the American 
Academy of Neurology guideline on the prediction of recovery from coma after car-
diopulmonary resuscitation.297 In the light of our own biomarker study next to 
current literature a similar role of serum biomarkers in TBI prognosis might be 
possible. 
 In addition to the current focus on injury and post-injury characteristics it is 
attractive to study the patient and with that the brain that is injured as well, similar 
to which has already been suggested and performed in mild TBI.121, 318 Each individual 
brain responds to and recovers from traumatic injury differently. Therefore genetic 
factors might also be determinants of outcome in TBI. As described in the 
introduction most research has been done on the polymorphisms of the APOE 
gene.171, 172, 319 In different, smaller studies the presence of the APOE e4 allele was 
associated with poor outcome in severe TBI.172 The next step would be to include 
information on the APOE gene - presence versus absence of an APOE e4 allele - of 
the individual patients in a multivariable (demographic, clinical, radiological) 
prognostic model, again preferably in a large multicenter study. Other genetic 
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polymorphisms that have been studied amongst others concerned the interleukin 
(IL)-1, IL-6, IL-10, ACE, CACNA1A, COMT, Dopamine D2 receptor, APOE promotor  and 
p53 genes with largely negative results thus far.171, 172, 319 We studied the association of 
tumor-necrosis-factor (TNF)-ε, TNF-ε, IL-6, IL-10, FcGR2A (all immunological proteins) 
and plasminogen-activator-inhibitor-1 (PAI-1) gene polymorphisms with outcome in 
a small population of mild, moderate and severe TBI patients. None of the 
polymorphisms of the individual genes were significantly related to outcome.320 
Nevertheless, further studies on the genetic factors influencing outcome in TBI are 
warranted.321 And although still in its infancy at this moment, the study and ultimate 
use of genetic factors in outcome prediction of TBI will become significant in the 
near future.
7.7 Conclusions and final remarks
Accurate and validated prognostic models can be highly valuable. Not only for daily 
clinical practice, they are also potentially useful for the inclusion of patients in 
clinical trials and quality control evaluation. The studies discussed in this thesis 
contribute to the development of better prognostic models in TBI, and are important 
steps in a process that hasn’t however reached the finish yet. In mild TBI the 
contribution of conventional variables including CT characteristics in outcome 
prediction is disappointing. Future prognostic studies should be more focused on 
novel potential predictors, e.g. health and psychosocial factors, new imaging 
techniques and biochemical markers, and make use of outcome measures more 
suited for mild TBI patients. 
 Regarding outcome prediction in moderate and severe TBI, a solid foundation 
has been laid by various preceding studies, especially IMPACT and CRASH, and this 
foundation is further strengthened through this thesis. However, current prognostic 
models, largely based on conventional demographic, clinical and CT characteristics, 
are imperfect. A beginning has been made with the study of biomarkers, novel 
imaging modalities and genetic factors, and their association with outcome; further 
large international multicenter observational cohort studies are needed.
 To support the use of our prognostic models by physicians and researchers, we 
have initiated a user-friendly web based prognostic calculator, similar to the online 
IMPACT and CRASH calculators. Through our website www.tbi-prognosis.com one 
can easily calculate the estimated probability of death and unfavorable outcome at 
six months post-injury for a specific moderate or severe TBI patient.
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Samenvatting in het Nederlands
Prognosestelling bij traumatisch hersenletsel
 - naar betere prognostische modellen 
De Nederlandse samenvatting van dit proefschrift is in het bijzonder gericht op 
niet-medici. Voor een meer diepgaande bespreking van de resultaten wordt de lezer 
verwezen naar het Engelstalige hoofdstuk ‘Summarizing discussion, future perspectives 
and conclusions’ (hoofdstuk 7). 
Jaarlijks bezoeken meer dan 35.000 patiënten met hersenletsel als gevolg van een 
ongeval of een klap tegen het hoofd de spoedeisende hulp (SEH) afdelingen van de 
Nederlandse ziekenhuizen. Maar ook wereldwijd behoort het traumatisch hersenletsel 
(THL) tot een van de meest frequent voorkomende neurologische aandoeningen. De 
patiënten zijn heel verschillend wat betreft leeftijd, ongevalsmechanisme, ernst van 
het THL en het uiteindelijke herstel. Daarnaast hoort THL bij de belangrijkste doods -
oorzaken en voornaamste veroorzakers van invaliditeit bij kinderen en jongvolwassenen. 
THL heeft een grote invloed op de kwaliteit van leven van het individu en diens 
naasten, maar het heeft ook een grote sociaaleconomische impact: de medische 
kosten die THL jaarlijks met zich meebrengt worden geschat op meer dan 70 miljoen 
euro per jaar.
 Voor patiënten en hun naasten is adequate informatie over het vermoedelijke 
verloop en het niveau van eventueel herstel na een THL - de prognose - van het grootste 
belang. Maar ook voor de artsen die bij de behandeling betrokken zijn, is deze informatie 
essentieel voor het maken van diverse keuzes, waaronder het eventueel staken van de 
behandeling. Dit proefschrift bestaat uit een aantal studies dat tot doel had om de prog-
nosestelling, zijnde het vroegtijdig voorspellen van de uiteindelijke uitkomst, bij THL 
verder te verbeteren.
Traumatisch hersenletsel
THL is het gevolg van een uitwendige mechanische kracht bij een verkeersongeval, val 
of geweldsdelict, die inwerkt op de schedel en de hersenen en deze structuren kan 
beschadigen. Er wordt, enigszins willekeurig, onderscheid gemaakt in focaal en diffuus 
hersenletsel. Focaal THL wordt veroorzaakt wanneer hersenweefsel lokaal, ter plaatse 
van direct inwerkende krachten, wordt beschadigd. Voorbeelden hiervan zijn de 
subdurale bloeding, de epidurale bloeding en de hersenkneuzing (contusio of 
contusie). Daarentegen is diffuus THL het gevolg van een snelle acceleratie-decelera-
tie beweging van het hoofd in voorachterwaartse of zijwaartse richting, met als 
gevolg wijdverspreid letsel aan de lange zenuwuitlopers (axonen) en bloedvaten. Een 
van de meest voorkomende diffuse hersenletsels is de diffuse axonale schade (Eng. 
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diffuse axonal injury [DAI]). Zowel focaal als diffuus THL komt regelmatig voor bij één 
en dezelfde patiënt, zeker wanneer het de meer ernstige hersenletsels betreft. 
Ernst van het THL en beeldvorming
De ernst van het THL wordt in eerste instantie gemeten door gebruik te maken van de 
Glasgow-comaschaal (GCS) score. Deze geeft de bewustzijnstoestand van een patiënt 
na het ongeval weer, en wordt bij voorkeur zo snel mogelijk afgenomen op de SEH: een 
lagere score betekent een lagere bewustzijnstoestand. Er wordt onderscheid gemaakt 
in licht traumatisch hersenletsel (LTHL) - 80% van alle patiënten met THL -, middelzwaar 
traumatisch hersenletsel (MTHL) en ernstig traumatisch hersenletsel (ETHL). De 
oudere termen ‘hersenschudding’ en ‘hersenkneuzing’ zijn strikt Nederlands en 
worden gezien de huidige nationale en internationale literatuur steeds minder 
gebruikt. Een lagere GCS score is over het geheel geassocieerd met een slechtere 
uitkomst na een THL. Daarnaast geeft ook de duur van het geheugenverlies na het 
ongeval, de zogenaamde posttraumatische amnesie (PTA), informatie over de ernst 
van het THL. 
 De initiële GCS score zegt echter vaak weinig over het onderliggende hersenen-
letsel (Figuur 1, hoofdstuk 1, pagina 13). Om de schade aan schedel, aangezicht en 
hersenen verder vast te stellen wordt op de SEH bij voorkeur gebruik gemaakt van de 
CT (Eng. Computed Tomography) scanner. Hiermee kunnen snel en relatief eenvoudig 
afbeeldingen van hoofd en hersenen worden vervaardigd, hetgeen ook duidelijkheid 
kan geven over de eventuele noodzaak tot neurochirurgisch ingrijpen. De afwijkingen 
die op de CT-scan van de hersenen kunnen worden gezien - te denken valt hierbij aan 
bloedingen (hematomen) en kneuzingshaarden (contusies) - hebben voor een 
belangrijk deel een relatie met de uitkomst, vooral na MTHL en ETHL. Vanwege een 
hogere gevoeligheid voor het vinden van traumatische afwijkingen wordt in de 
subacute en chronische fase steeds meer gebruik gemaakt van de MRI (Eng. Magnetic 
Resonance Imaging) scan om de hersenen af te beelden. 
Herstel en uitkomst
De meerderheid van de patiënten met een LTHL herstelt in het algemeen goed en het 
sterftecijfer is laag. Echter, tot 25% van de LTHL patiënten ervaart toch nog diverse 
klachten zes maanden na het ongeval. In de ernstigere THL categorieën, MTHL en 
ETHL, liggen de cijfers duidelijk anders. In de groep van patiënten met ETHL kan het 
sterftecijfer oplopen tot boven de 40%. Goed herstel wordt in slechts maximaal 25% 
van deze patiënten gezien. Vooral in onderzoeksverband, zo ook in de studies van dit 
proefschrift, wordt de uiteindelijke functionele uitkomst bepaald met behulp van de 
‘Glasgow Outcome Scale (Extended)’ (Tabel 3, hoofdstuk 1, pagina 24), die meestal zes 
tot twaalf maanden na het THL wordt afgenomen. Deze schaal loopt van 1 = dood tot 
8 = minimale beperkingen dan wel restloos herstel, en geeft, indien van toepassing, 
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ook de mate van invaliditeit weer. Vaak worden ten behoeve van statistische 
berekeningen scores samengevoegd, waarbij er wordt gekeken naar dood versus 
levend als uitkomstmaat of naar ongunstige (GOSE score 1-4) versus een gunstige 
uitkomst (GOSE score 5-8).
Prognosestelling
Zoals al eerder gezegd, is voor zowel patiënten en hun familieleden, als voor de 
betrokken artsen juiste informatie over het verloop en het niveau van eventueel 
herstel cruciaal. Om over de uiteindelijke uitkomst een uitspraak te kunnen doen, de 
prognosestelling, kan gebruik worden gemaakt van prognostische modellen. Dit zijn 
rekenkundige modellen die diverse demografische (bijvoorbeeld leeftijd), klinische 
(bijvoorbeeld de GCS score) en radiologische (bijvoorbeeld bepaalde afwijkingen in de 
hersenen zichtbaar op de CT-scan) factoren combineren om de kans op een bepaalde 
gekozen uitkomst, bijvoorbeeld het overlijden binnen zes maanden, te berekenen. 
Sommige prognostische modellen maken daarnaast gebruik van laboratoriumbepa-
lingen (bijvoorbeeld het glucosegehalte van het bloed). De belangrijkste statistische 
methoden die voor het opstellen van deze modellen worden gebruikt, zijn de univariate 
en multivariate (binaire) logistische regressie analyse. Deze modellen zijn geschikt 
voor gebruik in de dagelijkse klinische praktijk, maar kunnen daarnaast ook worden 
gebruikt voor wetenschappelijk onderzoek, zoals het selecteren van deelnemers voor 
een medicatiestudie, of voor ‘kwaliteit van zorg’-doeleinden.
 Prognostische modellen berekenen de kans op een bepaalde uitkomst voor een 
individuele patiënt. Maar deze modellen bieden geen absolute zekerheid betreffende 
deze uitkomst, er schuilt altijd enige onbetrouwbaarheid in de voorspelling voor een 
individuele patiënt. De mate van onbetrouwbaarheid wordt weergegeven door middel 
van het betrouwbaarheidsinterval. Bovendien zijn de op dit moment beschikbare 
prognostische modellen, los van het betrouwbaarheidsinterval, nog niet perfect wat 
betreft hun prognostische waarde. 
Methoden
De studies in dit proefschrift maken deel uit van de Radboud University Brain Injury 
Cohort Study (RUBICS), een studie die is gestart op 1 januari 1998. De database van deze 
studie omvat diverse gegevens, waaronder demografische data, klinische parameters 
en gegevens over CT-scans die zijn gemaakt, maar ook informatie over de uitkomst, 
van patiënten die zijn gezien op de SEH afdeling van het Universitair Medisch Centrum 
St. Radboud te Nijmegen. Voor het grootste deel van de studies in dit proefschrift zijn 
de gegevens gebruikt van patiënten met een THL die de SEH van 1998 tot en met 2005 
bezochten. 
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Doel(stellingen)
Dit proefschrift heeft als belangrijkste doel te komen tot een verbeterde prognose-
stelling in licht, middelzwaar en ernstig traumatisch hersenletsel. De studies waren 
gericht op de ontwikkeling van een methode om eenvoudiger dan nu gebruikelijk is de 
PTA vast te stellen. En daarnaast op het maken van een gedetailleerde analyse van de 
prognostische waarde van de CT-scan van het hoofd en op het ontwerpen van 
prognostische modellen gebaseerd op een combinatie van demografische, klinische 
en radiologische variabelen. Tot slot was een van de studies opgezet om te onderzoeken 
of een tweetal eiwitten bepaald in het bloed ook een voorspellende waarde hadden. 
Na een THL treedt er frequent een periode van geheugenverlies op: de posttraumati-
sche amnesie (PTA). Deze periode wordt gekenmerkt wordt door verwardheid, 
desoriëntatie, retrograde (teruggaand in de tijd) en anterograde (zich in de tijd naar 
voren uitstrekkende) amnesie. 
 Hoofdstuk 2 schetst de resultaten van de studie die wij verrichtten om te komen 
tot een nieuwe methode de PTA vast te stellen. De aanwezigheid en de duur van PTA 
zeggen iets over de ernst van het THL en zijn van belang voor het maken van diverse 
klinische beslissingen, zoals het al dan niet vervaardigen van een CT-scan van het 
hoofd en het ontslag naar huis. Uit de literatuur blijkt daarnaast dat de duur van de 
PTA verband houdt met de mate van herstel, de functionele uitkomst en de 
re-integratie na een THL. Dus achtten wij een juiste en praktisch eenvoudige 
meetmethode van belang om de PTA vast te stellen. Aan de beschikbare testmethoden 
kleven echter diverse nadelen: zo zijn sommige testmethodes erg uitgebreid, onhandig 
in het gebruik op een SEH, of wordt de anterograde amnesie niet afdoende getest. 
Gebaseerd op de resultaten verkregen van 126 patiënten en 31 gezonde proefpersonen 
en controlepatiënten, ontwierpen wij een nieuwe PTA-vragenlijst bestaande uit zeven 
items: leeftijd, naam van het ziekenhuis, tijd op moment van afname, dag van de 
week, maand van het jaar, manier van vervoer naar het ziekenhuis, en een kleine 
geheugentest waarbij de patiënt drie woorden dient te onthouden. Vervolgens 
toetsten wij deze schaal in een nieuwe groep van 132 patiënten met THL en 30 
controles. De statistische prestaties van onze PTA-schaal bleken vergelijkbaar met de 
reeds bestaande meetmethoden, daarbij kent onze schaal minder items en is minder 
complex in het gebruik. Het bepalen van de PTA kan nu dus net zo betrouwbaar als 
voorheen maar wel eenvoudiger.
 Het doel van de studie beschreven in Hoofdstuk 3 was tweeërlei. Allereerst was 
het doel om meer inzicht te krijgen in de samenstelling van een groep patiënten met 
licht THL, wat betreft diverse demografische, klinische en radiologische variabelen. En 
belangrijker nog, om díe variabelen te identificeren die van belang zijn voor de progno-
sestelling bij LTHL. In totaal waren de gegevens van 2784 patiënten bekend en bij 1999 
patiënten werd na het ongeval ook een CT van hoofd en hersenen gemaakt, waarop in 
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21% van de gevallen ook daadwerkelijk afwijkingen zichtbaar waren. Van de patiënten 
werd uiteindelijk 1% door de neurochirurg aan een traumatisch letsel geopereerd. Een 
opmerkelijke bevinding was dat bij 28% van de geïncludeerde patiënten sprake was 
van alcoholgebruik. 
 Uit de wetenschappelijke literatuur was al bekend dat de prognosestelling bij de 
categorie patiënten met een LTHL erg lastig kan zijn. Hoewel leeftijd, extracraniële 
(buiten de schedel gelegen) letsels (bijvoorbeeld fracturen van het aangezicht), en al-
coholintoxicatie wel een verband toonden met de uitkomst, bleek een prognostisch 
model maar een beperkte voorspellende waarde te hebben. De CT-bevindingen 
voegden aan deze klinische en demografische variabelen niets noemenswaardigs toe 
wat betreft de prognostische waarde. Niettemin zijn de bevindingen op de CT-scan 
voor de individuele patiënt wel degelijk van belang voor het verdere beleid, bijvoorbeeld 
ten aanzien van klinische observatie of eventuele neurochirurgische interventie.
De belangrijke waarde van de CT-scan in de prognosestelling bij patiënten met een 
middelzwaar of ernstig THL, in tegenstelling tot het LTHL, wordt al langere tijd 
onderkend en is al in meerdere studies aangetoond. Een van de belangrijkste CT karak-
teristieken in deze is de toestand van de basale cisternen, de diep aan de schedelbasis 
rondom de hersenstam gelegen ruimtes gevuld met hersenvocht. De prognostische 
waarde van het aspect van deze basale cisternen mag dan groot zijn, het is niet altijd 
duidelijk welke individuele cisternen precies in een betreffende publicatie worden 
bedoeld (zie hiervoor Figuur 1, hoofdstuk 4.1, pagina 85), vaak betreft dit de perime-
sencephale cisternen (mesencephalon = deel van de hersenstam). 
 Hoofdstuk 4.1 geeft de resultaten weer van de studie die was opgezet om de 
voorspellende waarde van afwijkingen aan de verschillende cisternen en ventrikels (de 
hersenkamers, ook gevuld met hersenvocht) te bepalen. Hiertoe werden de gegevens 
van ruim 600 volwassen patiënten met een middelzwaar of ernstig THL geanalyseerd. 
De grootste prognostische waarde werd gevonden voor de zogenaamde cisterna 
ambiens, gelegen links en rechts aan de achterzijde van de hersenstam, en de vierde 
ventrikel, de tussen hersenstam en kleine hersenen gelegen hersenkamer (te zien op 
bovengenoemde figuur). Beide bleken daarnaast nog krachtigere uitkomst voorspellers 
dan de zogenaamde ‘basale cisternen’.  
 Het aspect van de basale cisternen, zoals met een CT-scan van de hersenen te 
beoordelen is, maakt deel uit van diverse internationale CT-classificatiesystemen/ 
-scores en prognostische modellen. Hierin zijn ook twee andere belangrijke CT- 
bevindingen frequent opgenomen. Allereerst betreft dit het volume van een, indien 
aanwezig, binnen de schedel (= intracranieel) gelegen bloeding of kneuzingshaard. En 
daarnaast de mate van verplaatsing van de centraal gelegen hersenstructuren vanuit 
het midden naar links of naar rechts (Eng. midline shift) bijvoorbeeld door zwelling, 
een bloeding of contusiehaard. Vaak wordt er voor beide waarden een afkappunt 
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gehanteerd, dat echter per studie of classificatiesysteem kan verschillen (Tabel 1, 
hoofdstuk 4.2, pagina 105).  
 In Hoofdstuk 4.2 wordt de studie beschreven waarin voor dezelfde patiëntengroep 
als in 4.1 (zie boven) werd onderzocht of voor het volume van intracraniële laesies en 
de midline shift een verband kon worden aangetoond met de uitkomst op langere 
termijn (zes maanden na het ongeval), en dan met name tegen de achtergrond van de 
afkappunten gehanteerd in andere studies of CT-scores om zo het afkappunt te 
vinden met de hoogste voorspellende waarde. Echter, er bleek geen eenduidige 
afkapwaarde te bestaan, hoewel er wel een verband was tussen de grootte van een 
intracraniële afwijking en de midline shift met de uitkomst op zes maanden: toename 
van het laesievolume of de midline shift was geassocieerd met een toenemend 
percentage patiënten dat overleed of een ongunstige uitkomst had. Wij concludeerden 
dan ook dat in prognostische modellen het gebruik van volume en midline shift als 
continue variabele de voorkeur verdient boven het gebruik van afkapwaarden.   
In de studie weergegeven in Hoofdstuk 5 werden demografische (bijvoorbeeld 
leeftijd), klinische (bijvoorbeeld GCS score) en CT variabelen - rekening houdend met 
de bevindingen beschreven in de studies uit de hoofdstukken 4.1 en 4.2 - gecombineerd 
om hiermee tot prognostische modellen te komen voor patiënten met middelzwaar 
en ernstig THL, vergelijkbaar met de studie beschreven in hoofdstuk 3 aangaande 
LTHL. Er werd gebruik gemaakt van de gegevens van 605 patiënten, ook onderzocht in 
de studies uit hoofdstukken 4.1 en 4.2. Bijna driekwart hiervan was man en 70% was 
slachtoffer van een verkeersongeval. Zes maanden na het ongeval was uiteindelijk 
39% van de patiënten met ETHL overleden, hetgeen de ernst van het ETHL nog maar 
eens onderstreept. Van de patiënten met ETHL werd 12% neurochirurgisch geopereerd.
 De factoren met de grootste prognostische waarde die uiteindelijk werden 
geselecteerd voor het model verschilden afhankelijk van de gehanteerde uitkomstmaat: 
overlijden, ongunstige uitkomst (overlijden en ernstige handicap) of ongunstige 
uitkomst binnen de groep van overlevenden (ernstige handicap). Zo waren de 
prognostische factoren die een sterk verband toonden met overlijden: de leeftijd van 
de patiënt, reactiviteit van de pupillen op de SEH, de aanwezigheid al dan niet van een 
(te) lage bloeddruk (hypotensie) en een aantal CT kenmerken: aspect van de cisterna 
ambiens, het aantal contusiehaarden en aanwezigheid van druk op de 4e ventrikel.    
 In een meer recent (2009-2010) verzamelde groep Nederlandse patiënten (n=333) 
met MTHL of ETHL hebben wij onze prognostische modellen getoetst (= externe 
validatie) op hun voorspellende waarde in een nieuwe groep patiënten. Onze modellen 
bleken ook hier een goede voorspelling te geven van de uitkomst op zes maanden. Om het 
gebruik van onze modellen in de kliniek te vereenvoudigen hebben we een website 
ontwikkeld waarop de prognostische modellen zijn te gebruiken: www.tbi-prognosis.com. 
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Dat naast demografische, klinische en radiologische variabelen ook bepaalde biologische 
merkstoffen (Eng. biomarkers) een verband hebben met de uitkomst na een THL is 
vaker aangetoond. Er wordt gesuggereerd dat deze biomarkers een aanvullende 
voorspellende waarde zouden kunnen hebben in prognostische modellen bestaande 
uit de meer conventionele variabelen, zoals bijvoorbeeld leeftijd, GCS score en CT 
afwijkingen.
 De laatste studie van dit proefschrift, beschreven in Hoofdstuk 6, had tot doel de 
voorspellende waarde van twee biomarkers, namelijk de hersenspecifieke eiwitten 
GFAP (glial fibrillary acidic protein) en S100B, verder te onderzoeken bij patiënten met 
middelzwaar en ernstig THL. Hiertoe werd bij 79 patiënten het gehalte van deze twee 
eiwitten in het bloed, afgenomen zo spoedig mogelijk na het ongeval, bepaald. GFAP 
en S100B zijn eiwitten die voornamelijk in de diverse steuncellen - vooral van het as-
trocyten-type - van de hersenen worden aangemaakt en vrijkomen bij schade aan 
deze cellen.
 Vergeleken met patiënten die zes maanden na het ongeluk nog in leven waren, 
bleek bij de overleden patiënten het GFAP gehalte in het bloed in de acute fase 
gemiddeld meer dan 33 keer zo hoog te zijn geweest, het gehalte S100B was meer dan 
tweemaal verhoogd. Beide biomarkers bleken individueel een grotere prognostische 
waarde te hebben dan diverse traditionele voorspellers zoals leeftijd, pupilreacties en 
de GCS score. Combinaties van de biomarkers met de pupilreacties of de aanwezigheid 
van een intracraniële laesie aangetoond met de CT-scan gaven de hoogste 
voorspellende waarden op zowel overlijden als ongunstige uitkomst, hetgeen 
aangeeft dat biomarkers een toegevoegde waarde kunnen hebben in de prognosestel-
ling na een MTHL of ETHL.     
In het laatste deel van dit proefschrift, Hoofdstuk 7, worden de hierboven samen - 
gevatte resultaten bediscussieerd tegen de achtergrond van de huidige wetenschap-
pelijke literatuur. 
 De prognosestelling voor patiënten met LTHL blijkt heel anders te liggen dan voor 
patiënten met middelzwaar en ernstig THL. Hoewel in beide categorieën leeftijd een 
belangrijke rol speelt in het voorspellen van de uiteindelijke uitkomst, zijn er verder 
wat betreft de prognostische factoren weinig overeenkomsten. Een opvallende 
bevinding bij patiënten met LTHL was dat de CT-scan slechts een beperkte rol speelt 
als het gaat om het voorspellen van de uitkomst. Er kon een prognostisch model 
worden opgesteld, maar met slechts een matige voorspellende waarde. Op dit 
moment vraagt de prognosestelling bij LTHL dan ook om een meer individueel gerichte 
aanpak, die zo blijkt uit andere studies, ook rekening houdt met factoren als emotionele 
stress of gedrag. 
 Bij patiënten met middelzwaar en ernstig THL is het doen van een globale voorspelling 
over de uitkomst al heel goed mogelijk met eenvoudig beschikbare prognostische 
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factoren in de acute fase, maar een gedetailleerde voorspelling is tot op heden nog 
niet mogelijk. Onze modellen presteerden binnen deze THL categorieën duidelijk veel 
beter dan de LTHL modellen. Aangezien met de conventionele prognostische factoren 
(demografisch, klinisch en radiologisch van aard) tot op heden geen perfect 
voorspellend prognostisch model is gevonden - niet door ons maar ook niet door 
andere onderzoekers - pleiten onze bevindingen van de biomarker-studie ervoor dat 
deze verder onderzoek verdienen. 
Ten aanzien van het toekomstig onderzoek is een aantal ideeën te formuleren. Als het 
gaat om studies naar prognosestelling bij LTHL wordt het steeds duidelijker dat de 
GOSE, die ook wij gebruikten voor onze studies, niet de meest aangewezen 
uitkomstmaat is. Er dient daarnaast verder te worden gekeken naar andere potentiële 
prognostische factoren dan de traditionele variabelen die wij hebben gebruikt. 
Onderzoek dat overigens reeds plaatsvindt. Hierbij valt te denken aan studies naar 
meer patiëntgerelateerde factoren, bijvoorbeeld: de gezondheidstoestand of psychosociale 
omstandigheden van voor het ongeval. Voorts kunnen nieuwe beeldvormende technieken, 
waaronder de reguliere MRI-scan of de functionele MRI-scan (fMRI), meer inzicht 
geven in de opgelopen hersenschade dan de CT-scan en is hiervan mogelijk een hogere 
prognostische waarde te verwachten.
 Voor middelzwaar en ernstig THL is de ontwikkeling van prognostische modellen 
al ver gevorderd. Ook door middel van andere grote internationale studies zijn 
modellen geïntroduceerd. Helaas blijken alle prognostische modellen tot op heden 
niet foutloos. De traditionele demografische, klinische en radiologische variabelen 
hebben hun waarde in de prognosestelling bewezen, maar heel veel meer ruimte voor 
verbetering lijkt er hierin niet te verwachten. Het is hoog tijd dat er nu verder ook naar 
andere mogelijke voorspellende factoren wordt gekeken zoals biochemisch merk- 
stoffen (biomarkers) en naar genetische factoren die een rol kunnen spelen bij herstel 
na MTHL en ETHL. Ook, net als in LTHL, is het hier zinvol om de meer geavanceerde 
beeldvormende technieken op hun voorspellende waarde te onderzoeken. 
 Er is nog verder onderzoek nodig voordat prognostische modellen volledig in de 
dagelijkse kliniek kunnen worden gebruikt, zeker wat betreft beslissingen omtrent het 
staken van een behandeling. Het blijft tot slot belangrijk te beseffen dat er bij progno-
sestelling altijd sprake is van de berekening van een kans op een bepaalde uitkomst 
voor een individuele patiënt en er kan dus nooit absolute zekerheid worden gegeven. 
Daarnaast kent de kansberekening ook een bepaalde foutenmarge, hetgeen een extra 
component van onzekerheid toevoegt. Niettemin kunnen voor de prognosestelling bij 
een patiënt met middelzwaar of ernstig THL onze prognostische modellen - te 
raadplegen via www.tbi-prognosis.com - behulpzaam zijn. 
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Dankwoord
Promoveren doe je niet alleen, of beter nog, kún je niet alleen. Ik wil graag alle betrokkenen 
op gepaste, Tilburgse, wijze bedanken: “Dègge bedankt zèèt dè witte”. Meer woorden 
zijn eigenlijk ook niet nodig. En hoewel een goed verstaander aan een half woord genoeg 
heeft, toch die paar extra woorden van dank.
Mijn grootste dank gaat uit naar alle patiënten en hun familieleden zonder wie de 
onderzoeken uit dit proefschrift überhaupt nooit hadden kunnen worden uitgevoerd. 
Verder ben ik ook veel dank verschuldigd aan:
Mijn copromotor, dr. Pieter Vos, beste Pieter: jouw vertrouwen in mij (en je andere 
onderzoekers) was grenzeloos, ook al waren er wel eens momenten dat je twijfelde of 
‘het’ er ooit nog wel eens van zou komen (dé e-mail heb ik overigens nog steeds 
bewaard). Je gaf me de ruimte en een grote eigen verantwoordelijkheid. Naar ik hoop 
duurt onze samenwerking, ondanks mijn standplaats Groningen, nog vele jaren voort. 
We gaan in elk geval snel weer eens goed uit eten. Zal ik de wijn uitzoeken?
Mijn promotoren: professor dr. George Padberg en professor dr. George Borm. Beste 
professor Padberg: u stuurde me uiteindelijk naar Pieter Vos toen ik ‘verlegen zat’ om 
een promotieonderzoek. Ik kan hier en nu wel zeggen: dank daarvoor. Maar ook dank 
voor mijn opleiding tot neuroloog èn mijn promotie op een afdeling met een 
opleidings- en onderzoeksklimaat dat staat. Met name uw humor en de nimmer 
aflatende loyaliteit aan ‘uw’ neurologen in opleiding wil ik in het bijzonder nog 
noemen. Professor dr. George Borm, beste George: gelukkig hebben we niet gekozen 
voor statistiek op z’n ‘ janboerenfluitjes’. Fijn om met iemand te hebben gewerkt die 
nuchter en pragmatisch naar zijn eigen vak kan kijken en daarnaast dé statistiek helder 
wist over te brengen aan zijn qua kennis duidelijk te kort schietende promovendus en 
diens studenten.
Alle mede-auteurs van de artikelen die dit proefschrift maken tot wat het is geworden, 
en dan met name Tjemme Beems (helaas mag je het eindresultaat niet meemaken), 
Ton van der Vliet,  Arie van Vugt, Ronald Bartels, Astrid Hoedemaekers en Ramon 
Diaz-Arrastia: Dank voor de nuttige input, een positief kritische houding en gelukkig 
ook een compliment op z’n tijd.
Mijn collega ‘RUBICS’-onderzoeker Teuntje Andriessen, Teun! Wat moet ik zeggen na 
al die jaren? Gedeelde smart is halve smart? We vulden (vullen) elkaar prima aan: 
Jij MS Visio® en ik Photoshop® CMYK. Ik ben blij dat we samen zowel de diepe 
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onderzoek(er)sdalen zijn doorgekomen als ook gedeeld hebben in ‘grote’ triomfen. 
Veel succes met het afronden van jouw eigen proefschrift! Ook veel dank aan de 
 research-verpleegkundigen waar ik de afgelopen jaren mee heb samengewerkt: 
Jolanda Brauer, Manon de Hingh en Dick Drost.
De (toen nog) studenten die hebben meegewerkt aan de diverse onderzoeken: 
Janneke van Ekert, Amon Heijne, Lotje Vernooy, Peter Dieperink, Else Eleveld en Sadie 
Zwikker, jullie hulp en inspanning hebben mede geleid tot de totstandkoming van dit 
proefschrift. Veel succes met jullie eigen carrières!
Prof. dr. J.G. van der Hoeven, dr. R.H.M.A. Bartels en prof. dr. E.W. Steyerberg: dank dat 
u gedrieën als leden van de manuscriptcommissie heeft willen optreden.
Alle neurologen in opleiding waar ik Nijmegen mee heb samengewerkt: dank voor 
jullie collegialiteit en het plezier dat ik altijd (nou ja, vrijwel altijd) in mijn werk heb 
gehad maar ook tot ver daarbuiten heb beleefd (vooral de assistentenweekenden niet 
te vergeten!). Ik ben verder ook veel dank verschuldigd aan de stafleden Neurologie 
van het UMC St. Radboud en het Rijnstate ziekenhuis te Arnhem, van wie ik het vak 
heb mogen en kunnen afkijken.
Willemijn en Marieke: zeer veel dank voor de prachtige kaft, omdat het oog ook wat 
wil. Dames: het resultaat is prachtig geworden!
Collegae neurologen, in het bijzonder professor dr. Berry Kremer en dr. Joukje van der 
Naalt, en neurologen i.o. van het UMC Groningen: dank voor de soepele overgang 
Nijmegen - Groningen. Beste Joukje en Berry: fijn dat ik ruimte heb gekregen om mijn 
proefschrift af te ronden en dank voor de wijze coaching tijdens mijn eerste jaren als 
neuroloog. Vanzelfsprekend draag ik graag mijn steentje bij aan de inmiddels lange 
(sinds de jaren ‘70) ‘neurotrauma-traditie’ van het UMCG.
Arnoud Kappelle, Anja Gijtenbeek, Sandra Sprenger, Judith Jeuken en Pieter Wesseling: 
onder jullie bezielende leiding heb ik de eerste stappen gezet in de wereld die wetenschap 
heet. En dat is goed bevallen, zie hier het resultaat van een goed fundament.
Mijn paranimfen: het is erg prettig om jullie drieën aan mijn zijde te hebben. Titia, het 
beste kan ik maar het dankwoord uit jouw eigen proefschrift parafraseren: zondag 21 
augustus 1994 begon onze vriendschap met een legendarisch gesprek over een 
kermishorloge,1 ook ik hoop dat we het hier samen nog vele decennia over mogen 
hebben! Dat ik hier sta, heb ik natuurlijk ook aan jou en je altijd goed leesbare 
handschrift te danken. Maja, mijn grote voorbeeld op vele vlakken, maar vooral jouw 
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schrijverskunsten maakten mij geregeld jaloers, net als overigens de prijzen die jij op 
diverse congressen wist binnen te slepen. Ik hoop dat je (toch) bij mijn verdediging 
aanwezig kunt zijn. Bart, mijn allerbeste kennis: ‘Après nous le déluge!’ Toch? Gelukkig 
vond ik in jou ook een voorstander van archaïsch taalgebruik en iemand die niet vies is 
van enig cynisme en sarcasme op z’n tijd. Naast een prima collega, bleek je ook een 
uitstekend skileraar en kook ik nog geregeld volgens jouw recepten. Behalve 'Unagi', 
kan je me dat nog eens voordoen?
Familie en vrienden: dank voor het er ‘gewoon’ altijd zijn, voor deuren die altijd voor 
mij open staan. De geboden reflectie en relativering zijn erg goed voor mij (geweest). 
Nicol: van goede buur naar ‘verre’ vriend! Marije en Bianca dank voor jullie kritische 
blik ten aanzien van de tekst en inhoud van ‘mijn boekje’.
Baukje, Robert en Siem: Bedankt voor de niet af latende steun in en oprechte interesse 
voor alles wat ik doe. En niet te vergeten Robert: dank natuurlijk ook voor de mooie 
website: www.tbi-prognosis.com. Ik zal reclame voor je maken!
Willianne: een nieuwe liefde had zomaar slecht uit kunnen pakken voor de voortgang 
van het werk aan mijn proefschrift. Niets bleek minder waar: mede dankzij jouw 
‘strenge’ supervisie en steun bij die ‘laatste loodjes’ kwam er weer schot in de zaak. 
Wat ben ik wies met joe!
Pap en mam: Daarom. Dè gullie bedankt zèèt, enfin dat weten jullie wel.
- Bram
1 L.E.M. Niers, 2009, proefschrift Universiteit Utrecht, Probiotic bacteria for prevention of atopic diseases: 
Design and application, pg. 200. 
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Resume
Bram Jacobs was born on a hot summer night on August 25th, 1976, in Goirle, the 
Netherlands. After being raised in the always vibrant city of Tilburg, in 1994 he 
moved to Nijmegen to study Medicine at the Radboud University Nijmegen (at that 
time University of Nijmegen/ ‘Katholieke Universiteit Nijmegen’). In 2001 he received 
the university’s Student Award for his exceptional merits on behalf of the Nijmegen 
University.
 During his medical training he spent several months abroad for internships and 
research activities, successively in Egypt (Tanta), South-Africa (Pretoria) and Italy 
(Cesena and Bologna). His interest in both research and neurology was further 
stimulated throughout a research fellowship in the fields of neuro-oncology and 
neuropathology at the Radboud University Nijmegen Medical Centre (RUNMC).
 Bram received his medical degree in 2002 and in the same year he started his 
training in neurology at the Department of Neurology of the RUNMC (head: prof. dr. 
G.W.A.M. Padberg). He started his Ph.D. research in 2005, resulting in the current 
thesis on traumatic brain injury. The studies presented in this thesis were nominated 
three times for international awards. Unfortunately, Bram never had the pleasure of 
actually receiving one. He did obtain, however, several travel grants to present the 
results of his research at international conferences. 
 Almost throughout his entire training in neurology, Bram was board member 
and eventually chairman of the National Junior Doctors’ Association (LVAG). Amongst 
others he was member of a national committee on the improvement and modernisation 
of Dutch medical education, in line with the CanMEDS framework.
 At present, Bram is working as a neurologist at the Department of Neurology of 
the University Medical Centre Groningen (head: prof. dr. H.P.H. Kremer). Not surprisingly, 
his main areas of interest are neurotraumatology, emergency neurology and neurology 
at the intensive care unit.
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Het was op 25 augustus 1976, een warme zomernacht, dat Bram Jacobs het levenslicht 
zag in het Brabantse Goirle, Nederland. Na zijn opvoeding te hebben genoten in het 
altijd levendige Tilburg, vertrok hij in 1994 naar Nijmegen om Geneeskunde te 
studeren aan de Radboud Universiteit Nijmegen (toentertijd Katholieke Universiteit 
Nijmegen). In 2001 kreeg hij wegens uitzonderlijke verdiensten voor deze universiteit 
de Studentenonderscheiding.
 Tijdens zijn artsenopleiding bezocht hij, voor coschappen en een onderzoekstage, 
achtereenvolgens Egypte (Tanta), Zuid-Afrika (Pretoria) en Italië (Cesena en Bologna). 
Zijn interesse in de neurologie en het doen van onderzoek werd verder aangewakkerd 
gedurende een onderzoeksstage neuro-oncologie en neuropathologie aan het 
Universitair Medisch Centrum (UMC) St. Radboud te Nijmegen.
 Bram ontving zijn artsenbul in 2002 en begon nog in datzelfde jaar met zijn 
opleiding tot neuroloog op de Afdeling Neurologie van het UMC St. Radboud (hoofd 
en opleider: prof. dr. G.W.A.M. Padberg). In 2005 startte hij zijn promotieonderzoek 
dat uiteindelijk zou uitmonden in dit proefschrift over traumatisch hersenletsel. De 
onderzoeken die deel uit maken van dit proefschrift werden tot driemaal toe 
genomineerd voor een internationale onderscheiding. Helaas heeft Bram nooit het 
genoegen gehad er daadwerkelijk een te ontvangen. Wel heeft hij diverse reisbeurzen 
gekregen om de resultaten van zijn onderzoek op internationale congressen te 
presenteren.
 Vrijwel gedurende zijn gehele opleiding tot neuroloog, was Bram bestuurslid en 
uiteindelijk ook voorzitter van de Landelijke Vereniging voor Medisch Specialisten in 
Opleiding (voorheen Landelijke Vereniging voor Assistent-Geneeskundigen – LVAG). 
Hij was onder andere ook lid van een landelijke werkgroep met als taak het verbeteren 
en moderniseren van de Nederlandse specialistenopleidingen volgens het CanMEDS 
model.
 Tegenwoordig is Bram als neuroloog verbonden aan de Afdeling Neurologie van 
het Universitair Medisch Centrum Groningen (hoofd: prof. dr. H.P.H. Kremer). Zijn 
interesses omvatten, niet verrassend, de neurotraumatologie en neurologie op de 
spoedeisende hulp en intensive care.
